| 1 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 720).
|
| 2 |
ClinicalTrials.gov (NCT03684811) A Study of FT 2102 in Participants With Advanced Solid Tumors and Gliomas With an IDH1 Mutation. U.S. National Institutes of Health.
|
| 3 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 4 |
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell. 1991 Aug 23;66(4):663-74.
|
| 5 |
ClinicalTrials.gov (NCT04164901) Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO). U.S. National Institutes of Health.
|
| 6 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 7 |
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer. Ann Oncol. 2014 Jul;25(7):1346-55.
|
| 8 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 9 |
ClinicalTrials.gov (NCT00114309) 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma. U.S. National Institutes of Health.
|
| 10 |
Clinical pipeline report, company report or official report of Pherin Pharmaceuticals.
|
| 11 |
ClinicalTrials.gov (NCT04752813) A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB). U.S. National Institutes of Health.
|
| 12 |
ClinicalTrials.gov (NCT01290692) Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma. U.S. National Institutes of Health.
|
| 13 |
ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
|
| 14 |
ClinicalTrials.gov (NCT02713984) A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer
|
| 15 |
Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
|
| 16 |
ClinicalTrials.gov (NCT03252171) CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
|
| 17 |
Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55,900) in patients with recurrent malignant gliomas. Eur J Cancer. 1996 Apr;32A(4):636-40.
|
| 18 |
ClinicalTrials.gov (NCT00028158) Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer. U.S. National Institutes of Health.
|
| 19 |
ClinicalTrials.gov (NCT03566199) MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (PNOC015). U.S. National Institutes of Health.
|
| 20 |
ClinicalTrials.gov (NCT02331693) CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR
|
| 21 |
ClinicalTrials.gov (NCT02209376) Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma
|
| 22 |
ClinicalTrials.gov (NCT03638167) EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
|
| 23 |
ClinicalTrials.gov (NCT03500991) HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
|
| 24 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6057).
|
| 25 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 26 |
ClinicalTrials.gov (NCT04089449) A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas. U.S. National Institutes of Health.
|
| 27 |
Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656.
|
| 28 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013874)
|
| 29 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035804)
|
| 30 |
1'H-Indole-3'-Carbonyl-Thiazole-4-Carboxylic Acid Methyl Ester Blocked Human Glioma Cell Invasion via Aryl Hydrocarbon Receptor's Regulation of Cytoskeletal Contraction. Biomed Res Int. 2020 Oct 3;2020:2616930.
|
| 31 |
Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines. Br J Cancer. 2011 Feb 15;104(4):653-63.
|
| 32 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 33 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2402).
|
| 34 |
Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.Jpn J Cancer Res. 2001 Feb;92(2):211-9. doi: 10.1111/j.1349-7006.2001.tb01084.x.
|
| 35 |
Human glioblastomas overexpress ADAMTS-5 that degrades brevican.Acta Neuropathol. 2005 Sep;110(3):239-46. doi: 10.1007/s00401-005-1032-6. Epub 2005 Aug 30.
|
| 36 |
Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the beta 2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity.Biochem J. 1996 Sep 15;318 ( Pt 3)(Pt 3):1033-9. doi: 10.1042/bj3181033.
|
| 37 |
Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury.Cell Tissue Res. 2000 May;300(2):219-30. doi: 10.1007/s004410000184.
|
| 38 |
MicroRNA-625 inhibits the proliferation and increases the chemosensitivity of glioma by directly targeting AKT2.Am J Cancer Res. 2017 Sep 1;7(9):1835-1849. eCollection 2017.
|
| 39 |
High-throughput confirmation of differential display PCR results using reverse Northern blotting.J Neurosci Methods. 2003 Feb 15;123(1):47-54. doi: 10.1016/s0165-0270(02)00343-6.
|
| 40 |
Analysis of APCL, a brain-specific adenomatous polyposis coli homologue, for mutations and expression in brain tumors.Jpn J Cancer Res. 1999 Sep;90(9):982-6. doi: 10.1111/j.1349-7006.1999.tb00845.x.
|
| 41 |
Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas.Cancer Lett. 2015 Mar 28;358(2):220-231. doi: 10.1016/j.canlet.2014.12.044. Epub 2014 Dec 24.
|
| 42 |
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.J Biol Chem. 2005 Feb 4;280(5):3483-92. doi: 10.1074/jbc.M409906200. Epub 2004 Dec 16.
|
| 43 |
Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.Neuropeptides. 2010 Apr;44(2):177-85. doi: 10.1016/j.npep.2009.12.009. Epub 2010 Jan 18.
|
| 44 |
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray.Br J Cancer. 2003 May 6;88(9):1417-23. doi: 10.1038/sj.bjc.6600922.
|
| 45 |
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.Cancer Immunol Immunother. 2008 Jan;57(1):123-31. doi: 10.1007/s00262-007-0336-x. Epub 2007 May 24.
|
| 46 |
Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.Cancer Res. 2002 May 1;62(9):2592-9.
|
| 47 |
Suppression of chloride voltage-gated channel 3 expression increases sensitivity of human glioma U251 cells to cisplatin through lysosomal dysfunction.Oncol Lett. 2018 Jul;16(1):835-842. doi: 10.3892/ol.2018.8736. Epub 2018 May 18.
|
| 48 |
Expression of voltage-gated chloride channels in human glioma cells.J Neurosci. 2003 Jul 2;23(13):5572-82. doi: 10.1523/JNEUROSCI.23-13-05572.2003.
|
| 49 |
Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor.J Neurooncol. 1998 Aug;39(1):1-18. doi: 10.1023/a:1005901423332.
|
| 50 |
uPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cells.Stem Cell Res. 2014 May;12(3):716-29. doi: 10.1016/j.scr.2014.02.008. Epub 2014 Mar 12.
|
| 51 |
Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo.Nat Med. 1996 May;2(5):567-73. doi: 10.1038/nm0596-567.
|
| 52 |
Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' Outcome.Curr Cancer Drug Targets. 2019;19(3):210-221. doi: 10.2174/1568009618666180706165845.
|
| 53 |
Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.Eur Radiol. 2019 Jul;29(7):3467-3479. doi: 10.1007/s00330-019-06122-x. Epub 2019 Apr 10.
|
| 54 |
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.Nat Med. 2002 Aug;8(8):808-15. doi: 10.1038/nm735. Epub 2002 Jul 15.
|
| 55 |
Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.JCI Insight. 2019 Apr 4;4(7):e126140. doi: 10.1172/jci.insight.126140. eCollection 2019 Apr 4.
|
| 56 |
Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy.Blood. 1993 Aug 1;82(3):931-9.
|
| 57 |
Amplification and expression of a multidrug resistance gene in human glioma cell lines.J Neurosurg. 1990 Jan;72(1):96-101. doi: 10.3171/jns.1990.72.1.0096.
|
| 58 |
FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas.Front Oncol. 2019 Mar 13;9:103. doi: 10.3389/fonc.2019.00103. eCollection 2019.
|
| 59 |
18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence.Clin Nucl Med. 2020 Jan;45(1):e61-e62. doi: 10.1097/RLU.0000000000002668.
|
| 60 |
BCL-2-induced glioma cell invasiveness depends on furin-like proteases.J Neurochem. 2004 Dec;91(6):1275-83. doi: 10.1111/j.1471-4159.2004.02806.x.
|
| 61 |
Exposure to power frequency magnetic fields and X-rays induces GAP-43 gene expression in human glioma MO54 cells.Bioelectromagnetics. 2002 Dec;23(8):586-91. doi: 10.1002/bem.10057.
|
| 62 |
Posttranscriptional regulation of MRP/GS-X pump and gamma-glutamylcysteine synthetase expression by 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea and by cycloheximide in human glioma cells.Biochem Biophys Res Commun. 1997 Oct 9;239(1):51-6. doi: 10.1006/bbrc.1997.7423.
|
| 63 |
Cx43-Associated Secretome and Interactome Reveal Synergistic Mechanisms for Glioma Migration and MMP3 Activation.Front Neurosci. 2019 Mar 19;13:143. doi: 10.3389/fnins.2019.00143. eCollection 2019.
|
| 64 |
Inhibition of angiogenesis in human glioma cell lines by antisense RNA from the soluble guanylate cyclase genes, GUCY1A3 and GUCY1B3.Oncol Rep. 2004 Jul;12(1):47-52.
|
| 65 |
Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas.Acta Neuropathol. 1998 Oct;96(4):322-8. doi: 10.1007/s004010050901.
|
| 66 |
Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [(18)F]TFAHA.Sci Rep. 2019 Mar 5;9(1):3595. doi: 10.1038/s41598-019-40054-2.
|
| 67 |
The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC.Cancer Res. 1994 Sep 1;54(17):4760-3.
|
| 68 |
Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: a possible role in glioma cell proliferation and migration.Brain Res Mol Brain Res. 1996 Sep 5;41(1-2):1-7. doi: 10.1016/0169-328x(96)00058-7.
|
| 69 |
Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways.J Neurochem. 2003 Jan;84(2):222-32. doi: 10.1046/j.1471-4159.2003.01518.x.
|
| 70 |
Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo.Glia. 2003 Dec;44(3):296-301. doi: 10.1002/glia.10291.
|
| 71 |
A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma.Anticancer Drugs. 2008 Feb;19(2):133-42. doi: 10.1097/CAD.0b013e3282f24017.
|
| 72 |
Selective Uptake Into Drug Resistant Mammalian Cancer by Cell Penetrating Peptide-Mediated Delivery.Bioconjug Chem. 2018 Oct 17;29(10):3273-3284. doi: 10.1021/acs.bioconjchem.8b00429. Epub 2018 Oct 8.
|
| 73 |
Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas.Neurosci Lett. 2003 Jul 31;346(1-2):33-6. doi: 10.1016/s0304-3940(03)00562-7.
|
| 74 |
Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy.Drug Deliv. 2019 Dec;26(1):34-44. doi: 10.1080/10717544.2018.1534897.
|
| 75 |
The chicken lysozyme chromatin domain contains a second, widely expressed gene.Nucleic Acids Res. 2002 Jan 15;30(2):463-7. doi: 10.1093/nar/30.2.463.
|
| 76 |
Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells.J Neurochem. 2004 Sep;90(5):1156-62. doi: 10.1111/j.1471-4159.2004.02573.x.
|
| 77 |
DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma.EBioMedicine. 2019 Mar;41:185-199. doi: 10.1016/j.ebiom.2019.01.067. Epub 2019 Feb 14.
|
| 78 |
The reversal of MRP1 expression induced by low-frequency and low-intensity ultrasound and curcumin mediated by VEGF in brain glioma.Onco Targets Ther. 2019 May 13;12:3581-3593. doi: 10.2147/OTT.S195205. eCollection 2019.
|
| 79 |
The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase.Carcinogenesis. 2005 Dec;26(12):2069-77. doi: 10.1093/carcin/bgi183. Epub 2005 Jul 20.
|
| 80 |
Abnormal increase of miR-4262 promotes cell proliferation and migration by targeting large tumor suppressor 1 in gliomas.Pathol Res Pract. 2020 Feb;216(2):152778. doi: 10.1016/j.prp.2019.152778. Epub 2019 Dec 2.
|
| 81 |
Glioma migration can be blocked by nontoxic inhibitors of myosin II.Cancer Res. 1999 May 1;59(9):2076-82.
|
| 82 |
Expression of p120 nucleolar proliferating antigen in human gliomas and growth suppression of glioma cells by p120 ribozyme vector.Int J Oncol. 1999 Mar;14(3):417-24. doi: 10.3892/ijo.14.3.417.
|
| 83 |
Cloning and expression of a cDNA encoding a novel human neurotrophic factor.FEBS Lett. 1990 Jun 18;266(1-2):187-91. doi: 10.1016/0014-5793(90)81536-w.
|
| 84 |
Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.Nat Commun. 2018 Mar 13;9:16187. doi: 10.1038/ncomms16187.
|
| 85 |
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.Nat Genet. 2014 May;46(5):444-450. doi: 10.1038/ng.2938. Epub 2014 Apr 6.
|
| 86 |
Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors.J Mol Diagn. 2001 May;3(2):62-7. doi: 10.1016/S1525-1578(10)60653-8.
|
| 87 |
Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor.J Pharmacol Exp Ther. 1999 Feb;288(2):827-33.
|
| 88 |
Novel functional association of serine palmitoyltransferase subunit 1-A peptide in sphingolipid metabolism with cytochrome P4501A1 transactivation and proliferative capacity of the human Glioma LN18 brain tumor cell line.Int J Environ Res Public Health. 2006 Sep;3(3):252-61. doi: 10.3390/ijerph2006030030.
|
| 89 |
Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.Am J Pathol. 2002 Apr;160(4):1279-92. doi: 10.1016/S0002-9440(10)62555-2.
|
| 90 |
Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.Int J Oncol. 2005 Jan;26(1):159-67.
|
| 91 |
Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas.Brain Pathol. 2002 Apr;12(2):178-82. doi: 10.1111/j.1750-3639.2002.tb00432.x.
|
| 92 |
Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.Cancer Res. 1997 May 1;57(9):1673-7.
|
| 93 |
Elevated expression of DNA polymerase beta gene in glioma cell lines with acquired resistance to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea.Biochem Biophys Res Commun. 1996 Oct 14;227(2):558-63. doi: 10.1006/bbrc.1996.1545.
|
| 94 |
Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion.J Neurochem. 2005 Aug;94(4):970-9. doi: 10.1111/j.1471-4159.2005.03237.x.
|
| 95 |
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation.J Biol Chem. 2004 Jul 9;279(28):29004-12. doi: 10.1074/jbc.M403573200. Epub 2004 Apr 30.
|
| 96 |
Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion.Oncogene. 2005 Nov 24;24(53):7821-9. doi: 10.1038/sj.onc.1208909.
|
| 97 |
Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility.J Neuropathol Exp Neurol. 2004 Mar;63(3):210-22. doi: 10.1093/jnen/63.3.210.
|
| 98 |
Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors.Cancer Chemother Pharmacol. 1998;42(6):479-82. doi: 10.1007/s002800050848.
|
| 99 |
Evaluation of TNF-alpha/Bax gene therapy and radiation against C6 glioma xenografts.Technol Cancer Res Treat. 2003 Feb;2(1):41-50. doi: 10.1177/153303460300200106.
|
| 100 |
Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells.J Biol Chem. 1993 Nov 25;268(33):25068-74.
|
| 101 |
The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo.Cancer Res. 2005 Mar 1;65(5):1934-40. doi: 10.1158/0008-5472.CAN-04-3626.
|
| 102 |
Alteration of striatal dopaminergic function induced by glioma development: a microdialysis and immunohistological study in the rat striatum.Neurosci Lett. 2004 Jan 9;354(2):131-4. doi: 10.1016/j.neulet.2003.10.005.
|
| 103 |
Adrenergic activation of steroid 5alpha-reductase gene expression in rat C6 glioma cells: involvement of cyclic amp/protein kinase A-mediated signaling pathway.J Mol Neurosci. 2004;22(3):205-12. doi: 10.1385/JMN:22:3:205.
|
| 104 |
Steroidogenic acute regulatory protein expression in the normal human brain and intracranial tumors.Brain Res. 2003 Jul 18;978(1-2):245-9. doi: 10.1016/s0006-8993(03)02840-3.
|
| 105 |
Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice.Oncogene. 2005 Jun 2;24(24):3896-905. doi: 10.1038/sj.onc.1208553.
|
| 106 |
Expression of telomeric repeat binding factor-1 in astroglial brain tumors.Neurosurgery. 2005 Apr;56(4):802-10. doi: 10.1227/01.neu.0000156468.41461.6f.
|
| 107 |
Tenascin-cmediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in glioma.Cell Death Dis. 2019 Nov 21;10(12):879. doi: 10.1038/s41419-019-2102-3.
|
| 108 |
Epigenetics in high-grade astrocytomas: opportunities for prevention and detection of brain tumors.Ann N Y Acad Sci. 2003 Mar;983:232-42. doi: 10.1111/j.1749-6632.2003.tb05978.x.
|
| 109 |
Prognostic significance of CDC25B expression in gliomas.J Clin Pathol. 2006 Jul;59(7):725-8. doi: 10.1136/jcp.2005.029546.
|
| 110 |
Contactin is expressed in human astrocytic gliomas and mediates repulsive effects.Glia. 2006 Jan 1;53(1):1-12. doi: 10.1002/glia.20254.
|
| 111 |
DLK1: increased expression in gliomas and associated with oncogenic activities.Oncogene. 2006 Mar 23;25(13):1852-61. doi: 10.1038/sj.onc.1209219.
|
| 112 |
Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.Oncol Rep. 2006 Mar;15(3):595-601.
|
| 113 |
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1970-82. doi: 10.1158/1078-0432.CCR-05-2797.
|
| 114 |
Activity of lysosomal exoglycosidases in human gliomas.J Neurooncol. 2006 Dec;80(3):243-9. doi: 10.1007/s11060-006-9188-z. Epub 2006 May 19.
|
| 115 |
mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.Cancer Res. 2007 Dec 15;67(24):11712-20. doi: 10.1158/0008-5472.CAN-07-2223.
|
| 116 |
Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy.Antioxid Redox Signal. 2007 Sep;9(9):1449-56. doi: 10.1089/ars.2007.1673.
|
| 117 |
The pleiotropic roles of ADAM9 in the biology of solid tumors.Cell Mol Life Sci. 2018 Jul;75(13):2291-2301. doi: 10.1007/s00018-018-2796-x. Epub 2018 Mar 17.
|
| 118 |
Clinicopathological and prognostic significance of aberrant G protein-couple receptor 110 (GPR110) expression in gastric cancer.Pathol Res Pract. 2019 Mar;215(3):539-545. doi: 10.1016/j.prp.2018.12.004. Epub 2018 Dec 6.
|
| 119 |
Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.Oncotarget. 2017 May 16;8(20):33353-33364. doi: 10.18632/oncotarget.16495.
|
| 120 |
Differential Effects of Ang-2/VEGF-A Inhibiting Antibodies in Combination with Radio- or Chemotherapy in Glioma.Cancers (Basel). 2019 Mar 6;11(3):314. doi: 10.3390/cancers11030314.
|
| 121 |
A genetic variant in the APE1/Ref-1 gene promoter -141T/G may modulate risk of glioblastoma in a Chinese Han population.BMC Cancer. 2011 Mar 23;11:104. doi: 10.1186/1471-2407-11-104.
|
| 122 |
A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes.PLoS One. 2008 May 21;3(5):e2207. doi: 10.1371/journal.pone.0002207.
|
| 123 |
Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.Oncotarget. 2017 Feb 21;8(8):12695-12704. doi: 10.18632/oncotarget.8657.
|
| 124 |
Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approach.Histopathology. 2016 Aug;69(2):329-37. doi: 10.1111/his.12944. Epub 2016 Mar 21.
|
| 125 |
CD70, a novel target of CAR T-cell therapy for gliomas.Neuro Oncol. 2018 Jan 10;20(1):55-65. doi: 10.1093/neuonc/nox116.
|
| 126 |
Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.Mol Cancer. 2017 Jun 26;16(1):110. doi: 10.1186/s12943-017-0677-9.
|
| 127 |
Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction.BMC Cancer. 2016 Feb 8;16:72. doi: 10.1186/s12885-016-2118-3.
|
| 128 |
EGFL7 enhances surface expression of integrin (5)(1) to promote angiogenesis in malignant brain tumors.EMBO Mol Med. 2018 Sep;10(9):e8420. doi: 10.15252/emmm.201708420.
|
| 129 |
Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.Brain Res. 2018 Aug 1;1692:154-162. doi: 10.1016/j.brainres.2018.05.023. Epub 2018 May 18.
|
| 130 |
Imaging integrin (v)(3) positive glioma with a novel RGD dimer probe and the impact of antiangiogenic agent (Endostar) on its tumor uptake.Cancer Lett. 2013 Jul 10;335(1):75-80. doi: 10.1016/j.canlet.2013.01.053. Epub 2013 Feb 8.
|
| 131 |
FRK suppresses human glioma growth by inhibiting ITGB1/FAK signaling.Biochem Biophys Res Commun. 2019 Oct 1;517(4):588-595. doi: 10.1016/j.bbrc.2019.07.059. Epub 2019 Aug 5.
|
| 132 |
Overexpression of the Kininogen-1 inhibits proliferation and induces apoptosis of glioma cells.J Exp Clin Cancer Res. 2018 Aug 2;37(1):180. doi: 10.1186/s13046-018-0833-0.
|
| 133 |
LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/-catenin pathway and predicts poor survival of glioma patients.J Exp Clin Cancer Res. 2018 Sep 12;37(1):225. doi: 10.1186/s13046-018-0864-6.
|
| 134 |
The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.Int J Oncol. 2013 Mar;42(3):881-6. doi: 10.3892/ijo.2013.1773. Epub 2013 Jan 16.
|
| 135 |
A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma.J Exp Clin Cancer Res. 2019 Aug 20;38(1):366. doi: 10.1186/s13046-019-1341-6.
|
| 136 |
Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.Cancer Res. 2005 Nov 1;65(21):9843-50. doi: 10.1158/0008-5472.CAN-05-1842.
|
| 137 |
Regulation of glioma migration and invasion via modification of Rap2a activity by the ubiquitin ligase Nedd4-1.Oncol Rep. 2017 May;37(5):2565-2574. doi: 10.3892/or.2017.5572. Epub 2017 Apr 11.
|
| 138 |
Histone deacetylase SIRT6 inhibits glioma cell growth through down-regulating NOTCH3 expression.Acta Biochim Biophys Sin (Shanghai). 2018 Apr 1;50(4):417-424. doi: 10.1093/abbs/gmy019.
|
| 139 |
The Prognostic and Therapeutic Value of PD-L1 in Glioma.Front Pharmacol. 2019 Jan 9;9:1503. doi: 10.3389/fphar.2018.01503. eCollection 2018.
|
| 140 |
Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C- inhibitor as a potential prostate carcinoma therapeutic.Anticancer Drugs. 2019 Jan;30(1):65-71. doi: 10.1097/CAD.0000000000000694.
|
| 141 |
Long noncoding RNA LINC00515 promotes cell proliferation and inhibits apoptosis by sponging miR-16 and activating PRMT5 expression in human glioma.Onco Targets Ther. 2019 Apr 8;12:2595-2604. doi: 10.2147/OTT.S198087. eCollection 2019.
|
| 142 |
The p75 neurotrophin receptor enhances HIF-dependent signaling in glioma.Exp Cell Res. 2018 Oct 1;371(1):122-129. doi: 10.1016/j.yexcr.2018.08.002. Epub 2018 Aug 6.
|
| 143 |
RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells.Stem Cell Reports. 2017 Jan 10;8(1):125-139. doi: 10.1016/j.stemcr.2016.12.005.
|
| 144 |
Down-regulated microRNA-30b-3p inhibits proliferation, invasion and migration of glioma cells via inactivation of the AKT signaling pathway by up-regulating RECK.Biosci Rep. 2019 Aug 13;39(8):BSR20182226. doi: 10.1042/BSR20182226. Print 2019 Aug 30.
|
| 145 |
Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression.Onco Targets Ther. 2019 Nov 7;12:9407-9419. doi: 10.2147/OTT.S225678. eCollection 2019.
|
| 146 |
MiR-218 inhibits the tumorgenesis and proliferation of glioma cells by targeting Robo1.Cancer Biomark. 2016;16(3):309-17. doi: 10.3233/CBM-160568.
|
| 147 |
HOXC13-AS-miR-122-5p-SATB1-C-Myc feedback loop promotes migration, invasion and EMT process in glioma.Onco Targets Ther. 2019 Sep 2;12:7165-7173. doi: 10.2147/OTT.S220027. eCollection 2019.
|
| 148 |
QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.Cell Oncol (Dordr). 2019 Dec;42(6):801-813. doi: 10.1007/s13402-019-00463-x. Epub 2019 Jul 10.
|
| 149 |
Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin. FEBS Lett. 2006 Jun 26;580(15):3746-52. doi: 10.1016/j.febslet.2006.05.071. Epub 2006 Jun 9.
|
| 150 |
Mutant Isocitrate Dehydrogenase 1 Disrupts PKM2--Catenin-BRG1 Transcriptional Network-Driven CD47 Expression.Mol Cell Biol. 2018 Apr 16;38(9):e00001-18. doi: 10.1128/MCB.00001-18. Print 2018 May 1.
|
| 151 |
Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase.Cell Prolif. 2012 Apr;45(2):167-75. doi: 10.1111/j.1365-2184.2012.00807.x. Epub 2012 Jan 30.
|
| 152 |
Overexpression of Transforming Acidic Coiled CoilContaining Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma.Int J Mol Sci. 2017 Mar 4;18(3):235. doi: 10.3390/ijms18030235.
|
| 153 |
Cumulative evidence for relationships between multiple variants in the VTI1A and TCF7L2 genes and cancer incidence.Int J Cancer. 2018 Feb 1;142(3):498-513. doi: 10.1002/ijc.31074. Epub 2017 Nov 7.
|
| 154 |
Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma.Stem Cells Dev. 2013 Jul 1;22(13):1870-82. doi: 10.1089/scd.2012.0529. Epub 2013 Mar 26.
|
| 155 |
IRGM promotes glioma M2 macrophage polarization through p62/TRAF6/NF-B pathway mediated IL-8 production.Cell Biol Int. 2019 Feb;43(2):125-135. doi: 10.1002/cbin.11061.
|
| 156 |
A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo.Oncol Rep. 2014 Apr;31(4):1573-80. doi: 10.3892/or.2014.3012. Epub 2014 Feb 4.
|
| 157 |
Downregulation of ABCG2 protein inhibits migration and invasion in U251 glioma stem cells.Neuroreport. 2014 May 28;25(8):625-32. doi: 10.1097/WNR.0000000000000161.
|
| 158 |
Trifluoperazine prevents FOXO1 nuclear excretion and reverses doxorubicin-resistance in the SHG44/DOX drug-resistant glioma cell line.Int J Mol Med. 2018 Dec;42(6):3300-3308. doi: 10.3892/ijmm.2018.3885. Epub 2018 Sep 18.
|
| 159 |
ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. Cancer Res. 2011 May 1;71(9):3410-21.
|
| 160 |
MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma.Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819854132. doi: 10.1177/1533033819854132.
|
| 161 |
Expression and function of ABCG2 and XIAP in glioblastomas.J Neurooncol. 2017 May;133(1):47-57. doi: 10.1007/s11060-017-2422-z. Epub 2017 Apr 21.
|
| 162 |
An Adult Drosophila Glioma Model for Studying Pathometabolic Pathways of Gliomagenesis.Mol Neurobiol. 2019 Jun;56(6):4589-4599. doi: 10.1007/s12035-018-1392-2. Epub 2018 Oct 24.
|
| 163 |
Possible association between polymorphisms of human vascular endothelial growth factor A gene and susceptibility to glioma in a Chinese population.Int J Cancer. 2011 Jan 1;128(1):166-75. doi: 10.1002/ijc.25306.
|
| 164 |
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.Nat Genet. 2014 May;46(5):451-6. doi: 10.1038/ng.2936. Epub 2014 Apr 6.
|
| 165 |
Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma.Biomed Pharmacother. 2018 Feb;98:440-445. doi: 10.1016/j.biopha.2017.12.039. Epub 2017 Dec 27.
|
| 166 |
ADAM17 promotes glioma cell malignant phenotype.Mol Carcinog. 2012 Feb;51(2):150-64. doi: 10.1002/mc.20772. Epub 2011 Apr 7.
|
| 167 |
Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1.Oncotarget. 2014 Jun 30;5(12):4295-304. doi: 10.18632/oncotarget.2009.
|
| 168 |
Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers.Front Oncol. 2019 Feb 25;9:96. doi: 10.3389/fonc.2019.00096. eCollection 2019.
|
| 169 |
Adenosine deaminase and adenosine kinase expression in human glioma and their correlation with gliomaassociated epilepsy.Mol Med Rep. 2015 Nov;12(5):6509-16. doi: 10.3892/mmr.2015.4285. Epub 2015 Sep 2.
|
| 170 |
Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy.Neurochem Res. 2016 Jul;41(7):1774-83. doi: 10.1007/s11064-016-1893-1. Epub 2016 Apr 2.
|
| 171 |
Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.Hum Pathol. 2016 Dec;58:105-112. doi: 10.1016/j.humpath.2016.07.034. Epub 2016 Aug 27.
|
| 172 |
Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.J Pathol. 2013 Jul;230(3):310-21. doi: 10.1002/path.4192.
|
| 173 |
Correction to: inhibition of p38 MAPK activity leads to cell type-specific effects on the molecular circadian clock and time-dependent reduction of glioma cell invasiveness.BMC Cancer. 2019 Jan 23;19(1):101. doi: 10.1186/s12885-018-5238-0.
|
| 174 |
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.Nat Genet. 2017 May;49(5):789-794. doi: 10.1038/ng.3823. Epub 2017 Mar 27.
|
| 175 |
The role of anaplastic lymphoma kinase in pediatric cancers.Cancer Sci. 2017 Oct;108(10):1913-1920. doi: 10.1111/cas.13333. Epub 2017 Aug 24.
|
| 176 |
Angiopep-2-Conjugated "Core-Shell" Hybrid Nanovehicles for Targeted and pH-Triggered Delivery of Arsenic Trioxide into Glioma.Mol Pharm. 2019 Feb 4;16(2):786-797. doi: 10.1021/acs.molpharmaceut.8b01056. Epub 2019 Jan 24.
|
| 177 |
Suppression of Angiotensin-(1-7) on the Disruption of Blood-Brain Barrier in Rat of Brain Glioma.Pathol Oncol Res. 2019 Jan;25(1):429-435. doi: 10.1007/s12253-018-0471-z. Epub 2018 Sep 18.
|
| 178 |
Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor-B signaling pathway.Mol Med Rep. 2014 Mar;9(3):1068-74. doi: 10.3892/mmr.2014.1888. Epub 2014 Jan 8.
|
| 179 |
Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma.J Pathol. 2018 Jun;245(2):160-171. doi: 10.1002/path.5062. Epub 2018 Apr 2.
|
| 180 |
AnnexinA2 regulates glioma cell proliferation through the STAT3cyclinD1 pathway.Oncol Rep. 2019 Jul;42(1):399-413. doi: 10.3892/or.2019.7155. Epub 2019 May 9.
|
| 181 |
Enhanced Proapoptotic Effects of Water Dispersed Complexes of 4-Thiazolidinone-Based Chemotherapeutics with a PEG-Containing Polymeric Nanocarrier.Nanoscale Res Lett. 2019 Apr 23;14(1):140. doi: 10.1186/s11671-019-2945-7.
|
| 182 |
Radiation-Induced Changes in Tumor Vessels and Microenvironment Contribute to Therapeutic Resistance in Glioblastoma.Front Oncol. 2019 Nov 15;9:1259. doi: 10.3389/fonc.2019.01259. eCollection 2019.
|
| 183 |
AQP9 expression in glioblastoma multiforme tumors is limited to a small population of astrocytic cells and CD15(+)/CalB(+) leukocytes.PLoS One. 2013 Sep 25;8(9):e75764. doi: 10.1371/journal.pone.0075764. eCollection 2013.
|
| 184 |
Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo.Oncogene. 2011 Mar 17;30(11):1341-50. doi: 10.1038/onc.2010.513. Epub 2010 Nov 8.
|
| 185 |
ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL.BMC Cancer. 2018 May 29;18(1):599. doi: 10.1186/s12885-018-4517-0.
|
| 186 |
Integration of gene expression and methylation to unravel biological networks in glioblastoma patients.Genet Epidemiol. 2017 Feb;41(2):136-144. doi: 10.1002/gepi.22028. Epub 2016 Dec 26.
|
| 187 |
Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.Int J Cancer. 2014 Mar 15;134(6):1300-10. doi: 10.1002/ijc.28465. Epub 2013 Sep 30.
|
| 188 |
Overexpression of miR-1283 Inhibits Cell Proliferation and Invasion of Glioma Cells by Targeting ATF4.Oncol Res. 2019 Feb 21;27(3):325-334. doi: 10.3727/096504018X15251282086836. Epub 2018 May 1.
|
| 189 |
Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK.Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):E435-44. doi: 10.1073/pnas.1311121111. Epub 2014 Jan 13.
|
| 190 |
The sodium pump 1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway.Cell Biol Toxicol. 2019 Dec;35(6):521-539. doi: 10.1007/s10565-019-09462-y. Epub 2019 Feb 9.
|
| 191 |
Chk2 down-regulation by promoter hypermethylation in human bulk gliomas.Life Sci. 2010 Jan 30;86(5-6):185-91. doi: 10.1016/j.lfs.2009.11.023. Epub 2009 Dec 5.
|
| 192 |
Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.Pathol Res Pract. 2019 Nov;215(11):152617. doi: 10.1016/j.prp.2019.152617. Epub 2019 Aug 23.
|
| 193 |
Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma.CNS Neurosci Ther. 2020 Jul;26(7):777. doi: 10.1111/cns.13227. Epub 2019 Oct 2.
|
| 194 |
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.Nat Med. 2013 Jul;19(7):901-908. doi: 10.1038/nm.3217. Epub 2013 Jun 23.
|
| 195 |
Knockdown of BCL6 Inhibited Malignant Phenotype and Enhanced Sensitivity of Glioblastoma Cells to TMZ through AKT Pathway.Biomed Res Int. 2018 Oct 18;2018:6953506. doi: 10.1155/2018/6953506. eCollection 2018.
|
| 196 |
Targetome Analysis Revealed Involvement of MiR-126 in Neurotrophin Signaling Pathway: A Possible Role in Prevention of Glioma Development.Cell J. 2018 Jul;20(2):150-156. doi: 10.22074/cellj.2018.4901. Epub 2018 Mar 18.
|
| 197 |
-catenin regulates effects of miR-24 on the viability and autophagy of glioma cells.Exp Ther Med. 2019 Aug;18(2):1285-1290. doi: 10.3892/etm.2019.7680. Epub 2019 Jun 18.
|
| 198 |
Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization.Cancer Sci. 2018 Jul;109(7):2199-2210. doi: 10.1111/cas.13646. Epub 2018 Jun 28.
|
| 199 |
Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma.Neoplasia. 2017 Apr;19(4):261-270. doi: 10.1016/j.neo.2017.01.006. Epub 2017 Mar 7.
|
| 200 |
Laminin associated with BMP7 as potential secondary astrocytic glioma fiber differentiation targets.Eur Rev Med Pharmacol Sci. 2017 Aug;21(16):3611-3616.
|
| 201 |
Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.Clin Cancer Res. 2018 Jan 15;24(2):383-394. doi: 10.1158/1078-0432.CCR-17-1529. Epub 2017 Dec 5.
|
| 202 |
Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma.J Neurol. 2020 Mar;267(3):783-790. doi: 10.1007/s00415-019-09575-8. Epub 2019 Nov 21.
|
| 203 |
Disturbing miR-182 and -381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4.PLoS One. 2014 Jan 3;9(1):e84146. doi: 10.1371/journal.pone.0084146. eCollection 2014.
|
| 204 |
The treatment effects and the underlying mechanism of B cell translocation gene 1 on the oncogenesis of brain glioma.J Cell Biochem. 2019 Aug;120(8):13310-13320. doi: 10.1002/jcb.28605. Epub 2019 Mar 27.
|
| 205 |
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype.Front Mol Neurosci. 2019 Jan 24;12:2. doi: 10.3389/fnmol.2019.00002. eCollection 2019.
|
| 206 |
RETRACTED: Serine/threonine kinase BUB1 promotes proliferation and radio-resistance in glioblastoma.Pathol Res Pract. 2019 Aug;215(8):152508. doi: 10.1016/j.prp.2019.152508. Epub 2019 Jun 20.
|
| 207 |
A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma.J Transl Med. 2017 Oct 18;15(1):210. doi: 10.1186/s12967-017-1312-7.
|
| 208 |
Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase CA2 Gene as Resistance Factor.Cancers (Basel). 2019 Jun 30;11(7):921. doi: 10.3390/cancers11070921.
|
| 209 |
Targeting CAIX with [(64)Cu]XYIMSR-06 Small Molecular Radiotracer Enables Noninvasive PET Imaging of Malignant Glioma in U87 MG Tumor Cell Xenograft Mice.Mol Pharm. 2019 Apr 1;16(4):1532-1540. doi: 10.1021/acs.molpharmaceut.8b01210. Epub 2019 Mar 12.
|
| 210 |
CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.Mol Carcinog. 2017 Mar;56(3):945-959. doi: 10.1002/mc.22548. Epub 2016 Sep 22.
|
| 211 |
Loss-of-Function Mutations in Calcitonin Receptor (CALCR) Identify Highly Aggressive Glioblastoma with Poor Outcome.Clin Cancer Res. 2018 Mar 15;24(6):1448-1458. doi: 10.1158/1078-0432.CCR-17-1901. Epub 2017 Dec 20.
|
| 212 |
Arginylated Calreticulin Increases Apoptotic Response Induced by Bortezomib in Glioma Cells.Mol Neurobiol. 2019 Mar;56(3):1653-1664. doi: 10.1007/s12035-018-1182-x. Epub 2018 Jun 18.
|
| 213 |
CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas.CNS Neurosci Ther. 2016 Jun;22(6):518-24. doi: 10.1111/cns.12531. Epub 2016 Mar 25.
|
| 214 |
microRNA-149 targets caspase-2 in glioma progression.Oncotarget. 2016 May 3;7(18):26388-99. doi: 10.18632/oncotarget.8506.
|
| 215 |
Shuttling SLC2A4RG is regulated by 14-3-3 to modulate cell survival via caspase-3 and caspase-6 in human glioma.EBioMedicine. 2019 Feb;40:163-175. doi: 10.1016/j.ebiom.2019.01.030. Epub 2019 Jan 25.
|
| 216 |
MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.CNS Neurosci Ther. 2018 May;24(5):369-380. doi: 10.1111/cns.12785. Epub 2018 Jan 5.
|
| 217 |
From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D?all-trans retinoic acid + Temozolomide combination in treatment of GBM.Metab Brain Dis. 2019 Jun;34(3):687-704. doi: 10.1007/s11011-019-00412-5. Epub 2019 Apr 1.
|
| 218 |
Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.Tumour Biol. 2015 Dec;36(12):9621-30. doi: 10.1007/s13277-015-3720-8. Epub 2015 Jul 6.
|
| 219 |
Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma.Oncotarget. 2017 Aug 24;8(55):93580-93592. doi: 10.18632/oncotarget.20525. eCollection 2017 Nov 7.
|
| 220 |
Long noncoding RNA TPT1-AS1 downregulates the microRNA-770-5p expression to inhibit glioma cell autophagy and promote proliferation through STMN1 upregulation.J Cell Physiol. 2020 Apr;235(4):3679-3689. doi: 10.1002/jcp.29262. Epub 2019 Oct 21.
|
| 221 |
PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma.Sci Rep. 2017 Aug 7;7(1):7391. doi: 10.1038/s41598-017-07745-0.
|
| 222 |
Proteasome mediated degradation of CDC25C and Cyclin B1 in Demethoxycurcumin treated human glioma U87 MG cells to trigger G2/M cell cycle arrest.Toxicol Appl Pharmacol. 2018 Oct 1;356:76-89. doi: 10.1016/j.taap.2018.07.012. Epub 2018 Aug 4.
|
| 223 |
MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.Anticancer Drugs. 2019 Jan;30(1):81-88. doi: 10.1097/CAD.0000000000000700.
|
| 224 |
CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2.Oncogene. 2019 Feb;38(8):1183-1199. doi: 10.1038/s41388-018-0515-6. Epub 2018 Sep 26.
|
| 225 |
T11TS repress gliomagenic apoptosis of bone marrow hematopoietic stem cells.J Cell Physiol. 2018 Jan;233(1):269-290. doi: 10.1002/jcp.25874. Epub 2017 Mar 24.
|
| 226 |
Reduction of CD200 expression in glioma cells enhances microglia activation and tumor growth.J Neurosci Res. 2016 Dec;94(12):1460-1471. doi: 10.1002/jnr.23922. Epub 2016 Sep 15.
|
| 227 |
Heparanase promotes glioma progression via enhancing CD24 expression.Int J Cancer. 2019 Sep 15;145(6):1596-1608. doi: 10.1002/ijc.32375. Epub 2019 May 14.
|
| 228 |
B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma.Lab Invest. 2019 Jul;99(8):1117-1129. doi: 10.1038/s41374-019-0238-5. Epub 2019 Mar 26.
|
| 229 |
Monitoring in real time the effect of TLX overexpression on proliferation and migration of C6 cells.Neoplasma. 2017;64(1):48-55. doi: 10.4149/neo_2017_106.
|
| 230 |
MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas.Brain Pathol. 2015 Jul;25(4):491-504. doi: 10.1111/bpa.12194. Epub 2014 Nov 20.
|
| 231 |
Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.Tumour Biol. 2014 May;35(5):4411-7. doi: 10.1007/s13277-013-1580-7. Epub 2014 Jan 10.
|
| 232 |
Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion-associated candidate genes.Neuropathol Appl Neurobiol. 2012 Apr;38(2):201-12. doi: 10.1111/j.1365-2990.2011.01207.x.
|
| 233 |
CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastoma.Oncol Lett. 2018 May;15(5):7415-7422. doi: 10.3892/ol.2018.8227. Epub 2018 Mar 9.
|
| 234 |
IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma.Oncogene. 2019 Mar;38(11):1815-1831. doi: 10.1038/s41388-018-0525-4. Epub 2018 Oct 27.
|
| 235 |
Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway.J Cell Biochem. 2019 Dec;120(12):19784-19795. doi: 10.1002/jcb.29284. Epub 2019 Jul 26.
|
| 236 |
Histone deacetylase HDAC4 promotes the proliferation and invasion of glioma cells.Int J Oncol. 2018 Dec;53(6):2758-2768. doi: 10.3892/ijo.2018.4564. Epub 2018 Sep 18.
|
| 237 |
Insilico analysis identified miRNAbased therapeutic agents against glioblastoma multiforme.Oncol Rep. 2019 Apr;41(4):2194-2208. doi: 10.3892/or.2019.7022. Epub 2019 Feb 19.
|
| 238 |
CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo.Cancer Manag Res. 2018 Nov 15;10:5747-5758. doi: 10.2147/CMAR.S183696. eCollection 2018.
|
| 239 |
MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma.Cancer Cell Int. 2018 Dec 3;18:195. doi: 10.1186/s12935-018-0694-9. eCollection 2018.
|
| 240 |
miR-25 promotes glioma cell proliferation by targeting CDKN1C.Biomed Pharmacother. 2015 Apr;71:7-14. doi: 10.1016/j.biopha.2015.02.005. Epub 2015 Feb 19.
|
| 241 |
A scale-space method for detecting recurrent DNA copy number changes with analytical false discovery rate control.Nucleic Acids Res. 2013 May;41(9):e100. doi: 10.1093/nar/gkt155. Epub 2013 Mar 8.
|
| 242 |
Abnormal expression of circulating and tumor-infiltrating carcinoembryonic antigen-related cell adhesion molecule 1 in patients with glioma.Oncol Lett. 2018 Mar;15(3):3496-3503. doi: 10.3892/ol.2018.7786. Epub 2018 Jan 12.
|
| 243 |
Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
|
| 244 |
Imaging and Tissue Biomarkers of Choline Metabolism in Diffuse Adult Glioma: 18F-Fluoromethylcholine PET/CT, Magnetic Resonance Spectroscopy, and Choline Kinase .Cancers (Basel). 2019 Dec 7;11(12):1969. doi: 10.3390/cancers11121969.
|
| 245 |
Lentivirusmediated knockdown of chondroitin polymerizing factor inhibits glioma cell growth invitro.Oncol Rep. 2017 Aug;38(2):1149-1155. doi: 10.3892/or.2017.5731. Epub 2017 Jun 19.
|
| 246 |
Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas.J Exp Clin Cancer Res. 2012 May 11;31(1):44. doi: 10.1186/1756-9966-31-44.
|
| 247 |
Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance.J Neurochem. 2017 Aug;142(4):574-588. doi: 10.1111/jnc.14096. Epub 2017 Jul 7.
|
| 248 |
Hypomethylation of CNTFR is associated with proliferation and poor prognosis in lower grade gliomas.Sci Rep. 2017 Aug 1;7(1):7079. doi: 10.1038/s41598-017-07124-9.
|
| 249 |
A novel molecular agent for glioma angiogenesis imaging.Nucl Med Commun. 2017 Nov;38(11):919-926. doi: 10.1097/MNM.0000000000000735.
|
| 250 |
Jab1 promotes glioma cell proliferation by regulating Siah1/-catenin pathway.J Neurooncol. 2017 Jan;131(1):31-39. doi: 10.1007/s11060-016-2279-6. Epub 2016 Sep 17.
|
| 251 |
Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.Biochem Biophys Res Commun. 2019 Jan 22;508(4):1074-1081. doi: 10.1016/j.bbrc.2018.12.050. Epub 2018 Dec 13.
|
| 252 |
Human corticotrophin releasing factor inhibits cell proliferation and promotes apoptosis through upregulation of tumor protein p53 in human glioma.Oncol Lett. 2018 Jun;15(6):8378-8386. doi: 10.3892/ol.2018.8406. Epub 2018 Apr 2.
|
| 253 |
Deregulated expression of cry1 and cry2 in human gliomas.Asian Pac J Cancer Prev. 2012;13(11):5725-8. doi: 10.7314/apjcp.2012.13.11.5725.
|
| 254 |
Aberrant rhythmic expression of cryptochrome2 regulates the radiosensitivity of rat gliomas.Oncotarget. 2017 Sep 12;8(44):77809-77818. doi: 10.18632/oncotarget.20835. eCollection 2017 Sep 29.
|
| 255 |
MiR-532-5p acts as a tumor suppressor and inhibits glioma cell proliferation by targeting CSF1.Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8964-8970. doi: 10.26355/eurrev_201910_19295.
|
| 256 |
Increased invasive phenotype of CSF-1R expression in glioma cells via the ERK1/2 signaling pathway.Cancer Gene Ther. 2019 May;26(5-6):136-144. doi: 10.1038/s41417-018-0053-y. Epub 2018 Oct 26.
|
| 257 |
SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions.Mol Cancer Res. 2004 Nov;2(11):595-605.
|
| 258 |
CSPG4 Shows Promise for Glioblastoma CAR T Therapy.Cancer Discov. 2018 May;8(5):524-525. doi: 10.1158/2159-8290.CD-NB2018-032. Epub 2018 Mar 14.
|
| 259 |
NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma.Cancer Immunol Immunother. 2018 Feb;67(2):237-246. doi: 10.1007/s00262-017-2066-z. Epub 2017 Oct 20.
|
| 260 |
Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion.PLoS One. 2012;7(9):e45910. doi: 10.1371/journal.pone.0045910. Epub 2012 Sep 28.
|
| 261 |
Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression.Semin Cancer Biol. 2015 Dec;35:71-84. doi: 10.1016/j.semcancer.2015.08.010. Epub 2015 Aug 29.
|
| 262 |
Cathepsin L promotes ionizing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3/CUX1 pathway.Cell Signal. 2018 Apr;44:62-71. doi: 10.1016/j.cellsig.2018.01.012. Epub 2018 Jan 10.
|
| 263 |
The Role of CXCR3 in Neurological Diseases.Curr Neuropharmacol. 2019;17(2):142-150. doi: 10.2174/1570159X15666171109161140.
|
| 264 |
CYP2C9 polymorphisms in human tumors. Anticancer Res. 2006 Jan-Feb;26(1A):299-305.
|
| 265 |
Berberine Induces CYP2J2 Expression in Human U251 Glioma Cells via Regulation of Peroxisome Proliferator-Activated Receptor Alpha.Pharmacology. 2020;105(5-6):360-368. doi: 10.1159/000503884. Epub 2019 Oct 31.
|
| 266 |
Daam2 driven degradation of VHL promotes gliomagenesis. Elife. 2017 Oct 20;6. pii: e31926.
|
| 267 |
D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate.Cancer Gene Ther. 2012 Jan;19(1):1-18. doi: 10.1038/cgt.2011.59. Epub 2011 Sep 16.
|
| 268 |
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma.Br J Cancer. 2019 Mar;120(5):481-487. doi: 10.1038/s41416-018-0368-3. Epub 2019 Feb 12.
|
| 269 |
Identification of expressed genes characterizing long-term survival in malignant glioma patients.Oncogene. 2006 Sep 28;25(44):5994-6002. doi: 10.1038/sj.onc.1209585. Epub 2006 May 1.
|
| 270 |
Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.J Neurooncol. 2017 Jun;133(2):297-307. doi: 10.1007/s11060-017-2457-1. Epub 2017 May 29.
|
| 271 |
miR-517a is up-regulated in glioma and promotes glioma tumorigenesis in vitro and in vivo.Biosci Rep. 2019 May 2;39(5):BSR20181196. doi: 10.1042/BSR20181196. Print 2019 May 31.
|
| 272 |
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma.Clin Cancer Res. 2019 Feb 15;25(4):1261-1271. doi: 10.1158/1078-0432.CCR-18-2312. Epub 2018 Nov 5.
|
| 273 |
TMZ regulates GBM stemness via MMP14-DLL4-Notch3 pathway.Int J Cancer. 2020 Apr 15;146(8):2218-2228. doi: 10.1002/ijc.32636. Epub 2019 Oct 1.
|
| 274 |
A genomics approach identifies selective effects of trans-resveratrol in cerebral cortex neuron and glia gene expression.PLoS One. 2017 Apr 25;12(4):e0176067. doi: 10.1371/journal.pone.0176067. eCollection 2017.
|
| 275 |
Dynamin 2 mediates PDGFR-SHP-2-promoted glioblastoma growth and invasion.Oncogene. 2012 May 24;31(21):2691-702. doi: 10.1038/onc.2011.436. Epub 2011 Sep 26.
|
| 276 |
Targeted therapy of intracranial glioma model mice with curcumin nanoliposomes.Int J Nanomedicine. 2018 Mar 15;13:1601-1610. doi: 10.2147/IJN.S157019. eCollection 2018.
|
| 277 |
Genotype-based gene signature of glioma risk.Neuro Oncol. 2017 Jul 1;19(7):940-950. doi: 10.1093/neuonc/now288.
|
| 278 |
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response.Oncogenesis. 2017 Dec 14;6(12):401. doi: 10.1038/s41389-017-0003-9.
|
| 279 |
Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.J Clin Invest. 2013 Jun;123(6):2475-87. doi: 10.1172/JCI63623. Epub 2013 May 1.
|
| 280 |
Regulation of Glioma Cells Migration by DYRK2.Neurochem Res. 2017 Nov;42(11):3093-3102. doi: 10.1007/s11064-017-2345-2. Epub 2017 Jul 4.
|
| 281 |
Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1.Gene. 2019 Feb 20;686:1-7. doi: 10.1016/j.gene.2018.10.065. Epub 2018 Oct 23.
|
| 282 |
Long noncoding RNA FLVCR1-AS1 aggravates biological behaviors of glioma cells via targeting miR-4731-5p/E2F2 axis.Biochem Biophys Res Commun. 2020 Jan 15;521(3):716-720. doi: 10.1016/j.bbrc.2019.10.106. Epub 2019 Nov 5.
|
| 283 |
Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.J Cell Physiol. 2019 Sep;234(9):15496-15509. doi: 10.1002/jcp.28197. Epub 2019 Jan 28.
|
| 284 |
Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.PLoS One. 2013;8(4):e60930. doi: 10.1371/journal.pone.0060930. Epub 2013 Apr 5.
|
| 285 |
Inhibition of eIF4F complex loading inhibits the survival of malignant glioma.Oncol Rep. 2018 Oct;40(4):2399-2407. doi: 10.3892/or.2018.6587. Epub 2018 Jul 20.
|
| 286 |
FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.J Natl Cancer Inst. 2015 May 13;107(8):djv137. doi: 10.1093/jnci/djv137. Print 2015 Aug.
|
| 287 |
Hypoxia-inducible factor 2: a novel target in gliomas.Future Med Chem. 2018 Sep 1;10(18):2227-2236.
|
| 288 |
Ephs and Ephrins in malignant gliomas.Growth Factors. 2014 Dec;32(6):190-201. doi: 10.3109/08977194.2014.985787. Epub 2014 Nov 24.
|
| 289 |
N-Glycosylation of Extracellular Vesicles from HEK-293 and Glioma Cell Lines.Anal Chem. 2018 Jul 3;90(13):7871-7879. doi: 10.1021/acs.analchem.7b05455. Epub 2018 Jun 19.
|
| 290 |
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.Cancer Res. 2009 Feb 1;69(3):836-44. doi: 10.1158/0008-5472.CAN-08-2590. Epub 2009 Jan 27.
|
| 291 |
miR-10a controls glioma migration and invasion through regulating epithelial-mesenchymal transition via EphA8.FEBS Lett. 2015 Mar 12;589(6):756-65. doi: 10.1016/j.febslet.2015.02.005. Epub 2015 Feb 12.
|
| 292 |
Ligand-dependent EphB4 activation serves as an anchoring signal in glioma cells.Cancer Lett. 2019 May 1;449:56-65. doi: 10.1016/j.canlet.2019.02.021. Epub 2019 Feb 15.
|
| 293 |
JAK-2 V617F mutation increases heparanase procoagulant activity.Thromb Haemost. 2016 Jan;115(1):73-80. doi: 10.1160/TH15-04-0320. Epub 2015 Oct 22.
|
| 294 |
Evaluation of (99m)Tc-HYNIC-(ser)(3)-LTVPWY peptide for glioblastoma imaging.Int J Radiat Biol. 2020 Apr;96(4):502-509. doi: 10.1080/09553002.2020.1704906. Epub 2019 Dec 20.
|
| 295 |
High epiregulin expression in human U87 glioma cells relies on IRE1 and promotes autocrine growth through EGF receptor.BMC Cancer. 2013 Dec 13;13:597. doi: 10.1186/1471-2407-13-597.
|
| 296 |
The Increased Expression of Estrogen-Related Receptor Correlates with Wnt5a and Poor Prognosis in Patients with Glioma.Mol Cancer Ther. 2019 Jan;18(1):173-184. doi: 10.1158/1535-7163.MCT-17-0782. Epub 2018 Oct 15.
|
| 297 |
Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression.J Exp Clin Cancer Res. 2019 Dec 10;38(1):486. doi: 10.1186/s13046-019-1474-7.
|
| 298 |
Polycomb group expression signatures in the malignant progression of gliomas.Oncol Lett. 2017 Apr;13(4):2583-2590. doi: 10.3892/ol.2017.5753. Epub 2017 Feb 20.
|
| 299 |
F10 gene hypomethylation, a putative biomarker for glioma prognosis.J Neurooncol. 2012 May;107(3):479-85. doi: 10.1007/s11060-011-0775-2. Epub 2011 Dec 13.
|
| 300 |
Increasing of Blood-Brain Tumor Barrier Permeability through Transcellular and Paracellular Pathways by Microbubble-Enhanced Diagnostic Ultrasound in a C6 Glioma Model.Front Neurosci. 2017 Feb 23;11:86. doi: 10.3389/fnins.2017.00086. eCollection 2017.
|
| 301 |
The role of thrombin in gliomas.J Thromb Haemost. 2005 Sep;3(9):1917-23. doi: 10.1111/j.1538-7836.2005.01446.x. Epub 2005 Jun 24.
|
| 302 |
Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas.Clin Cancer Res. 2019 Jan 15;25(2):747-759. doi: 10.1158/1078-0432.CCR-18-1222. Epub 2018 Sep 28.
|
| 303 |
miR-25-3p promotes glioma cell proliferation and migration by targeting FBXW7 and DKK3.Exp Ther Med. 2019 Jul;18(1):769-778. doi: 10.3892/etm.2019.7583. Epub 2019 May 15.
|
| 304 |
Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.Br J Cancer. 2011 Mar 1;104(5):798-807. doi: 10.1038/bjc.2011.12. Epub 2011 Feb 8.
|
| 305 |
Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326.Oncotarget. 2015 Sep 8;6(26):21934-49. doi: 10.18632/oncotarget.4290.
|
| 306 |
Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1.J Exp Clin Cancer Res. 2019 Aug 22;38(1):371. doi: 10.1186/s13046-019-1361-2.
|
| 307 |
Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas.Invest New Drugs. 2018 Apr;36(2):323-331. doi: 10.1007/s10637-017-0503-7. Epub 2017 Aug 29.
|
| 308 |
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.J Natl Cancer Inst. 2019 Mar 1;111(3):292-300. doi: 10.1093/jnci/djy107.
|
| 309 |
A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma.Oncotarget. 2017 Jul 17;8(40):68291-68304. doi: 10.18632/oncotarget.19309. eCollection 2017 Sep 15.
|
| 310 |
The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.J Pharmacol Exp Ther. 2018 Jan;364(1):77-86. doi: 10.1124/jpet.117.244434. Epub 2017 Oct 12.
|
| 311 |
Enhancing the anti-glioma therapy of doxorubicin by honokiol with biodegradable self-assembling micelles through multiple evaluations.Sci Rep. 2017 Feb 27;7:43501. doi: 10.1038/srep43501.
|
| 312 |
Allergy may confer better survival on patients with gliomas.Clin Neurol Neurosurg. 2019 Feb;177:63-67. doi: 10.1016/j.clineuro.2018.12.021. Epub 2018 Dec 31.
|
| 313 |
FOXC1 silencing inhibits the epithelialtomesenchymal transition of glioma cells: Involvement of catenin signaling.Mol Med Rep. 2019 Jan;19(1):251-261. doi: 10.3892/mmr.2018.9650. Epub 2018 Nov 13.
|
| 314 |
High expression of forkhead box protein C2 is related to poor prognosis in human gliomas.Asian Pac J Cancer Prev. 2014;15(24):10621-5. doi: 10.7314/apjcp.2014.15.24.10621.
|
| 315 |
The Application of FOXO1A Expression Predicts Aggressive Behavior and Poor Prognosis in Gliomas.Appl Immunohistochem Mol Morphol. 2020 Jan;28(1):74-82. doi: 10.1097/PAI.0000000000000710.
|
| 316 |
Long noncoding RNA SNHG12 facilitates the tumorigenesis of glioma through miR-101-3p/FOXP1 axis.Gene. 2018 Nov 15;676:315-321. doi: 10.1016/j.gene.2018.08.034. Epub 2018 Aug 8.
|
| 317 |
Forkhead box Q1: A key player in the pathogenesis of tumors (Review).Int J Oncol. 2016 Jul;49(1):51-8. doi: 10.3892/ijo.2016.3517. Epub 2016 May 12.
|
| 318 |
Incubation and application of transgenic green fluorescent nude mice in visualization studies on glioma tissue remodeling.Chin Med J (Engl). 2012 Dec;125(24):4349-54.
|
| 319 |
Long noncoding RNA ferritin heavy polypeptide 1 pseudogene3 controls glioma cell proliferation and apoptosis via regulation of the microRNA?24?p/tumor protein D52 axis.Mol Med Rep. 2018 Nov;18(5):4239-4246. doi: 10.3892/mmr.2018.9491. Epub 2018 Sep 14.
|
| 320 |
FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates angiogenesis in Glioma.J Exp Clin Cancer Res. 2019 Feb 8;38(1):65. doi: 10.1186/s13046-019-1065-7.
|
| 321 |
Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood-brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis.J Neurooncol. 2019 Jul;143(3):405-415. doi: 10.1007/s11060-019-03188-x. Epub 2019 May 18.
|
| 322 |
miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt--catenin pathway.J Exp Clin Cancer Res. 2019 Aug 16;38(1):358. doi: 10.1186/s13046-019-1370-1.
|
| 323 |
Coordinated Expression of Ras Suppressor 1 (RSU-1) and Growth Differentiation Factor 15 (GDF15) Affects Glioma Cell Invasion.Cancers (Basel). 2019 Aug 13;11(8):1159. doi: 10.3390/cancers11081159.
|
| 324 |
Golgin-160 and GMAP210 play an important role in U251 cells migration and invasion initiated by GDNF.PLoS One. 2019 Jan 29;14(1):e0211501. doi: 10.1371/journal.pone.0211501. eCollection 2019.
|
| 325 |
Site specific hypermethylation of CpGs in Connexin genes 30, 26 and 43 in different grades of glioma and attenuated levels of their mRNAs.Int J Neurosci. 2019 Mar;129(3):273-282. doi: 10.1080/00207454.2018.1526802. Epub 2018 Oct 23.
|
| 326 |
Chronic treatment with ginsenoside Rg3 induces Akt-dependent senescence in human glioma cells.Int J Oncol. 2012 Nov;41(5):1669-74. doi: 10.3892/ijo.2012.1604. Epub 2012 Aug 23.
|
| 327 |
Abnormal activity of transcription factors gli in high-grade gliomas.PLoS One. 2019 Feb 7;14(2):e0211980. doi: 10.1371/journal.pone.0211980. eCollection 2019.
|
| 328 |
GLIPR1 inhibits the proliferation and induces the differentiation of cancer-initiating cells by regulating miR-16 in osteosarcoma.Oncol Rep. 2016 Sep;36(3):1585-91. doi: 10.3892/or.2016.4949. Epub 2016 Jul 19.
|
| 329 |
High expression of GLO1 indicates unfavorable clinical outcomes in glioma patients.J Neurosurg Sci. 2022 Jun;66(3):228-233. doi: 10.23736/S0390-5616.19.04805-7. Epub 2019 Nov 13.
|
| 330 |
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme.Neuro Oncol. 2013 May;15(5):618-25. doi: 10.1093/neuonc/nos338. Epub 2013 Feb 14.
|
| 331 |
GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic Profile.Cell Stem Cell. 2019 Aug 1;25(2):241-257.e8. doi: 10.1016/j.stem.2019.06.004. Epub 2019 Jul 11.
|
| 332 |
The PGI-KLF4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas.Neoplasma. 2014;61(4):401-10. doi: 10.4149/neo_2014_049.
|
| 333 |
MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and stemness of glioma stem cells via reactive oxygen species.Oncotarget. 2015 Sep 8;6(26):22006-27. doi: 10.18632/oncotarget.4292.
|
| 334 |
LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway.Neurotherapeutics. 2018 Oct;15(4):1139-1157. doi: 10.1007/s13311-018-0649-9.
|
| 335 |
AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.Neuro Oncol. 2009 Jun;11(3):260-73. doi: 10.1215/15228517-2008-094. Epub 2008 Oct 28.
|
| 336 |
Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.Cancer Sci. 2018 Dec;109(12):3874-3882. doi: 10.1111/cas.13826. Epub 2018 Nov 5.
|
| 337 |
G-protein-coupled receptor kinase-5 promotes glioblastoma progression by targeting the nuclear factor kappa B pathway.Am J Transl Res. 2018 Nov 15;10(11):3370-3384. eCollection 2018.
|
| 338 |
The Role of Metabotropic Glutamate Receptor 1 Dependent Signaling in Glioma Viability.J Pharmacol Exp Ther. 2018 Oct;367(1):59-70. doi: 10.1124/jpet.118.250159. Epub 2018 Jul 27.
|
| 339 |
The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo.Oncotarget. 2019 Apr 19;10(29):2824-2834. doi: 10.18632/oncotarget.26854. eCollection 2019 Apr 19.
|
| 340 |
An endogenous and ectopic expression of metabotropic glutamate receptor 8 (mGluR8) inhibits proliferation and increases chemosensitivity of human neuroblastoma and glioma cells.Cancer Lett. 2018 Sep 28;432:1-16. doi: 10.1016/j.canlet.2018.06.004. Epub 2018 Jun 6.
|
| 341 |
Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced.Neuro Oncol. 2002 Apr;4(2):95-101. doi: 10.1093/neuonc/4.2.95.
|
| 342 |
Molecular screening and genetic diversity analysis of anticancer Azurin-encoding and Azurin-like genes in human gut microbiome deduced through cultivation-dependent and cultivation-independent studies.Int Microbiol. 2019 Dec;22(4):437-449. doi: 10.1007/s10123-019-00070-8. Epub 2019 Mar 20.
|
| 343 |
Analysis of the expression of HAX-1 gene in human glioma.Neurosci Lett. 2017 Sep 14;657:189-193. doi: 10.1016/j.neulet.2017.07.039. Epub 2017 Jul 25.
|
| 344 |
Formononetin sensitizes glioma cells to doxorubicin through preventing EMT via inhibition of histone deacetylase 5.Int J Clin Exp Pathol. 2015 Jun 1;8(6):6434-41. eCollection 2015.
|
| 345 |
Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c-Jun signaling pathway.J Neurochem. 2020 Jan;152(2):221-234. doi: 10.1111/jnc.14849. Epub 2019 Aug 25.
|
| 346 |
Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/-catenin signaling pathway.Int J Biol Macromol. 2019 May 1;128:521-530. doi: 10.1016/j.ijbiomac.2019.01.121. Epub 2019 Jan 23.
|
| 347 |
AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.J Pharm Sci. 2019 Nov;108(11):3684-3694. doi: 10.1016/j.xphs.2019.08.017. Epub 2019 Aug 26.
|
| 348 |
Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells.Clin Cancer Res. 2019 Jan 15;25(2):844-855. doi: 10.1158/1078-0432.CCR-18-1854. Epub 2018 Oct 15.
|
| 349 |
Decreased human leukocyte antigen A*02:01 frequency is associated with risk of glioma and existence of human cytomegalovirus: a case-control study in Northern China.Cancer Immunol Immunother. 2017 Oct;66(10):1265-1273. doi: 10.1007/s00262-017-2018-7. Epub 2017 May 18.
|
| 350 |
HMME-based PDT restores expression and function of transporter associated with antigen processing 1 (TAP1) and surface presentation of MHC class I antigen in human glioma.J Neurooncol. 2011 Nov;105(2):199-210. doi: 10.1007/s11060-011-0584-7. Epub 2011 Apr 26.
|
| 351 |
Downregulation of miR-130a promotes cell growth and epithelial to mesenchymal transition by activating HMGB2 in glioma.Int J Biochem Cell Biol. 2017 Dec;93:25-31. doi: 10.1016/j.biocel.2017.08.010. Epub 2017 Aug 26.
|
| 352 |
Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence.J Cell Mol Med. 2020 Jan;24(1):276-284. doi: 10.1111/jcmm.14717. Epub 2019 Nov 20.
|
| 353 |
PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.Oncotarget. 2015 May 30;6(15):13006-18. doi: 10.18632/oncotarget.3514.
|
| 354 |
WITHDRAWN: Knockdown of LncRNA HOXA11 Antisense Promotes Glioma Cell Apoptosis Via Sponging MiR-140-5p.Oncol Res. 2017 Jun 12. doi: 10.3727/096504017X14972669062547. Online ahead of print.
|
| 355 |
HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF- pathways.Oncotarget. 2015 Sep 29;6(29):27778-93. doi: 10.18632/oncotarget.4813.
|
| 356 |
CD133 in brain tumor: the prognostic factor.Oncotarget. 2017 Feb 14;8(7):11144-11159. doi: 10.18632/oncotarget.14406.
|
| 357 |
Long noncoding RNA HOXB13-AS1 regulates HOXB13 gene methylation by interacting with EZH2 in glioma.Cancer Med. 2018 Sep;7(9):4718-4728. doi: 10.1002/cam4.1718. Epub 2018 Aug 13.
|
| 358 |
Ras-Induced miR-146a and 193a Target Jmjd6 to Regulate Melanoma Progression.Front Genet. 2018 Dec 18;9:675. doi: 10.3389/fgene.2018.00675. eCollection 2018.
|
| 359 |
Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic-Induced Apoptosis.Mol Cancer Ther. 2017 Jan;16(1):156-168. doi: 10.1158/1535-7163.MCT-16-0262. Epub 2016 Oct 24.
|
| 360 |
Glucose-regulated protein 94 is a novel glioma biomarker and promotes the aggressiveness of glioma via Wnt/-catenin signaling pathway.Tumour Biol. 2015 Dec;36(12):9357-64. doi: 10.1007/s13277-015-3635-4. Epub 2015 Jun 25.
|
| 361 |
Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells.J Exp Clin Cancer Res. 2019 Sep 13;38(1):402. doi: 10.1186/s13046-019-1413-7.
|
| 362 |
Hsc70 Interacts with 4GalT5 to Regulate the Growth of Gliomas.Neuromolecular Med. 2019 Mar;21(1):33-41. doi: 10.1007/s12017-018-08520-8. Epub 2019 Jan 3.
|
| 363 |
A new potential anti-cancer beta-carboline derivative decreases the expression levels of key proteins involved in glioma aggressiveness: A proteomic investigation.Drug Dev Res. 2020 Feb;81(1):32-42. doi: 10.1002/ddr.21600. Epub 2019 Sep 9.
|
| 364 |
Rosmarinic acid and siRNA combined therapy represses Hsp27 (HSPB1) expression and induces apoptosis in human glioma cells.Cell Stress Chaperones. 2018 Sep;23(5):885-896. doi: 10.1007/s12192-018-0896-z. Epub 2018 Apr 7.
|
| 365 |
Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.Histochem Cell Biol. 2018 Mar;149(3):235-244. doi: 10.1007/s00418-018-1631-7. Epub 2018 Jan 10.
|
| 366 |
Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma.Exp Mol Pathol. 2015 Apr;98(2):192-9. doi: 10.1016/j.yexmp.2015.01.013. Epub 2015 Jan 21.
|
| 367 |
Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target.Cancer Res. 2013 Mar 1;73(5):1559-69. doi: 10.1158/0008-5472.CAN-12-1943. Epub 2012 Dec 13.
|
| 368 |
Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.Cancer Res. 2014 Mar 15;74(6):1822-32. doi: 10.1158/0008-5472.CAN-13-1839. Epub 2014 Jan 14.
|
| 369 |
Tryptophan Metabolism Contributes to Radiation-Induced Immune Checkpoint Reactivation in Glioblastoma.Clin Cancer Res. 2018 Aug 1;24(15):3632-3643. doi: 10.1158/1078-0432.CCR-18-0041. Epub 2018 Apr 24.
|
| 370 |
IFN?sensitizes TRAILinduced apoptosis by upregulation of death receptor 5 in malignant glioma cells.Oncol Rep. 2019 Dec;42(6):2635-2643. doi: 10.3892/or.2019.7383. Epub 2019 Oct 22.
|
| 371 |
IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling.Cell Commun Signal. 2018 Sep 19;16(1):61. doi: 10.1186/s12964-018-0273-7.
|
| 372 |
Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.J Biol Chem. 2015 Sep 18;290(38):23401-15. doi: 10.1074/jbc.M115.664037. Epub 2015 Aug 5.
|
| 373 |
Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma.J Int Med Res. 2014 Jun;42(3):651-8. doi: 10.1177/0300060513503926. Epub 2014 Apr 17.
|
| 374 |
Association between IL-13 Gene rs20541 Polymorphism and Glioma Susceptibility: A Meta-Analysis.Oncol Res Treat. 2018;41(1-2):14-21. doi: 10.1159/000480518. Epub 2018 Jan 22.
|
| 375 |
Interleukin-13 receptor 2 is a novel marker and potential therapeutic target for human melanoma.Sci Rep. 2019 Feb 4;9(1):1281. doi: 10.1038/s41598-019-39018-3.
|
| 376 |
T Cells in Peripheral Blood of Glioma Patients.Med Sci Monit. 2018 Mar 27;24:1784-1792. doi: 10.12659/msm.905932.
|
| 377 |
IL-24 Induces Apoptosis via Upregulation of RNA-Activated Protein Kinase and Enhances Temozolomide-Induced Apoptosis in Glioma Cells.Oncol Res. 2014;22(3):159-65. doi: 10.3727/096504015X14298122915628.
|
| 378 |
Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating.J Pharm Sci. 2019 May;108(5):1726-1735. doi: 10.1016/j.xphs.2018.11.046. Epub 2018 Dec 8.
|
| 379 |
Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.EBioMedicine. 2018 Jul;33:49-56. doi: 10.1016/j.ebiom.2018.06.014. Epub 2018 Jun 29.
|
| 380 |
Overexpression of ILK promotes temozolomide resistance in glioma cells.Mol Med Rep. 2017 Mar;15(3):1297-1304. doi: 10.3892/mmr.2017.6157. Epub 2017 Jan 26.
|
| 381 |
The oncofetal protein IMP3: a novel grading tool and predictor of poor clinical outcome in human gliomas.Biomed Res Int. 2015;2015:413897. doi: 10.1155/2015/413897. Epub 2015 Jan 28.
|
| 382 |
Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity.Proteomics. 2013 Jul;13(14):2113-24. doi: 10.1002/pmic.201200261. Epub 2013 Jun 14.
|
| 383 |
Dissecting Glioma Invasiveness in a 3D-Organotypic Model.Trends Mol Med. 2017 Sep;23(9):776-777. doi: 10.1016/j.molmed.2017.07.009. Epub 2017 Aug 3.
|
| 384 |
LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma.J Cell Biochem. 2020 Mar;121(3):2170-2183. doi: 10.1002/jcb.29440. Epub 2019 Nov 3.
|
| 385 |
Integrin 4 is involved in the regulation of glioma-induced motility of bone marrow mesenchymal stem cells.Oncol Rep. 2015 Aug;34(2):779-86. doi: 10.3892/or.2015.4012. Epub 2015 May 28.
|
| 386 |
A novel circular RNA, hsa_circ_0046701, promotes carcinogenesis by increasing the expression of miR-142-3p target ITGB8 in glioma.Biochem Biophys Res Commun. 2018 Mar 25;498(1):254-261. doi: 10.1016/j.bbrc.2018.01.076. Epub 2018 Jan 12.
|
| 387 |
Modulation of p75 neurotrophin receptor under hypoxic conditions induces migration and invasion of C6 glioma cells.Clin Exp Metastasis. 2015 Jan;32(1):73-81. doi: 10.1007/s10585-014-9692-z. Epub 2014 Dec 20.
|
| 388 |
Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1 interaction with cofactors p300/CBP.Clin Cancer Res. 2012 Dec 15;18(24):6623-33. doi: 10.1158/1078-0432.CCR-12-0861. Epub 2012 Aug 24.
|
| 389 |
Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1.Neuro Oncol. 2013 Oct;15(10):1330-41. doi: 10.1093/neuonc/not086. Epub 2013 Aug 1.
|
| 390 |
Role of KCNB1 in the prognosis of gliomas and autophagy modulation.Sci Rep. 2017 Feb 8;7(1):14. doi: 10.1038/s41598-017-00045-7.
|
| 391 |
RNA interference with EAG1 enhances interferon gamma injury to glioma cells in vitro.Anticancer Res. 2013 Mar;33(3):865-70.
|
| 392 |
Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells.J Neurosci. 2002 Mar 1;22(5):1840-9. doi: 10.1523/JNEUROSCI.22-05-01840.2002.
|
| 393 |
Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.Oncogene. 2017 Apr 27;36(17):2423-2434. doi: 10.1038/onc.2016.395. Epub 2016 Nov 28.
|
| 394 |
Downregulation of KDM4A Suppresses the Survival of Glioma Cells by Promoting Autophagy.J Mol Neurosci. 2016 Oct;60(2):137-44. doi: 10.1007/s12031-016-0796-6. Epub 2016 Aug 11.
|
| 395 |
Histone demethylase KDM5A inhibits glioma cells migration and invasion by down regulating ZEB1.Biomed Pharmacother. 2018 Mar;99:72-80. doi: 10.1016/j.biopha.2018.01.020. Epub 2018 Jan 8.
|
| 396 |
Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.Int J Mol Med. 2016 Jul;38(1):172-82. doi: 10.3892/ijmm.2016.2614. Epub 2016 May 30.
|
| 397 |
The histone H3 Lys 27 demethylase KDM6B promotes migration and invasion of glioma cells partly by regulating the expression of SNAI1.Neurochem Int. 2019 Mar;124:123-129. doi: 10.1016/j.neuint.2019.01.006. Epub 2019 Jan 8.
|
| 398 |
Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model.Theranostics. 2018 Aug 7;8(16):4462-4476. doi: 10.7150/thno.24395. eCollection 2018.
|
| 399 |
Ketohexokinase is involved in fructose utilization and promotes tumor progression in glioma.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1298-1306. doi: 10.1016/j.bbrc.2018.07.040. Epub 2018 Jul 19.
|
| 400 |
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.Nat Genet. 2009 Aug;41(8):905-8. doi: 10.1038/ng.408. Epub 2009 Jul 5.
|
| 401 |
Reciprocal regulation of integrin 4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits.J Exp Clin Cancer Res. 2019 Jan 18;38(1):23. doi: 10.1186/s13046-019-1034-1.
|
| 402 |
NKG2D ligands in glioma stem-like cells: expression in situ and in vitro.Histochem Cell Biol. 2018 Mar;149(3):219-233. doi: 10.1007/s00418-018-1633-5. Epub 2018 Jan 22.
|
| 403 |
Karyopherin1 regulates proliferation of human glioma cells via Wnt/-catenin pathway.Biochem Biophys Res Commun. 2016 Sep 23;478(3):1189-97. doi: 10.1016/j.bbrc.2016.08.093. Epub 2016 Aug 24.
|
| 404 |
LAPTM4B-35 is a novel prognostic factor for glioblastoma.J Neurooncol. 2017 Apr;132(2):295-303. doi: 10.1007/s11060-017-2369-0. Epub 2017 Jan 18.
|
| 405 |
LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.Biomed Pharmacother. 2019 Aug;116:109013. doi: 10.1016/j.biopha.2019.109013. Epub 2019 May 27.
|
| 406 |
LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.J Mol Neurosci. 2019 May;68(1):38-48. doi: 10.1007/s12031-019-1262-z. Epub 2019 Feb 15.
|
| 407 |
Association of decreased levels of lipopolysaccharide-binding protein with OKN-007-induced regression of tumor growth in an F98 rat glioma model.J Neurosurg. 2019 Oct 18;133(6):1695-1703. doi: 10.3171/2019.7.JNS182435.
|
| 408 |
Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma.Int J Cancer. 2019 Jul 15;145(2):517-530. doi: 10.1002/ijc.32102. Epub 2019 Jan 22.
|
| 409 |
Galectin-3 in preneoplastic lesions of glioma.J Neurooncol. 2013 Jan;111(2):123-32. doi: 10.1007/s11060-012-1005-2. Epub 2012 Nov 23.
|
| 410 |
Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment.Nano Lett. 2019 Nov 13;19(11):8318-8332. doi: 10.1021/acs.nanolett.9b03968. Epub 2019 Oct 17.
|
| 411 |
Lgr4 promotes glioma cell proliferation through activation of Wnt signaling.Asian Pac J Cancer Prev. 2013;14(8):4907-11. doi: 10.7314/apjcp.2013.14.8.4907.
|
| 412 |
MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.Diagn Pathol. 2014 Nov 14;9:211. doi: 10.1186/s13000-014-0211-y.
|
| 413 |
LIN28 is involved in glioma carcinogenesis and predicts outcomes of glioblastoma multiforme patients.PLoS One. 2014 Jan 24;9(1):e86446. doi: 10.1371/journal.pone.0086446. eCollection 2014.
|
| 414 |
The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.Cell Death Differ. 2015 Sep;22(9):1517-25. doi: 10.1038/cdd.2015.7. Epub 2015 Feb 27.
|
| 415 |
Clinical relevance of lysyl oxidase-like 2 and functional mechanisms in glioma.Onco Targets Ther. 2018 May 9;11:2699-2708. doi: 10.2147/OTT.S164056. eCollection 2018.
|
| 416 |
Target identification reveals lanosterol synthase as a vulnerability in glioma.Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7957-7962. doi: 10.1073/pnas.1820989116. Epub 2019 Mar 28.
|
| 417 |
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioblastoma cell chemotaxis via Lyn activation.Carcinogenesis. 2014 Jan;35(1):218-26. doi: 10.1093/carcin/bgt289. Epub 2013 Aug 23.
|
| 418 |
Transcriptional repression of Mad-Max complex by human umbilical cord blood stem cells downregulates extracellular signal-regulated kinase in glioblastoma.Stem Cells Dev. 2012 Jul 1;21(10):1779-93. doi: 10.1089/scd.2011.0424. Epub 2011 Nov 21.
|
| 419 |
Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.Neoplasma. 2018;65(4):604-609. doi: 10.4149/neo_2018_170625N440.
|
| 420 |
MAGEA6 promotes human glioma cell survival via targeting AMPK1.Cancer Lett. 2018 Jan 1;412:21-29. doi: 10.1016/j.canlet.2017.09.051. Epub 2017 Oct 9.
|
| 421 |
Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.EMBO J. 2020 Jan 2;39(1):e102030. doi: 10.15252/embj.2019102030. Epub 2019 Nov 27.
|
| 422 |
Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy.J Neural Transm (Vienna). 2018 Nov;125(11):1553-1566. doi: 10.1007/s00702-018-1927-8. Epub 2018 Sep 27.
|
| 423 |
MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment.Cell Mol Immunol. 2016 Sep;13(5):658-68. doi: 10.1038/cmi.2015.46. Epub 2015 Jul 20.
|
| 424 |
Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.CNS Neurosci Ther. 2020 Mar;26(3):297-308. doi: 10.1111/cns.13197. Epub 2019 Jul 18.
|
| 425 |
High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.Mol Med Rep. 2017 Jul;16(1):224-230. doi: 10.3892/mmr.2017.6560. Epub 2017 May 10.
|
| 426 |
Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-B-dependent Manner.Cancer Cell. 2016 Feb 8;29(2):201-13. doi: 10.1016/j.ccell.2016.01.005.
|
| 427 |
RRM2 is a potential prognostic biomarker with functional significance in glioma.Int J Biol Sci. 2019 Jan 1;15(3):533-543. doi: 10.7150/ijbs.30114. eCollection 2019.
|
| 428 |
MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5.Biochem Biophys Res Commun. 2016 Sep 23;478(3):1158-64. doi: 10.1016/j.bbrc.2016.08.085. Epub 2016 Aug 18.
|
| 429 |
Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.Exp Cell Res. 2019 Mar 15;376(2):221-226. doi: 10.1016/j.yexcr.2019.02.014. Epub 2019 Feb 16.
|
| 430 |
Autophagy-related gene expression is an independent prognostic indicator of glioma.Oncotarget. 2017 May 9;8(37):60987-61000. doi: 10.18632/oncotarget.17719. eCollection 2017 Sep 22.
|
| 431 |
Genetic Predisposition to Glioma Mediated by a MAPKAP1 Enhancer Variant.Cell Mol Neurobiol. 2020 May;40(4):643-652. doi: 10.1007/s10571-019-00763-8. Epub 2019 Nov 26.
|
| 432 |
CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma.Mult Scler. 2018 Aug;24(9):1212-1223. doi: 10.1177/1352458517717804. Epub 2017 Jun 28.
|
| 433 |
Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells.Biochem Pharmacol. 2015 Jul 15;96(2):119-30. doi: 10.1016/j.bcp.2015.05.007. Epub 2015 May 19.
|
| 434 |
CD146 is highly expressed in glioma stem cells and acts as a cell cycle regulator.J Neurooncol. 2019 Aug;144(1):21-32. doi: 10.1007/s11060-019-03200-4. Epub 2019 May 30.
|
| 435 |
MCL1 gene silencing promotes senescence and apoptosis of glioma cells via inhibition of the PI3K/Akt signaling pathway.IUBMB Life. 2019 Jan;71(1):81-92. doi: 10.1002/iub.1944. Epub 2018 Oct 8.
|
| 436 |
Overexpression of MCM6 predicts poor survival in patients with glioma.Hum Pathol. 2018 Aug;78:182-187. doi: 10.1016/j.humpath.2018.04.024. Epub 2018 May 9.
|
| 437 |
Minichromosome Maintenance (MCM) Family as potential diagnostic and prognostic tumor markers for human gliomas.BMC Cancer. 2014 Jul 21;14:526. doi: 10.1186/1471-2407-14-526.
|
| 438 |
MFI2-AS1 regulates the aggressive phenotypes in glioma by modulating MMP14 via a positive feedback loop.Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5884-5895. doi: 10.26355/eurrev_201907_18333.
|
| 439 |
MerTK as a therapeutic target in glioblastoma. Neuro Oncol. 2018 Jan 10;20(1):92-102.
|
| 440 |
N-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1.FEBS Lett. 2020 Jan;594(2):358-366. doi: 10.1002/1873-3468.13596. Epub 2019 Sep 17.
|
| 441 |
Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.Ann Nucl Med. 2019 Jun;33(6):394-403. doi: 10.1007/s12149-019-01346-9. Epub 2019 Feb 28.
|
| 442 |
Significance of TERT and ATRX mutations in glioma.Oncol Lett. 2019 Jan;17(1):95-102. doi: 10.3892/ol.2018.9634. Epub 2018 Oct 29.
|
| 443 |
Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation. Mol Cancer Res. 2018 Jan;16(1):32-46. doi: 10.1158/1541-7786.MCR-17-0397. Epub 2017 Oct 17.
|
| 444 |
Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix.Carcinogenesis. 2010 Feb;31(2):311-7. doi: 10.1093/carcin/bgp297. Epub 2009 Dec 4.
|
| 445 |
Sevoflurane suppresses migration and invasion of glioma cells by regulating miR-146b-5p and MMP16.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3306-3314. doi: 10.1080/21691401.2019.1648282.
|
| 446 |
Long Non-Coding RNA BCAR4 Promotes Growth, Invasion and Tumorigenicity by Targeting miR-2276 to Upregulate MMP7 Expression in Glioma.Onco Targets Ther. 2019 Dec 12;12:10963-10973. doi: 10.2147/OTT.S226026. eCollection 2019.
|
| 447 |
Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells.J Neurooncol. 2011 Jun;103(2):267-76. doi: 10.1007/s11060-010-0398-z. Epub 2010 Sep 16.
|
| 448 |
Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma.Cancer Med. 2019 Jul;8(8):3811-3821. doi: 10.1002/cam4.2312. Epub 2019 May 29.
|
| 449 |
MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation.Cancer Res. 2019 Jul 1;79(13):3383-3394. doi: 10.1158/0008-5472.CAN-18-1010. Epub 2019 Apr 30.
|
| 450 |
The melatonin-MT1 receptor axis modulates tumor growth in PTEN-mutated gliomas.Biochem Biophys Res Commun. 2018 Feb 19;496(4):1322-1330. doi: 10.1016/j.bbrc.2018.02.010.
|
| 451 |
Atypical central neurocytoma with novel EWSR1-ATF1 fusion and MUTYH mutation detected by next-generation sequencing.BMJ Case Rep. 2019 Jan 14;12(1):bcr-2018-226455. doi: 10.1136/bcr-2018-226455.
|
| 452 |
The expression patterns of Msi1 related with the glioma grade and the cytoplasmic Msi1 promotes angiogenesis.Tissue Cell. 2013 Feb;45(1):1-6. doi: 10.1016/j.tice.2012.08.006. Epub 2012 Sep 25.
|
| 453 |
Adult IDH wild-type lower-grade gliomas should be further stratified.Neuro Oncol. 2017 Oct 1;19(10):1327-1337. doi: 10.1093/neuonc/nox078.
|
| 454 |
Overexpression of MYC binding protein promotes invasion and migration in gastric cancer.Oncol Lett. 2018 Apr;15(4):5243-5249. doi: 10.3892/ol.2018.7944. Epub 2018 Feb 2.
|
| 455 |
MiR-29b inhibits the growth of glioma via MYCN dependent way.Oncotarget. 2017 Jul 11;8(28):45224-45233. doi: 10.18632/oncotarget.16780.
|
| 456 |
PPM1D mutations silence NAPRT geneexpression and confer NAMPT inhibitor sensitivity in glioma.Nat Commun. 2019 Aug 22;10(1):3790. doi: 10.1038/s41467-019-11732-6.
|
| 457 |
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors.Nat Med. 2012 Dec;18(12):1827-34. doi: 10.1038/nm.3013. Epub 2012 Nov 25.
|
| 458 |
miR-6743-5p, as a direct upstream regulator of GRIM-19, enhances proliferation and suppresses apoptosis in glioma cells.Biosci Rep. 2017 Dec 12;37(6):BSR20171038. doi: 10.1042/BSR20171038. Print 2017 Dec 22.
|
| 459 |
A new molecular probe: An NRP-1 targeting probe for the grading diagnosis of glioma in nude mice.Neurosci Lett. 2020 Jan 1;714:134617. doi: 10.1016/j.neulet.2019.134617. Epub 2019 Nov 6.
|
| 460 |
TNF- mediated MEK-ERK signaling in invasion with putative network involving NF-B and STAT-6: a new perspective in glioma.Cell Biol Int. 2019 Nov;43(11):1257-1266. doi: 10.1002/cbin.11125. Epub 2019 Jul 16.
|
| 461 |
Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction.J Cell Physiol. 2019 May;234(5):6820-6830. doi: 10.1002/jcp.27430. Epub 2018 Nov 11.
|
| 462 |
Expression of Nm23 in gliomas and its effect on migration and invasion in vitro.Anticancer Res. 2006 Jan-Feb;26(1A):249-58.
|
| 463 |
Interference of Notch 2 inhibits the progression of gliomas and induces cell apoptosis by induction of the cell cycle at the G0/G1 phase.Mol Med Rep. 2015 Jan;11(1):734-8. doi: 10.3892/mmr.2014.2747. Epub 2014 Oct 22.
|
| 464 |
C-type natriuretic peptide-modified lipid vesicles: fabrication and use for the treatment of brain glioma.Oncotarget. 2017 Jun 20;8(25):40906-40921. doi: 10.18632/oncotarget.16641.
|
| 465 |
Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?.Br J Cancer. 2008 Oct 7;99(7):1153-60. doi: 10.1038/sj.bjc.6604641. Epub 2008 Sep 9.
|
| 466 |
CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth.Mol Neurobiol. 2019 May;56(5):3260-3279. doi: 10.1007/s12035-018-1240-4. Epub 2018 Aug 16.
|
| 467 |
Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.J Exp Clin Cancer Res. 2017 Jan 9;36(1):9. doi: 10.1186/s13046-016-0482-0.
|
| 468 |
Interference with NTSR1 Expression Exerts an Anti-Invasion Effect via the Jun/miR-494/SOCS6 Axis of Glioblastoma Cells.Cell Physiol Biochem. 2018;49(6):2382-2395. doi: 10.1159/000493838. Epub 2018 Sep 27.
|
| 469 |
miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma.Int J Mol Med. 2016 Jun;37(6):1627-35. doi: 10.3892/ijmm.2016.2562. Epub 2016 Apr 13.
|
| 470 |
SiRNA-mediated knockdown against NUF2 suppresses tumor growth and induces cell apoptosis in human glioma cells.Cell Mol Biol (Noisy-le-grand). 2014 Nov 25;60(4):30-6.
|
| 471 |
Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1.Brain Pathol. 2019 May;29(3):336-350. doi: 10.1111/bpa.12670. Epub 2018 Dec 21.
|
| 472 |
Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy.Chem Sci. 2018 Jan 31;9(10):2674-2689. doi: 10.1039/c7sc04853j. eCollection 2018 Mar 14.
|
| 473 |
Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.Neoplasia. 2015 Feb;17(2):225-37. doi: 10.1016/j.neo.2015.01.001.
|
| 474 |
P2X4R silence suppresses glioma cell growth through BDNF/TrkB/ATF4 signaling pathway.J Cell Biochem. 2019 Apr;120(4):6322-6329. doi: 10.1002/jcb.27919. Epub 2018 Oct 25.
|
| 475 |
The role of microglia and P2X7 receptors in gliomas.J Neuroimmunol. 2019 Jul 15;332:138-146. doi: 10.1016/j.jneuroim.2019.04.010. Epub 2019 Apr 20.
|
| 476 |
P2Y1 nucleotide receptor silencing and its effect on glioma C6 calcium signaling.Acta Biochim Pol. 2012;59(4):711-7. doi: 10.18388/abp.2012_2115. Epub 2012 Dec 20.
|
| 477 |
Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade.Acta Neuropathol Commun. 2017 Jan 10;5(1):4. doi: 10.1186/s40478-016-0405-5.
|
| 478 |
P2Y14 receptor activation decreases interleukin-6 production and glioma GL261 cell proliferation in microglial transwell cultures.J Neurooncol. 2018 Mar;137(1):23-31. doi: 10.1007/s11060-017-2700-9. Epub 2017 Nov 30.
|
| 479 |
Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane.Oncotarget. 2017 May 30;8(22):35877-35889. doi: 10.18632/oncotarget.16270.
|
| 480 |
Impact of four lncRNA polymorphisms (rs2151280, rs7763881, rs1136410, and rs3787016) on glioma risk and prognosis: A case-control study.Mol Carcinog. 2019 Dec;58(12):2218-2229. doi: 10.1002/mc.23110. Epub 2019 Sep 5.
|
| 481 |
TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ.Cell Death Dis. 2019 Aug 5;10(8):583. doi: 10.1038/s41419-019-1805-9.
|
| 482 |
Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation.Acta Pharmacol Sin. 2017 Nov;38(11):1543-1553. doi: 10.1038/aps.2017.112. Epub 2017 Aug 17.
|
| 483 |
PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor.Oncoimmunology. 2018 Nov 20;8(2):e1541535. doi: 10.1080/2162402X.2018.1541535. eCollection 2019.
|
| 484 |
Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.Oncol Rep. 2014 Jul;32(1):250-60. doi: 10.3892/or.2014.3176. Epub 2014 May 15.
|
| 485 |
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.Mol Cancer Ther. 2014 Oct;13(10):2384-98. doi: 10.1158/1535-7163.MCT-14-0172. Epub 2014 Aug 7.
|
| 486 |
CCAAT/enhancer-binding protein delta regulates the stemness of glioma stem-like cells through activating PDGFA expression upon inflammatory stimulation.J Neuroinflammation. 2019 Jul 12;16(1):146. doi: 10.1186/s12974-019-1535-z.
|
| 487 |
IGFBP2 expression predicts IDH-mutant glioma patient survival.Oncotarget. 2017 Jan 3;8(1):191-202. doi: 10.18632/oncotarget.13329.
|
| 488 |
SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance.Oncotarget. 2017 Nov 30;9(1):192-204. doi: 10.18632/oncotarget.22773. eCollection 2018 Jan 2.
|
| 489 |
The lncRNA-DLEU2/miR-186-5p/PDK3 axis promotes the progress of glioma cells.Am J Transl Res. 2019 Aug 15;11(8):4922-4934. eCollection 2019.
|
| 490 |
Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.Int J Clin Exp Pathol. 2015 Nov 1;8(11):14214-20. eCollection 2015.
|
| 491 |
Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.World Neurosurg. 2019 Nov;131:346-355. doi: 10.1016/j.wneu.2019.06.221.
|
| 492 |
Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy.Mol Ther. 2006 Dec;14(6):789-97. doi: 10.1016/j.ymthe.2006.07.011. Epub 2006 Oct 10.
|
| 493 |
Expression of Progesterone Receptor Membrane Component 1 (PGRMC1), Progestin and AdipoQ Receptor 7 (PAQPR7), and Plasminogen Activator Inhibitor 1 RNA-Binding Protein (PAIRBP1) in Glioma Spheroids In Vitro.Biomed Res Int. 2016;2016:8065830. doi: 10.1155/2016/8065830. Epub 2016 Jun 1.
|
| 494 |
Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin.Mol Med Rep. 2015 Jul;12(1):1515-23. doi: 10.3892/mmr.2015.3475. Epub 2015 Mar 12.
|
| 495 |
The effect of nanoparticle size and NLS density on nuclear targeting in cancer and normal cells; impaired nuclear import and aberrant nanoparticle intracellular trafficking in glioma.J Control Release. 2017 May 10;253:30-36. doi: 10.1016/j.jconrel.2017.02.029. Epub 2017 Feb 27.
|
| 496 |
Pin1-Nanog expression in human glioma is correlated with advanced tumor progression.Oncol Rep. 2013 Aug;30(2):560-6. doi: 10.3892/or.2013.2481. Epub 2013 May 23.
|
| 497 |
PinX1 inhibits cell proliferation, migration and invasion in glioma cells.Med Oncol. 2015 Mar;32(3):73. doi: 10.1007/s12032-015-0545-7. Epub 2015 Feb 20.
|
| 498 |
LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.Biomed Pharmacother. 2019 Sep;117:109069. doi: 10.1016/j.biopha.2019.109069. Epub 2019 Jun 7.
|
| 499 |
Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.Clin Cancer Res. 2007 Jul 15;13(14):4051-60. doi: 10.1158/1078-0432.CCR-06-3032.
|
| 500 |
Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.Mol Neurobiol. 2016 Nov;53(9):6511-6525. doi: 10.1007/s12035-015-9518-2. Epub 2015 Nov 28.
|
| 501 |
Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migration.J Cell Biochem. 2011 Jan;112(1):39-48. doi: 10.1002/jcb.22710.
|
| 502 |
PLD1 overexpression promotes invasion and migration and function as a risk factor for Chinese glioma patients.Oncotarget. 2017 Jul 5;8(34):57039-57046. doi: 10.18632/oncotarget.18961. eCollection 2017 Aug 22.
|
| 503 |
Phospholipase D activates HIF-1-VEGF pathway via phosphatidic acid.Exp Mol Med. 2014 Dec 19;46(12):e126. doi: 10.1038/emm.2014.86.
|
| 504 |
Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.BMC Cancer. 2013 Dec 11;13:590. doi: 10.1186/1471-2407-13-590.
|
| 505 |
Long noncoding RNA ENST00000413528 sponges microRNA-593-5p to modulate human glioma growth via polo-like kinase 1.CNS Neurosci Ther. 2019 Aug;25(8):842-854. doi: 10.1111/cns.13121. Epub 2019 Mar 28.
|
| 506 |
PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma.Cancer Lett. 2019 Feb 28;443:91-107. doi: 10.1016/j.canlet.2018.11.034. Epub 2018 Dec 4.
|
| 507 |
Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma.Oncotarget. 2017 Jun 27;8(26):41947-41962. doi: 10.18632/oncotarget.16710.
|
| 508 |
Reduced expression of proteolipid protein 2 increases ER stress-induced apoptosis and autophagy in glioblastoma.J Cell Mol Med. 2020 Mar;24(5):2847-2856. doi: 10.1111/jcmm.14840. Epub 2019 Nov 28.
|
| 509 |
Lipoprotein lipase and phospholipid transfer protein overexpression in human glioma cells and their effect on cell growth, apoptosis, and migration.Acta Biochim Biophys Sin (Shanghai). 2017 Jan;49(1):62-73. doi: 10.1093/abbs/gmw117. Epub 2016 Nov 17.
|
| 510 |
ROS-Responsive Blended Nanoparticles: Cascade-Amplifying Synergistic Effects of Sonochemotherapy with On-demand Boosted Drug Release During SDT Process.Adv Healthc Mater. 2019 Sep;8(18):e1900720. doi: 10.1002/adhm.201900720. Epub 2019 Aug 13.
|
| 511 |
S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion.Asian Pac J Cancer Prev. 2015;16(7):2883-7. doi: 10.7314/apjcp.2015.16.7.2883.
|
| 512 |
TWIST1 Heterodimerization with E12 Requires Coordinated Protein Phosphorylation to Regulate Periostin Expression.Cancers (Basel). 2019 Sep 18;11(9):1392. doi: 10.3390/cancers11091392.
|
| 513 |
Tumor-Associated Fibronectin Targeted Liposomal Nanoplatform for Cyclophilin A siRNA Delivery and Targeted Malignant Glioblastoma Therapy.Front Pharmacol. 2018 Oct 17;9:1194. doi: 10.3389/fphar.2018.01194. eCollection 2018.
|
| 514 |
ROS-p53-cyclophilin-D signaling mediates salinomycin-induced glioma cell necrosis.J Exp Clin Cancer Res. 2015 May 30;34(1):57. doi: 10.1186/s13046-015-0174-1.
|
| 515 |
Serine/Threonine Protein Phosphatase-5 Accelerates Cell Growth and Migration in Human Glioma.Cell Mol Neurobiol. 2015 Jul;35(5):669-77. doi: 10.1007/s10571-015-0162-1. Epub 2015 Mar 22.
|
| 516 |
MeCP2 Differentially Regulate the Myelin MBP and PLP Protein Expression in Oligodendrocytes and C6 Glioma.J Mol Neurosci. 2018 Jul;65(3):343-350. doi: 10.1007/s12031-018-1112-4. Epub 2018 Jul 10.
|
| 517 |
Identification of novel LncRNA targeting Smad2/PKC signal pathway to negatively regulate malignant progression of glioblastoma.J Cell Physiol. 2020 Apr;235(4):3835-3848. doi: 10.1002/jcp.29278. Epub 2019 Oct 11.
|
| 518 |
Knockdown of PKC expression inhibits growth, induces apoptosis and decreases invasiveness of human glioma cells partially through Stat3.J Mol Neurosci. 2015 Jan;55(1):21-31. doi: 10.1007/s12031-014-0341-4. Epub 2014 Jun 4.
|
| 519 |
IL-10 and PRKDC polymorphisms are associated with glioma patient survival.Oncotarget. 2016 Dec 6;7(49):80680-80687. doi: 10.18632/oncotarget.13028.
|
| 520 |
The role of protein arginine-methyltransferase 1 in gliomagenesis.BMB Rep. 2012 Aug;45(8):470-5. doi: 10.5483/BMBRep.2012.45.8.022.
|
| 521 |
Overexpression of Protease Serine 8 Inhibits Glioma Cell Proliferation, Migration, and Invasion via Suppressing the Akt/mTOR Signaling Pathway.Oncol Res. 2017 Jul 5;25(6):923-930. doi: 10.3727/096504016X14798241682647. Epub 2016 Nov 24.
|
| 522 |
Prostate stem cell antigen is expressed in normal and malignant human brain tissues.Oncol Lett. 2018 Mar;15(3):3081-3084. doi: 10.3892/ol.2017.7632. Epub 2017 Dec 18.
|
| 523 |
Presenilin-1 holoprotein is an interacting partner of sarco endoplasmic reticulum calcium-ATPase and confers resistance to endoplasmic reticulum stress.J Alzheimers Dis. 2010;20(1):261-73. doi: 10.3233/JAD-2010-1360.
|
| 524 |
RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signaling.Neuro Oncol. 2012 Aug;14(8):994-1006. doi: 10.1093/neuonc/nos138. Epub 2012 Jun 29.
|
| 525 |
PSMB8 regulates glioma cell migration, proliferation, and apoptosis through modulating ERK1/2 and PI3K/AKT signaling pathways.Biomed Pharmacother. 2018 Apr;100:205-212. doi: 10.1016/j.biopha.2018.01.170. Epub 2018 Feb 9.
|
| 526 |
Automated fluorescent miscroscopic image analysis of PTBP1 expression in glioma.PLoS One. 2017 Mar 10;12(3):e0170991. doi: 10.1371/journal.pone.0170991. eCollection 2017.
|
| 527 |
MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.Cell Signal. 2017 Jan;30:142-153. doi: 10.1016/j.cellsig.2016.09.007. Epub 2016 Sep 28.
|
| 528 |
Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway.PLoS One. 2015 Jun 22;10(6):e0131059. doi: 10.1371/journal.pone.0131059. eCollection 2015.
|
| 529 |
Circular RNA Pleiotrophin promotes carcinogenesis in glioma via regulation of microRNA-122/SRY-box transcription factor 6 axis.Eur J Cancer Prev. 2020 Mar;29(2):165-173. doi: 10.1097/CEJ.0000000000000535.
|
| 530 |
PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.Theranostics. 2018 Feb 7;8(6):1527-1539. doi: 10.7150/thno.22699. eCollection 2018.
|
| 531 |
Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p.Biosci Rep. 2019 May 14;39(5):BSR20182389. doi: 10.1042/BSR20182389. Print 2019 May 31.
|
| 532 |
PTPN2 induced by inflammatory response and oxidative stress contributed to glioma progression.J Cell Biochem. 2019 Nov;120(11):19044-19051. doi: 10.1002/jcb.29227. Epub 2019 Jun 26.
|
| 533 |
Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth.Nat Commun. 2017 Jun 1;8:15080. doi: 10.1038/ncomms15080.
|
| 534 |
RTEL1 tagging SNPs and haplotypes were associated with glioma development.Diagn Pathol. 2013 May 17;8:83. doi: 10.1186/1746-1596-8-83.
|
| 535 |
[ARTICLE WITHDRAWN] Long Noncoding RNA TUNAR Represses Growth, Migration, and Invasion of Human Glioma Cells Through Regulating miR-200a and Rac1.Oncol Res. 2018 Dec 27;27(1):107-115. doi: 10.3727/096504018X15205622257163. Epub 2018 Mar 14.
|
| 536 |
Overexpression of RACK1 Promotes Metastasis by Enhancing Epithelial-Mesenchymal Transition and Predicts Poor Prognosis in Human Glioma.Int J Environ Res Public Health. 2016 Oct 18;13(10):1021. doi: 10.3390/ijerph13101021.
|
| 537 |
BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors.Cancers (Basel). 2019 Aug 28;11(9):1262. doi: 10.3390/cancers11091262.
|
| 538 |
Overexpression of EPAC2 reduces the invasion of glioma cells via MMP-2.Oncol Lett. 2019 Jun;17(6):5080-5086. doi: 10.3892/ol.2019.10200. Epub 2019 Mar 29.
|
| 539 |
A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.Cancer Cell. 2015 Dec 14;28(6):730-742. doi: 10.1016/j.ccell.2015.10.008. Epub 2015 Dec 5.
|
| 540 |
RIP2 promotes glioma cell growth by regulating TRAF3 and activating the NFB and p38 signaling pathways.Oncol Rep. 2018 Jun;39(6):2915-2923. doi: 10.3892/or.2018.6397. Epub 2018 Apr 23.
|
| 541 |
Serum ROCK1 mRNA is of great diagnostic value for glioma patients.Medicine (Baltimore). 2019 May;98(19):e15413. doi: 10.1097/MD.0000000000015413.
|
| 542 |
Opposing signaling of ROCK1 and ROCK2 determines the switching of substrate specificity and the mode of migration of glioblastoma cells.Mol Neurobiol. 2014 Apr;49(2):900-15. doi: 10.1007/s12035-013-8568-6. Epub 2013 Oct 30.
|
| 543 |
Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis.Oncotarget. 2017 Apr 4;8(14):23978-23995. doi: 10.18632/oncotarget.15074.
|
| 544 |
ROS generation and autophagosome accumulation contribute to the DMAMCL-induced inhibition of glioma cell proliferation by regulating the ROS/MAPK signaling pathway and suppressing the Akt/mTOR signaling pathway.Onco Targets Ther. 2019 Mar 7;12:1867-1880. doi: 10.2147/OTT.S195329. eCollection 2019.
|
| 545 |
Aberrant expression of RSK1 characterizes high-grade gliomas with immune infiltration.Mol Oncol. 2020 Jan;14(1):159-179. doi: 10.1002/1878-0261.12595. Epub 2019 Dec 11.
|
| 546 |
MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.Am J Cancer Res. 2017 Apr 1;7(4):784-800. eCollection 2017.
|
| 547 |
COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value.Oncotarget. 2016 Oct 25;7(43):70494-70503. doi: 10.18632/oncotarget.12038.
|
| 548 |
Silencing of R-Spondin1 increases radiosensitivity of glioma cells.Oncotarget. 2015;6(12):9756-65. doi: 10.18632/oncotarget.3395.
|
| 549 |
Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth.Cancer Lett. 2018 Apr 1;418:147-158. doi: 10.1016/j.canlet.2018.01.035. Epub 2018 Jan 12.
|
| 550 |
Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3/-Catenin Signaling Axis.Front Pharmacol. 2019 Nov 15;10:1358. doi: 10.3389/fphar.2019.01358. eCollection 2019.
|
| 551 |
Overexpression of SCUBE2 Inhibits Proliferation, Migration, and Invasion in Glioma Cells.Oncol Res. 2017 Mar 13;25(3):437-444. doi: 10.3727/096504016X14747335734344. Epub 2016 Sep 30.
|
| 552 |
Effect of Hydroxyethyl Starch Loading on Glycocalyx Shedding and Cerebral Metabolism During Surgery.J Surg Res. 2020 Feb;246:274-283. doi: 10.1016/j.jss.2019.09.030. Epub 2019 Oct 12.
|
| 553 |
ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma.Cell Death Dis. 2019 Oct 7;10(10):757. doi: 10.1038/s41419-019-1986-2.
|
| 554 |
Distinct molecular profile of diffuse cerebellar gliomas.Acta Neuropathol. 2017 Dec;134(6):941-956. doi: 10.1007/s00401-017-1771-1. Epub 2017 Aug 29.
|
| 555 |
Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties.PLoS One. 2015 Jun 1;10(6):e0127517. doi: 10.1371/journal.pone.0127517. eCollection 2015.
|
| 556 |
Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas.J Exp Clin Cancer Res. 2012 Oct 11;31(1):85. doi: 10.1186/1756-9966-31-85.
|
| 557 |
UPF1 regulates the malignant biological behaviors of glioblastoma cells via enhancing the stability of Linc-00313.Cell Death Dis. 2019 Aug 19;10(9):629. doi: 10.1038/s41419-019-1845-1.
|
| 558 |
Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas.Biomaterials. 2013 Jun;34(18):4532-43. doi: 10.1016/j.biomaterials.2013.02.067. Epub 2013 Mar 19.
|
| 559 |
Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells.Cancer Res. 2019 Apr 1;79(7):1369-1382. doi: 10.1158/0008-5472.CAN-18-2558. Epub 2019 Jan 25.
|
| 560 |
Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner.Oncogene. 2014 Aug 28;33(35):4433-41. doi: 10.1038/onc.2013.390. Epub 2013 Sep 30.
|
| 561 |
Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma.Int J Cancer. 2019 May 15;144(10):2539-2554. doi: 10.1002/ijc.31985. Epub 2019 Jan 5.
|
| 562 |
Regulating glioma stem cells by hypoxia through the Notch1 and Oct3/4 signaling pathway.Oncol Lett. 2018 Nov;16(5):6315-6322. doi: 10.3892/ol.2018.9442. Epub 2018 Sep 17.
|
| 563 |
3'-Deoxy-3'-[(18)F]-fluorothymidine ([(18)F]-FLT) transport in newly diagnosed glioma: correlation with nucleoside transporter expression, vascularization, and blood-brain barrier permeability.Brain Tumor Pathol. 2013 Oct;30(4):215-23. doi: 10.1007/s10014-013-0136-2. Epub 2013 Feb 20.
|
| 564 |
Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.J Cell Biochem. 2019 Jun;120(6):10205-10214. doi: 10.1002/jcb.28305. Epub 2018 Dec 28.
|
| 565 |
Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas. Neuroreport. 2004 Mar 22;15(4):575-8.
|
| 566 |
Targeted Delivery of Nanoparticulate Cytochrome C into Glioma Cells Through the Proton-Coupled Folate Transporter.Biomolecules. 2019 Apr 18;9(4):154. doi: 10.3390/biom9040154.
|
| 567 |
A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma.Front Neurol. 2018 Dec 17;9:1087. doi: 10.3389/fneur.2018.01087. eCollection 2018.
|
| 568 |
Synthesis and evaluation of (18)F-hexafluorophosphate as a novel PET probe for imaging of sodium/iodide symporter in a murine C6-glioma tumor model.Bioorg Med Chem. 2018 Jan 1;26(1):225-231. doi: 10.1016/j.bmc.2017.11.034. Epub 2017 Nov 23.
|
| 569 |
Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy.Cell Death Dis. 2018 Sep 27;9(10):1010. doi: 10.1038/s41419-018-1062-3.
|
| 570 |
Ste20-like kinase is upregulated in glioma and induces glioma invasion.Neoplasma. 2018;65(2):185-191. doi: 10.4149/neo_2018_170318N193.
|
| 571 |
Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.Nat Commun. 2018 Jun 27;9(1):2504. doi: 10.1038/s41467-018-04936-9.
|
| 572 |
Circular RNA circ-SMAD7 promoted glioma cell proliferation and metastasis by upregulating PCNA.Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):10035-10041. doi: 10.26355/eurrev_201911_19570.
|
| 573 |
Anti-glioma Effects of Caffeic Acid Phenethyl Ester and Dasatinib Combination Therapy in an in vivo Rat Glioma Model.Anticancer Agents Med Chem. 2018;18(12):1729-1735. doi: 10.2174/1871520618666180515144835.
|
| 574 |
Biological Role and Therapeutic Targeting of TGF-(3) in Glioblastoma.Mol Cancer Ther. 2017 Jun;16(6):1177-1186. doi: 10.1158/1535-7163.MCT-16-0465. Epub 2017 Apr 4.
|
| 575 |
SET and MYND domain-containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity.Oncol Rep. 2015 Nov;34(5):2722-30. doi: 10.3892/or.2015.4239. Epub 2015 Sep 1.
|
| 576 |
Common variation in genes related to innate immunity and risk of adult glioma.Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1651-8. doi: 10.1158/1055-9965.EPI-08-1041.
|
| 577 |
ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.Neuro Oncol. 2013 Aug;15(8):990-1007. doi: 10.1093/neuonc/not039. Epub 2013 Apr 10.
|
| 578 |
Author Correction: Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1-SOX2 positive-feedback loop.Nat Neurosci. 2019 May;22(5):840. doi: 10.1038/s41593-019-0388-1.
|
| 579 |
Long noncoding RNA LINC00511 induced by SP1 accelerates the glioma progression through targeting miR-124-3p/CCND2 axis.J Cell Mol Med. 2019 Jun;23(6):4386-4394. doi: 10.1111/jcmm.14331. Epub 2019 Apr 11.
|
| 580 |
Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models.Theranostics. 2019 Oct 11;9(24):7447-7457. doi: 10.7150/thno.34883. eCollection 2019.
|
| 581 |
SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/-catenin signaling pathways.Oncol Rep. 2016 Jun;35(6):3566-76. doi: 10.3892/or.2016.4757. Epub 2016 Apr 20.
|
| 582 |
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.J Clin Invest. 2019 Jan 2;129(1):137-149. doi: 10.1172/JCI121266. Epub 2018 Nov 19.
|
| 583 |
Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.Oncotarget. 2017 Apr 11;8(15):24815-24827. doi: 10.18632/oncotarget.15820.
|
| 584 |
Serine arginine protein kinase 1 (SRPK1): a moonlighting protein with theranostic ability in cancer prevention.Mol Biol Rep. 2019 Feb;46(1):1487-1497. doi: 10.1007/s11033-018-4545-5. Epub 2018 Dec 8.
|
| 585 |
SSRP1 silencing inhibits the proliferation and malignancy of human glioma cells via the MAPK signaling pathway.Oncol Rep. 2017 Nov;38(5):2667-2676. doi: 10.3892/or.2017.5982. Epub 2017 Sep 21.
|
| 586 |
Anti-SSTR2 peptide based targeted delivery of potent PLGA encapsulated 3,3'-diindolylmethane nanoparticles through blood brain barrier prevents glioma progression.Oncotarget. 2017 Jun 27;8(39):65339-65358. doi: 10.18632/oncotarget.18689. eCollection 2017 Sep 12.
|
| 587 |
Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth.J Neurooncol. 2019 May;143(1):35-47. doi: 10.1007/s11060-019-03143-w. Epub 2019 Apr 16.
|
| 588 |
Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1.Cancer Lett. 2018 Mar 1;416:66-74. doi: 10.1016/j.canlet.2017.11.033. Epub 2017 Nov 28.
|
| 589 |
Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma.PLoS One. 2013 Nov 28;8(11):e81803. doi: 10.1371/journal.pone.0081803. eCollection 2013.
|
| 590 |
Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility.Int J Cancer. 2019 Nov 1;145(9):2372-2382. doi: 10.1002/ijc.32179. Epub 2019 Mar 18.
|
| 591 |
MST1 suppresses viability and promotes apoptosis of glioma cells via upregulating SIRT6 expression.J Integr Neurosci. 2019 Jun 30;18(2):117-126. doi: 10.31083/j.jin.2019.02.122.
|
| 592 |
Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-B/MMP-9 pathway.J Pathol. 2012 Feb;226(3):534-43. doi: 10.1002/path.3008. Epub 2011 Dec 5.
|
| 593 |
Knockdown of Serine Threonine Tyrosine Kinase 1 (STYK1) Inhibits the Migration and Tumorigenesis in Glioma Cells.Oncol Res. 2017 Jul 5;25(6):931-937. doi: 10.3727/096504016X14772424117423. Epub 2016 Oct 27.
|
| 594 |
HP1 is highly expressed in glioma cells and facilitates cell proliferation and survival.Cancer Biomark. 2017 Dec 6;20(4):453-460. doi: 10.3233/CBM-170249.
|
| 595 |
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events.J Neurol. 2019 Sep;266(9):2273-2276. doi: 10.1007/s00415-019-09410-0. Epub 2019 Jun 5.
|
| 596 |
TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas.Neurol Sci. 2013 Oct;34(10):1745-50. doi: 10.1007/s10072-013-1326-8. Epub 2013 Feb 9.
|
| 597 |
TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.J Exp Clin Cancer Res. 2017 Nov 6;36(1):155. doi: 10.1186/s13046-017-0619-9.
|
| 598 |
Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma.Brain Res. 2007 Feb 23;1134(1):45-52. doi: 10.1016/j.brainres.2006.11.093. Epub 2007 Jan 2.
|
| 599 |
Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.ACS Appl Mater Interfaces. 2019 Jan 16;11(2):1841-1854. doi: 10.1021/acsami.8b18664. Epub 2019 Jan 4.
|
| 600 |
The miR-26a/AP-2/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.Theranostics. 2019 Jul 28;9(19):5497-5516. doi: 10.7150/thno.33800. eCollection 2019.
|
| 601 |
TGF-2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells' invasion.J Exp Clin Cancer Res. 2017 Nov 16;36(1):162. doi: 10.1186/s13046-017-0628-8.
|
| 602 |
The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.Oncotarget. 2017 Apr 4;8(14):22325-22343. doi: 10.18632/oncotarget.16479.
|
| 603 |
Deciphering the complex role of thrombospondin-1 in glioblastoma development.Nat Commun. 2019 Mar 8;10(1):1146. doi: 10.1038/s41467-019-08480-y.
|
| 604 |
Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma.Clin Cancer Res. 2018 Jun 15;24(12):2951-2962. doi: 10.1158/1078-0432.CCR-17-1839. Epub 2018 Mar 21.
|
| 605 |
Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation.Int J Mol Sci. 2018 Jul 25;19(8):2168. doi: 10.3390/ijms19082168.
|
| 606 |
Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor.BMC Cancer. 2019 May 20;19(1):473. doi: 10.1186/s12885-019-5700-7.
|
| 607 |
Thymosin 4 gene silencing decreases stemness and invasiveness in glioblastoma.Brain. 2014 Feb;137(Pt 2):433-48. doi: 10.1093/brain/awt333. Epub 2013 Dec 18.
|
| 608 |
Emodin induced necroptosis in the glioma cell line U251 via the TNF-/RIP1/RIP3 pathway.Invest New Drugs. 2020 Feb;38(1):50-59. doi: 10.1007/s10637-019-00764-w. Epub 2019 Mar 28.
|
| 609 |
Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas.Clin Cancer Res. 2009 Sep 1;15(17):5457-65. doi: 10.1158/1078-0432.CCR-09-1125. Epub 2009 Aug 25.
|
| 610 |
Epigenetic reactivation of RANK in glioblastoma cells by curcumin: involvement of STAT3 inhibition.DNA Cell Biol. 2013 Jun;32(6):292-7. doi: 10.1089/dna.2013.2042. Epub 2013 Apr 27.
|
| 611 |
Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.J Neurooncol. 2018 Jun;138(2):241-250. doi: 10.1007/s11060-018-2799-3. Epub 2018 Feb 16.
|
| 612 |
BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.PLoS One. 2013 Dec 20;8(12):e83250. doi: 10.1371/journal.pone.0083250. eCollection 2013.
|
| 613 |
NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.Cancer Lett. 2016 Oct 1;380(2):568-576. doi: 10.1016/j.canlet.2015.06.026. Epub 2015 Aug 20.
|
| 614 |
An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas.Clin Cancer Res. 2012 Sep 1;18(17):4657-68. doi: 10.1158/1078-0432.CCR-12-0990. Epub 2012 Jul 10.
|
| 615 |
PDGFR--activated ACK1-AKT signaling promotes glioma tumorigenesis.Int J Cancer. 2015 Apr 15;136(8):1769-80. doi: 10.1002/ijc.29234. Epub 2014 Oct 8.
|
| 616 |
Inhibition of DNA-PK potentiates the synergistic effect of NK314 and etoposide combination on human glioblastoma cells.Mol Biol Rep. 2020 Jan;47(1):67-76. doi: 10.1007/s11033-019-05105-x. Epub 2019 Oct 3.
|
| 617 |
53BP1 is a haploinsufficient tumor suppressor and protects cells from radiation response in glioma.Cancer Res. 2012 Oct 15;72(20):5250-60. doi: 10.1158/0008-5472.CAN-12-0045. Epub 2012 Aug 21.
|
| 618 |
Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.Theranostics. 2015 Jan 1;5(1):86-96. doi: 10.7150/thno.10062. eCollection 2015.
|
| 619 |
RNA interferencemediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells.Mol Med Rep. 2015 Nov;12(5):6617-25. doi: 10.3892/mmr.2015.4280. Epub 2015 Sep 2.
|
| 620 |
Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.Oncotarget. 2016 Jan 19;7(3):2354-66. doi: 10.18632/oncotarget.6221.
|
| 621 |
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma.Nat Commun. 2017 Nov 13;8(1):1454. doi: 10.1038/s41467-017-01731-w.
|
| 622 |
Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in Glioblastoma.Cell Rep. 2019 Feb 26;26(9):2274-2281.e5. doi: 10.1016/j.celrep.2019.01.109.
|
| 623 |
Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway.Biomed Pharmacother. 2018 Mar;99:59-64. doi: 10.1016/j.biopha.2018.01.054. Epub 2018 Jan 8.
|
| 624 |
TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3.Cancer Res. 2018 Apr 1;78(7):1792-1804. doi: 10.1158/0008-5472.CAN-17-2774. Epub 2018 Jan 31.
|
| 625 |
Transient receptor potential canonical channels are essential for chemotactic migration of human malignant gliomas.J Cell Physiol. 2011 Jul;226(7):1879-88. doi: 10.1002/jcp.22518.
|
| 626 |
TRPC5induced autophagy promotes the TMZresistance of glioma cells via the CAMMK/AMPK/mTOR pathway.Oncol Rep. 2019 Jun;41(6):3413-3423. doi: 10.3892/or.2019.7095. Epub 2019 Apr 2.
|
| 627 |
Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness.Cancer Res. 2010 Jan 1;70(1):418-27. doi: 10.1158/0008-5472.CAN-09-2654. Epub 2009 Dec 22.
|
| 628 |
TRPM8 is required for survival and radioresistance of glioblastoma cells.Oncotarget. 2017 Sep 30;8(56):95896-95913. doi: 10.18632/oncotarget.21436. eCollection 2017 Nov 10.
|
| 629 |
The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation.Int J Cancer. 2012 Oct 1;131(7):E1067-77. doi: 10.1002/ijc.27588. Epub 2012 Apr 27.
|
| 630 |
TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma.Neuro Oncol. 2020 Feb 20;22(2):240-252. doi: 10.1093/neuonc/noz183.
|
| 631 |
HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells.Biomed Pharmacother. 2016 Oct;83:898-904. doi: 10.1016/j.biopha.2016.08.004. Epub 2016 Aug 10.
|
| 632 |
FUS1 acts as a tumor-suppressor gene by upregulating miR-197 in human glioblastoma.Oncol Rep. 2015 Aug;34(2):868-76. doi: 10.3892/or.2015.4069. Epub 2015 Jun 16.
|
| 633 |
FABP7 Protects Astrocytes Against ROS Toxicity via Lipid Droplet Formation.Mol Neurobiol. 2019 Aug;56(8):5763-5779. doi: 10.1007/s12035-019-1489-2. Epub 2019 Jan 24.
|
| 634 |
TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport.Sci Rep. 2017 Mar 24;7:42928. doi: 10.1038/srep42928.
|
| 635 |
Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells. J Neurooncol. 2005 May;72(3):217-23. doi: 10.1007/s11060-004-3012-4.
|
| 636 |
Aberrant Activation of -Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.Cancer Res. 2019 Jan 1;79(1):72-85. doi: 10.1158/0008-5472.CAN-18-1304. Epub 2018 Nov 13.
|
| 637 |
Overexpression of ubiquitin specific proteases 44 promotes the malignancy of glioma by stabilizing tumor-promoter securin.Oncotarget. 2017 Mar 22;8(35):58231-58246. doi: 10.18632/oncotarget.16447. eCollection 2017 Aug 29.
|
| 638 |
Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway.Oncol Rep. 2016 Nov;36(5):2935-2945. doi: 10.3892/or.2016.5099. Epub 2016 Sep 16.
|
| 639 |
VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells. Cell Death Dis. 2018 Sep 24;9(10):988.
|
| 640 |
MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells.Cell Cycle. 2017 Oct 18;16(20):1954-1964. doi: 10.1080/15384101.2017.1367071. Epub 2017 Sep 12.
|
| 641 |
Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases.J Cell Biochem. 2019 Nov;120(11):18588-18598. doi: 10.1002/jcb.29217. Epub 2019 Jun 29.
|
| 642 |
A positive feedback loop of miR-30a-5p-WWP1-NF-B in the regulation of glioma development.Int J Biochem Cell Biol. 2019 Jul;112:39-49. doi: 10.1016/j.biocel.2019.04.003. Epub 2019 Apr 10.
|
| 643 |
Expression of WW domain-containing protein 2 is correlated with pathological grade and recurrence of glioma. J Cancer Res Ther. 2017 Oct-Dec;13(6):1032-1037.
|
| 644 |
Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma.Anticancer Res. 2019 Dec;39(12):6635-6643. doi: 10.21873/anticanres.13878.
|
| 645 |
Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer.Cancer Lett. 2014 Feb 1;343(1):6-13. doi: 10.1016/j.canlet.2013.09.002. Epub 2013 Sep 7.
|
| 646 |
Blood-based DNA methylation of DNA repair genes in the non-homologous end-joining (NEHJ) pathway in patient with glioma.Int J Clin Exp Pathol. 2015 Aug 1;8(8):9463-7. eCollection 2015.
|
| 647 |
Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma.Cancer Cell. 2019 Jun 10;35(6):868-884.e6. doi: 10.1016/j.ccell.2019.05.003.
|
| 648 |
Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers.Genes Chromosomes Cancer. 2000 Sep;29(1):16-25. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1007>3.3.co;2-9.
|
| 649 |
Low microRNA-622 expression predicts poor prognosis and is associated with ZEB2 in glioma.Onco Targets Ther. 2019 Sep 10;12:7387-7397. doi: 10.2147/OTT.S218161. eCollection 2019.
|
| 650 |
Single-Cell Transcriptomics Uncovers Glial Progenitor Diversity and Cell Fate Determinants during Development and Gliomagenesis.Cell Stem Cell. 2019 May 2;24(5):707-723.e8. doi: 10.1016/j.stem.2019.03.006. Epub 2019 Apr 11.
|
| 651 |
Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors.Lab Invest. 2011 Jul;91(7):1068-78. doi: 10.1038/labinvest.2011.56. Epub 2011 Apr 11.
|
| 652 |
Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis.Dev Biol. 2007 May 15;305(2):599-614. doi: 10.1016/j.ydbio.2007.03.004. Epub 2007 Mar 12.
|
| 653 |
Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors: implications for stem cell mitosis and centrosome dynamics.Stem Cell Res. 2014 Jul;13(1):135-43. doi: 10.1016/j.scr.2014.05.001. Epub 2014 May 11.
|
| 654 |
CBX7 negatively regulates migration and invasion in glioma via Wnt/-catenin pathway inactivation.Oncotarget. 2017 Jun 13;8(24):39048-39063. doi: 10.18632/oncotarget.16587.
|
| 655 |
Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).Hum Gene Ther. 2012 Apr;23(4):419-27. doi: 10.1089/hum.2011.158. Epub 2012 Mar 9.
|
| 656 |
EGFR and C/EBP- oncogenic signaling is bidirectional in human glioma and varies with the C/EBP- isoform.FASEB J. 2016 Dec;30(12):4098-4108. doi: 10.1096/fj.201600550R. Epub 2016 Aug 29.
|
| 657 |
RNAi for contactin 2 inhibits proliferation of U87-glioma stem cells by downregulating AICD, EGFR, and HES1.Onco Targets Ther. 2017 Feb 13;10:791-801. doi: 10.2147/OTT.S113390. eCollection 2017.
|
| 658 |
Carboxypeptidase E transmits its anti-migratory function in glioma cells via transcriptional regulation of cell architecture and motility regulating factors.Int J Oncol. 2017 Aug;51(2):702-714. doi: 10.3892/ijo.2017.4051. Epub 2017 Jun 21.
|
| 659 |
Effect of Nicotine on CYP2B1 Expression in a Glioma Animal Model and Analysis of CYP2B6 Expression in Pediatric Gliomas.Int J Mol Sci. 2018 Jun 16;19(6):1790. doi: 10.3390/ijms19061790.
|
| 660 |
Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity.Int J Biochem Cell Biol. 2012 May;44(5):738-47. doi: 10.1016/j.biocel.2012.01.011. Epub 2012 Jan 28.
|
| 661 |
Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma.PLoS One. 2013 Nov 26;8(11):e81345. doi: 10.1371/journal.pone.0081345. eCollection 2013.
|
| 662 |
Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD.Cancer Gene Ther. 2008 Nov;15(11):703-12. doi: 10.1038/cgt.2008.45. Epub 2008 Jul 4.
|
| 663 |
Hu antigen R (HuR) multimerization contributes to glioma disease progression.J Biol Chem. 2017 Oct 13;292(41):16999-17010. doi: 10.1074/jbc.M117.797878. Epub 2017 Aug 8.
|
| 664 |
EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line.Mol Cancer Ther. 2008 Sep;7(9):2768-78. doi: 10.1158/1535-7163.MCT-07-2263.
|
| 665 |
Deficiency of the IRE1-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.J Virol. 2018 Feb 26;92(6):e01331-17. doi: 10.1128/JVI.01331-17. Print 2018 Mar 15.
|
| 666 |
RETRACTED: Downregulation of miR-204 expression correlates with poor clinical outcome of glioma patients.Hum Pathol. 2017 May;63:46-52. doi: 10.1016/j.humpath.2016.12.031. Epub 2017 Feb 21.
|
| 667 |
3-polyunsaturated fatty acids induce cell death through apoptosis and autophagy in glioblastoma cells: In vitro and in vivo.Oncol Rep. 2018 Jan;39(1):239-246. doi: 10.3892/or.2017.6101. Epub 2017 Nov 16.
|
| 668 |
Identification of a novel role of IL-13R2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway.J Transl Med. 2018 Dec 20;16(1):369. doi: 10.1186/s12967-018-1746-6.
|
| 669 |
Human malignant glioma cells expressing functional formylpeptide receptor recruit endothelial progenitor cells for neovascularization.Int Immunopharmacol. 2010 Dec;10(12):1602-7. doi: 10.1016/j.intimp.2010.09.016. Epub 2010 Oct 8.
|
| 670 |
High Expression Levels of Fascin-1 Protein in Human Gliomas and its Clinical Relevance.Open Med (Wars). 2018 Oct 25;13:544-550. doi: 10.1515/med-2018-0080. eCollection 2018.
|
| 671 |
Novel insights into GnRH receptor activity: role in the control of human glioblastoma cell proliferation.Oncol Rep. 2009 May;21(5):1277-82. doi: 10.3892/or_00000351.
|
| 672 |
HDAC3 Expression Correlates with the Prognosis and Grade of Patients with Glioma: A Diversification Analysis Based on Transcriptome and Clinical Evidence.World Neurosurg. 2018 Nov;119:e145-e158. doi: 10.1016/j.wneu.2018.07.076. Epub 2018 Jul 24.
|
| 673 |
High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas.Oncogene. 2008 Aug 7;27(34):4745-51. doi: 10.1038/onc.2008.110. Epub 2008 Apr 14.
|
| 674 |
Down-regulation of IKK expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.Oncotarget. 2015 Oct 20;6(32):33077-90. doi: 10.18632/oncotarget.5310.
|
| 675 |
Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells.Clin Cancer Res. 2012 Nov 1;18(21):5949-60. doi: 10.1158/1078-0432.CCR-12-0319. Epub 2012 Sep 10.
|
| 676 |
Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression.Neoplasia. 2009 May;11(5):485-96. doi: 10.1593/neo.81526.
|
| 677 |
Prognostic impact of CD68 and kallikrein 6 in human glioma.Anticancer Res. 2009 Aug;29(8):3269-79.
|
| 678 |
Role of lymphocyte-specific protein tyrosine kinase (LCK) in the expansion of glioma-initiating cells by fractionated radiation.Biochem Biophys Res Commun. 2010 Nov 26;402(4):631-6. doi: 10.1016/j.bbrc.2010.10.072. Epub 2010 Oct 29.
|
| 679 |
ZEB1 regulates glioma stemness through LIF repression.Sci Rep. 2017 Feb 28;7(1):69. doi: 10.1038/s41598-017-00106-x.
|
| 680 |
1H HR-MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas.NMR Biomed. 2009 Jul;22(6):629-37. doi: 10.1002/nbm.1377.
|
| 681 |
NEDD9 regulates 3D migratory activity independent of the Rac1 morphology switch in glioma and neuroblastoma.Mol Cancer Res. 2014 Feb;12(2):264-73. doi: 10.1158/1541-7786.MCR-13-0513. Epub 2013 Dec 13.
|
| 682 |
MiR-128 promotes the apoptosis of glioma cells via binding to NEK2.Eur Rev Med Pharmacol Sci. 2018 Dec;22(24):8781-8788. doi: 10.26355/eurrev_201812_16645.
|
| 683 |
MiR-125a-3p regulates glioma apoptosis and invasion by regulating Nrg1.PLoS One. 2015 Jan 5;10(1):e0116759. doi: 10.1371/journal.pone.0116759. eCollection 2015.
|
| 684 |
Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21830-5. doi: 10.1073/pnas.0906831106. Epub 2009 Dec 14.
|
| 685 |
A novel interaction of PAK4 with PPAR to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma.Oncogene. 2017 Sep 14;36(37):5309-5320. doi: 10.1038/onc.2016.261. Epub 2017 May 22.
|
| 686 |
Chronophin regulates active vitamin B6 levels and transcriptomic features of glioblastoma cell lines cultured under non-adherent, serum-free conditions.BMC Cancer. 2018 May 3;18(1):524. doi: 10.1186/s12885-018-4440-4.
|
| 687 |
Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines.Oncogene. 2009 Sep 3;28(35):3121-31. doi: 10.1038/onc.2009.168. Epub 2009 Jun 22.
|
| 688 |
RIP1 and RIP3 contribute to shikonin-induced DNA double-strand breaks in glioma cells via increase of intracellular reactive oxygen species.Cancer Lett. 2017 Apr 1;390:77-90. doi: 10.1016/j.canlet.2017.01.004. Epub 2017 Jan 17.
|
| 689 |
Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.J Neurooncol. 2015 May;123(1):161-9. doi: 10.1007/s11060-015-1780-7. Epub 2015 Apr 10.
|
| 690 |
The 37-kDa laminin receptor precursor regulates the malignancy of human glioma cells.Cell Biochem Funct. 2016 Oct;34(7):516-521. doi: 10.1002/cbf.3225.
|
| 691 |
Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?.Am J Surg Pathol. 2008 Oct;32(10):1444-53. doi: 10.1097/PAS.0b013e31817ce978.
|
| 692 |
Overexpression of S100A9 in human glioma and in-vitro inhibition by aspirin.Eur J Cancer Prev. 2013 Nov;22(6):585-95. doi: 10.1097/CEJ.0b013e328364f1c9.
|
| 693 |
S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN.Biochem Biophys Res Commun. 2008 Feb 22;366(4):963-8. doi: 10.1016/j.bbrc.2007.12.054. Epub 2007 Dec 26.
|
| 694 |
Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.Cancer Gene Ther. 2004 May;11(5):325-32. doi: 10.1038/sj.cgt.7700675.
|
| 695 |
Heat Shock Protein 47 Promotes Glioma Angiogenesis.Brain Pathol. 2016 Jan;26(1):31-42. doi: 10.1111/bpa.12256. Epub 2015 May 7.
|
| 696 |
High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.J Neurooncol. 2018 May;138(1):49-53. doi: 10.1007/s11060-018-2785-9. Epub 2018 Feb 5.
|
| 697 |
Expression and functional roles of Smad1 and BMPR-IB in glioma development.Cancer Invest. 2009 Aug;27(7):734-40. doi: 10.1080/07357900802620786.
|
| 698 |
Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.Int J Cancer. 2007 Apr 15;120(8):1704-11. doi: 10.1002/ijc.22472.
|
| 699 |
Proteolytic cleavage of human acid-sensing ion channel 1 by the serine protease matriptase.J Biol Chem. 2010 Aug 27;285(35):27130-27143. doi: 10.1074/jbc.M110.153213. Epub 2010 Jul 2.
|
| 700 |
Agonist OX40 immunotherapy improves survival in glioma-bearing mice and is complementary with vaccination with irradiated GM-CSF-expressing tumor cells.Neuro Oncol. 2018 Jan 10;20(1):44-54. doi: 10.1093/neuonc/nox125.
|
| 701 |
Nuclear Factor of Activated T Cells-dependent Down-regulation of the Transcription Factor Glioma-associated Protein 1 (GLI1) Underlies the Growth Inhibitory Properties of Arachidonic Acid.J Biol Chem. 2016 Jan 22;291(4):1933-1947. doi: 10.1074/jbc.M115.691972. Epub 2015 Nov 24.
|
| 702 |
TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma.Tumour Biol. 2016 Nov;37(11):14721-14731. doi: 10.1007/s13277-016-5317-2. Epub 2016 Sep 14.
|
| 703 |
Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1.Nat Med. 2012 Aug;18(8):1232-8. doi: 10.1038/nm.2827. Epub 2012 Jul 22.
|
| 704 |
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.J Neurooncol. 2005 Sep;74(2):113-21. doi: 10.1007/s11060-004-6152-7.
|
| 705 |
Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors.Brain Res Mol Brain Res. 1994 Nov;27(1):51-7. doi: 10.1016/0169-328x(94)90183-x.
|
| 706 |
Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.Cancer Res. 2005 May 1;65(9):3617-23. doi: 10.1158/0008-5472.CAN-05-0048.
|
| 707 |
MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.Mol Cancer Res. 2016 Oct;14(10):984-993. doi: 10.1158/1541-7786.MCR-16-0172. Epub 2016 Jun 30.
|
| 708 |
NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.J Cell Physiol. 2019 Feb;234(2):1630-1642. doi: 10.1002/jcp.27033. Epub 2018 Aug 29.
|
| 709 |
pH, Lactate, and Hypoxia: Reciprocity in Regulating High-Affinity Monocarboxylate Transporter Expression in Glioblastoma.Neoplasia. 2017 Feb;19(2):121-134. doi: 10.1016/j.neo.2016.12.011. Epub 2017 Jan 13.
|
| 710 |
Aberrant neuronal differentiation is common in glioma but is associated neither with epileptic seizures nor with better survival.Sci Rep. 2018 Oct 8;8(1):14965. doi: 10.1038/s41598-018-33282-5.
|
| 711 |
NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis.J Neurooncol. 2011 Aug;104(1):119-27. doi: 10.1007/s11060-010-0486-0. Epub 2010 Dec 24.
|
| 712 |
Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo.Neuro Oncol. 2012 May;14(5):561-73. doi: 10.1093/neuonc/nos066. Epub 2012 Apr 14.
|
| 713 |
A novel integrated gene coexpression analysis approach reveals a prognostic three-transcription-factor signature for glioma molecular subtypes.BMC Syst Biol. 2016 Aug 26;10 Suppl 3(Suppl 3):71. doi: 10.1186/s12918-016-0315-y.
|
| 714 |
Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation.J Proteome Res. 2019 Mar 1;18(3):960-969. doi: 10.1021/acs.jproteome.8b00663. Epub 2019 Jan 9.
|
| 715 |
GLUT5 increases fructose utilization and promotes tumor progression in glioma.Biochem Biophys Res Commun. 2018 Jun 2;500(2):462-469. doi: 10.1016/j.bbrc.2018.04.103. Epub 2018 Apr 19.
|
| 716 |
Expression Profile Analysis of Zinc Transporters (ZIP4, ZIP9, ZIP11, ZnT9) in Gliomas and their Correlation with IDH1 Mutation Status.Asian Pac J Cancer Prev. 2015;16(8):3355-60. doi: 10.7314/apjcp.2015.16.8.3355.
|
| 717 |
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk.Oncotarget. 2015 Dec 15;6(40):42468-77. doi: 10.18632/oncotarget.6468.
|
| 718 |
ZIP4 is a novel molecular marker for glioma.Neuro Oncol. 2013 Aug;15(8):1008-16. doi: 10.1093/neuonc/not042. Epub 2013 Apr 17.
|
| 719 |
Activation of C6 glioblastoma cell ceruloplasmin expression by neighboring human brain endothelia-derived interleukins in an in vitro blood-brain barrier model system.Cell Commun Signal. 2014 Oct 14;12:65. doi: 10.1186/s12964-014-0065-7.
|
| 720 |
Overexpression of riboflavin transporter 2 contributes toward progression and invasion of glioma.Neuroreport. 2016 Oct 19;27(15):1167-73. doi: 10.1097/WNR.0000000000000674.
|
| 721 |
Association of three common single nucleotide polymorphisms of SLC7A7 with the development of glioma in a Chinese population.Genet Mol Res. 2017 May 10;16(2). doi: 10.4238/gmr16029026.
|
| 722 |
The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma.Mol Cells. 2017 Oct;40(10):761-772. doi: 10.14348/molcells.2017.0104. Epub 2017 Oct 17.
|
| 723 |
NHE5 regulates growth factor signaling, integrin trafficking, and degradation in glioma cells.Clin Exp Metastasis. 2019 Dec;36(6):527-538. doi: 10.1007/s10585-019-10001-6. Epub 2019 Oct 8.
|
| 724 |
New trends in glioma cancer therapy: Targeting Na(+) /H (+) exchangers.J Cell Physiol. 2020 Feb;235(2):658-665. doi: 10.1002/jcp.29014. Epub 2019 Jun 27.
|
| 725 |
Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.Neuropathol Appl Neurobiol. 2009 Aug;35(4):342-52. doi: 10.1111/j.1365-2990.2009.00993.x.
|
| 726 |
Detection of choline transporter-like 1 protein CTL1 in neuroblastoma x glioma cells and in the CNS, and its role in choline uptake.J Neurochem. 2009 Aug;110(4):1297-309. doi: 10.1111/j.1471-4159.2009.06218.x. Epub 2009 Jun 10.
|
| 727 |
Differential activity of bcl-2 and ICE enzyme family protease inhibitors on Fas and puromycin-induced apoptosis of glioma cells.Biochim Biophys Acta. 1997 Nov 27;1359(2):174-80. doi: 10.1016/s0167-4889(97)00096-7.
|
| 728 |
Nucleoside diphosphate kinase beta (Nm23-R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma.Exp Cell Res. 2000 Nov 25;261(1):127-38. doi: 10.1006/excr.2000.5037.
|
| 729 |
Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1,alpha-hydroxylase (CYP 27B1) in human malignant glioma.Clin Cancer Res. 2001 Apr;7(4):868-75.
|
| 730 |
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.Hum Gene Ther. 1998 Jun 10;9(9):1261-73. doi: 10.1089/hum.1998.9.9-1261.
|
| 731 |
Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo.J Natl Cancer Inst. 1999 Jul 21;91(14):1233-41. doi: 10.1093/jnci/91.14.1233.
|
| 732 |
Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.Cancer Gene Ther. 2006 Feb;13(2):203-14. doi: 10.1038/sj.cgt.7700874.
|
| 733 |
Indomethacin stimulates activity and expression of ecto-5'-nucleotidase/CD73 in glioma cell lines. Eur J Pharmacol. 2007 Aug 13;569(1-2):8-15.
|
| 734 |
Activation of AMP-activated kinase modulates sensitivity of glioma cells against epidermal growth factor receptor inhibition.Int J Oncol. 2016 Jul;49(1):173-80. doi: 10.3892/ijo.2016.3498. Epub 2016 Apr 25.
|
| 735 |
Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy.Mol Cell. 2017 Jun 1;66(5):684-697.e9. doi: 10.1016/j.molcel.2017.04.026. Epub 2017 May 25.
|
| 736 |
circCPA4 acts as a prognostic factor and regulates the proliferation and metastasis of glioma.J Cell Mol Med. 2019 Oct;23(10):6658-6665. doi: 10.1111/jcmm.14541. Epub 2019 Aug 19.
|
| 737 |
Silencing Drp1 inhibits glioma cells proliferation and invasion by RHOA/ ROCK1 pathway.Biochem Biophys Res Commun. 2016 Sep 16;478(2):663-8. doi: 10.1016/j.bbrc.2016.08.003. Epub 2016 Aug 3.
|
| 738 |
Potential regulation of glioma through the induction of apoptosis signaling via Egl-9 family hypoxia-inducible factor 3.Oncol Lett. 2017 Feb;13(2):893-897. doi: 10.3892/ol.2016.5492. Epub 2016 Dec 14.
|
| 739 |
Gamma-glutamylcyclotransferase promotes the growth of human glioma cells by activating Notch-Akt signaling.Biochem Biophys Res Commun. 2016 Mar 18;471(4):616-20. doi: 10.1016/j.bbrc.2016.01.165. Epub 2016 Jan 30.
|
| 740 |
Downregulation of glycine decarboxylase enhanced cofilin-mediated migration in hepatocellular carcinoma cells.Free Radic Biol Med. 2018 May 20;120:1-12. doi: 10.1016/j.freeradbiomed.2018.03.003. Epub 2018 Mar 7.
|
| 741 |
WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma.Cell Death Dis. 2018 Mar 1;9(3):347. doi: 10.1038/s41419-018-0376-5.
|
| 742 |
The NF-B RelB protein is an oncogenic driver of mesenchymal glioma.PLoS One. 2013;8(2):e57489. doi: 10.1371/journal.pone.0057489. Epub 2013 Feb 25.
|
| 743 |
Folate metabolism genetic polymorphisms and meningioma and glioma susceptibility in adults.Oncotarget. 2017 Jul 4;8(34):57265-57277. doi: 10.18632/oncotarget.18986. eCollection 2017 Aug 22.
|
| 744 |
Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients.Genet Mol Res. 2012 Aug 29;11(3):2939-45. doi: 10.4238/2012.June.15.7.
|
| 745 |
Quantitative proteomic analysis of global effect of LLL12 on U87 cell's proteome: An insight into the molecular mechanism of LLL12.J Proteomics. 2015 Jan 15;113:127-42. doi: 10.1016/j.jprot.2014.09.020. Epub 2014 Oct 5.
|
| 746 |
The Circadian Gene Per1 Plays an Important Role in Radiation-Induced Apoptosis and DNA Damage in Glioma.Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2195-2201. doi: 10.31557/APJCP.2019.20.7.2195.
|
| 747 |
Identification of UGP2 as a progression marker that promotes cell growth and motility in human glioma.J Cell Biochem. 2019 Aug;120(8):12489-12499. doi: 10.1002/jcb.28515. Epub 2019 Feb 28.
|
| 748 |
Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote glioma progression by sponging miR-126-5p.J Cell Physiol. 2018 Sep;233(9):6822-6831. doi: 10.1002/jcp.26432. Epub 2018 Mar 25.
|
| 749 |
Sulfotransferase 1A1 (SULT1A1) polymorphism and susceptibility to primary brain tumors.J Cancer Res Clin Oncol. 2008 Jan;134(1):109-14. doi: 10.1007/s00432-007-0256-3. Epub 2007 Jun 29.
|
| 750 |
Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression.Am J Pathol. 2003 Jan;162(1):19-27. doi: 10.1016/S0002-9440(10)63794-7.
|
| 751 |
p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3.Genes Dev. 2003 Feb 15;17(4):476-87. doi: 10.1101/gad.1040003.
|
| 752 |
Bag-1 and Bcl-2 gene transfer in malignant glioma: modulation of cell cycle regulation and apoptosis.Brain Pathol. 2000 Apr;10(2):223-34. doi: 10.1111/j.1750-3639.2000.tb00256.x.
|
| 753 |
Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.Nat Commun. 2017 Jul 11;8:15987. doi: 10.1038/ncomms15987.
|
| 754 |
ERCC1 and ERCC2 polymorphisms and adult glioma.Neuro Oncol. 2005 Oct;7(4):495-507. doi: 10.1215/S1152851705000037.
|
| 755 |
Isolation of the TSLL1 and TSLL2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane proteins.Oncogene. 2001 Aug 30;20(38):5401-7. doi: 10.1038/sj.onc.1204696.
|
| 756 |
CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics.Cancer Res. 2005 Dec 1;65(23):10930-7. doi: 10.1158/0008-5472.CAN-05-1890.
|
| 757 |
Low-frequency ultrasound irradiation increases blood-tumor barrier permeability by transcellular pathway in a rat glioma model.J Mol Neurosci. 2012 Sep;48(1):281-90. doi: 10.1007/s12031-012-9770-0. Epub 2012 Apr 20.
|
| 758 |
Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.Br J Cancer. 2003 Apr 22;88(8):1277-80. doi: 10.1038/sj.bjc.6600862.
|
| 759 |
Regulation of myeloid leukemia factor-1 interacting protein (MLF1IP) expression in glioblastoma.Brain Res. 2005 Jun 14;1047(1):56-64. doi: 10.1016/j.brainres.2005.04.017.
|
| 760 |
Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).Glia. 2004 Mar;45(4):392-405. doi: 10.1002/glia.10343.
|
| 761 |
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.Cancer Cell. 2005 Sep;8(3):211-26. doi: 10.1016/j.ccr.2005.08.002.
|
| 762 |
Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro.Clin Cancer Res. 2001 Aug;7(8):2480-9.
|
| 763 |
Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma.Oncogene. 1997 Mar 6;14(9):1075-81. doi: 10.1038/sj.onc.1200925.
|
| 764 |
Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.Int J Cancer. 2006 Nov 15;119(10):2330-8. doi: 10.1002/ijc.22108.
|
| 765 |
Identification of a hTid-1 mutation which sensitizes gliomas to apoptosis.FEBS Lett. 2004 Dec 17;578(3):323-30. doi: 10.1016/j.febslet.2004.11.034.
|
| 766 |
Interferon gamma up-regulates alpha 2 macroglobulin expression in human astrocytoma cells.J Neuroimmunol. 1994 Aug;53(1):31-7. doi: 10.1016/0165-5728(94)90061-2.
|
| 767 |
Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.Cancer Res. 2006 Sep 1;66(17):8492-500. doi: 10.1158/0008-5472.CAN-05-4211.
|
| 768 |
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.Cancer Res. 2005 Apr 1;65(7):2565-71. doi: 10.1158/0008-5472.CAN-04-4283.
|
| 769 |
Retinoic acid induces gene expression of fibroblast growth factor-9 during induction of neuronal differentiation of mouse embryonal carcinoma P19 cells.FEBS Lett. 1995 Aug 21;370(3):231-5. doi: 10.1016/0014-5793(95)00836-x.
|
| 770 |
LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma.CNS Neurosci Ther. 2020 Jan;26(1):66-75. doi: 10.1111/cns.13152. Epub 2019 May 17.
|
| 771 |
Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response.J Exp Clin Cancer Res. 2019 Apr 5;38(1):147. doi: 10.1186/s13046-019-1151-x.
|
| 772 |
The contribution of genetic and epigenetic mechanisms to gene silencing in oligodendrogliomas.Cancer Res. 2003 Nov 15;63(22):7600-5.
|
| 773 |
Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines.Br J Cancer. 1999 Jun;80(7):940-5. doi: 10.1038/sj.bjc.6690447.
|
| 774 |
Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.Anticancer Drugs. 2006 Aug;17(7):733-51. doi: 10.1097/01.cad.0000217429.67455.18.
|
| 775 |
hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo.Biochem Biophys Res Commun. 1999 Aug 11;261(3):646-51. doi: 10.1006/bbrc.1999.1040.
|
| 776 |
Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines.Oncol Rep. 2003 May-Jun;10(3):609-16.
|
| 777 |
Identification of a novel Bcl-2 related gene, BRAG-1, in human glioma.Oncogene. 1996 Mar 7;12(5):947-51.
|
| 778 |
Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma.J Immunol. 2004 Oct 1;173(7):4352-9. doi: 10.4049/jimmunol.173.7.4352.
|
| 779 |
Current transients associated with BK channels in human glioma cells.J Membr Biol. 2003 Jun 1;193(3):201-13. doi: 10.1007/s00232-003-2019-7.
|
| 780 |
Extensive splice variation and localization of the EHK-1 receptor tyrosine kinase in adult human brain and glial tumors.Brain Res Mol Brain Res. 1997 Jun;46(1-2):17-24. doi: 10.1016/s0169-328x(96)00268-9.
|
| 781 |
Downregulation of laminin alpha4 chain expression inhibits glioma invasion in vitro and in vivo.Int J Cancer. 2005 Oct 20;117(1):41-50. doi: 10.1002/ijc.21102.
|
| 782 |
Isolation of novel differentially expressed genes related to human glioma using cDNA microarray and characterizations of two novel full-length genes.J Neurooncol. 2002 Feb;56(3):197-208. doi: 10.1023/a:1015079705841.
|
| 783 |
Resveratrol inhibits glioma cell growth via targeting LRIG1.J BUON. 2018 Mar-Apr;23(2):403-409.
|
| 784 |
Accessing key steps of human tumor progression in vivo by using an avian embryo model.Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1643-8. doi: 10.1073/pnas.0408622102. Epub 2005 Jan 21.
|
| 785 |
Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines.Am J Pathol. 1993 Mar;142(3):883-92.
|
| 786 |
Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells.Int J Oncol. 2006 Oct;29(4):981-7.
|
| 787 |
Overexpression of RFT induces G1-S arrest and apoptosis via p53/p21(Waf1) pathway in glioma cell.Biochem Biophys Res Commun. 2004 May 7;317(3):902-8. doi: 10.1016/j.bbrc.2004.03.120.
|
| 788 |
Expression of the genes of methyl-binding domain proteins in human gliomas.Oncol Rep. 2002 Mar-Apr;9(2):393-5.
|
| 789 |
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.Nat Genet. 2013 Jun;45(6):602-12. doi: 10.1038/ng.2611. Epub 2013 Apr 14.
|
| 790 |
Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma.Anticancer Res. 2004 Mar-Apr;24(2B):547-52.
|
| 791 |
Identification and characterization of NBEAL1, a novel human neurobeachin-like 1 protein gene from fetal brain, which is up regulated in glioma.Brain Res Mol Brain Res. 2004 Jun 18;125(1-2):147-55. doi: 10.1016/j.molbrainres.2004.02.022.
|
| 792 |
NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.Cancer Res. 2019 May 15;79(10):2593-2603. doi: 10.1158/0008-5472.CAN-18-3297. Epub 2019 Apr 2.
|
| 793 |
NOB1: A Potential Biomarker or Target in Cancer.Curr Drug Targets. 2019;20(10):1081-1089. doi: 10.2174/1389450120666190308145346.
|
| 794 |
Regulation of glioma cell migration by serine-phosphorylated P311.Neoplasia. 2005 Sep;7(9):862-72. doi: 10.1593/neo.05190.
|
| 795 |
PBOV1 is a human de novo gene with tumor-specific expression that is associated with a positive clinical outcome of cancer.PLoS One. 2013;8(2):e56162. doi: 10.1371/journal.pone.0056162. Epub 2013 Feb 13.
|
| 796 |
PCBP2 promotes the development of glioma by regulating FHL3/TGF-/Smad signaling pathway.J Cell Physiol. 2020 Apr;235(4):3280-3291. doi: 10.1002/jcp.29104. Epub 2019 Nov 6.
|
| 797 |
Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas.Neoplasia. 2005 Mar;7(3):193-9. doi: 10.1593/neo.04490.
|
| 798 |
Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors.Brain Res Mol Brain Res. 2005 Apr 27;135(1-2):93-103. doi: 10.1016/j.molbrainres.2004.12.008.
|
| 799 |
PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model.Clin Cancer Res. 2005 Aug 15;11(16):5965-70. doi: 10.1158/1078-0432.CCR-05-0371.
|
| 800 |
Loss of pigment epithelium derived factor expression in glioma progression.J Clin Pathol. 2003 Apr;56(4):277-82. doi: 10.1136/jcp.56.4.277.
|
| 801 |
Regulation of the uPA gene in various grades of human glioma cells.Int J Oncol. 2001 Jan;18(1):71-9.
|
| 802 |
A novel serine protease highly expressed in the pancreas is expressed in various kinds of cancer cells.FEBS J. 2005 Oct;272(19):4911-23. doi: 10.1111/j.1742-4658.2005.04901.x.
|
| 803 |
Low density lipoprotein receptor related protein gene amplification and 766T polymorphism in astrocytomas.Neurosci Lett. 1998 Oct 30;256(1):5-8. doi: 10.1016/s0304-3940(98)00734-4.
|
| 804 |
Expression of a receptor protein tyrosine phosphatase in human glial tumors.J Neurooncol. 1998 Feb;36(3):209-17. doi: 10.1023/a:1005840420136.
|
| 805 |
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.Nat Genet. 2016 Mar;48(3):273-82. doi: 10.1038/ng.3500. Epub 2016 Feb 1.
|
| 806 |
Human brain tumor cell culture characterization after immunostimulatory gene transfer.Neurosurgery. 2002 May;50(5):1094-102. doi: 10.1097/00006123-200205000-00027.
|
| 807 |
Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.Oncogene. 2004 Mar 25;23(13):2408-19. doi: 10.1038/sj.onc.1207407.
|
| 808 |
Role of ribosomal protein mutations in tumor development (Review).Int J Oncol. 2016 Apr;48(4):1313-24. doi: 10.3892/ijo.2016.3387. Epub 2016 Feb 9.
|
| 809 |
Vascular gene expression in nonneoplastic and malignant brain.Am J Pathol. 2004 Aug;165(2):601-8. doi: 10.1016/s0002-9440(10)63324-x.
|
| 810 |
Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.Neurosurgery. 1990 Jul;27(1):83-96.
|
| 811 |
Valproate robustly enhances AP-1 mediated gene expression.Brain Res Mol Brain Res. 1999 Jan 22;64(1):52-8. doi: 10.1016/s0169-328x(98)00303-9.
|
| 812 |
Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells.J Neurooncol. 2002 Sep;59(3):193-8. doi: 10.1023/a:1019966918589.
|
| 813 |
MicroRNA?76?p inhibits the migration and proangiogenic abilities of hypoxiatreated glioma cells through hypoxiainducible factor?.Int J Mol Med. 2019 Jun;43(6):2387-2397. doi: 10.3892/ijmm.2019.4157. Epub 2019 Apr 4.
|
| 814 |
Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells.Oncogene. 2000 Aug 31;19(37):4210-20. doi: 10.1038/sj.onc.1203783.
|
| 815 |
Shc3 affects human high-grade astrocytomas survival.Oncogene. 2005 Aug 4;24(33):5198-206. doi: 10.1038/sj.onc.1208708.
|
| 816 |
The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.Cell Mol Neurobiol. 2019 Aug;39(6):769-782. doi: 10.1007/s10571-019-00677-5. Epub 2019 Apr 22.
|
| 817 |
The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.Neuro Oncol. 2019 Jun 10;21(6):742-754. doi: 10.1093/neuonc/noz038.
|
| 818 |
Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.J Cell Physiol. 2019 Aug;234(10):17589-17599. doi: 10.1002/jcp.28383. Epub 2019 Mar 1.
|
| 819 |
Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.Cancer Res. 2003 Jun 15;63(12):3364-9.
|
| 820 |
SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy.Neurosci Lett. 2005 Jun 10-17;381(1-2):74-9. doi: 10.1016/j.neulet.2005.02.013. Epub 2005 Mar 2.
|
| 821 |
Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: a pharmacological and functional study.J Neuroimmunol. 2005 Jul;164(1-2):48-56. doi: 10.1016/j.jneuroim.2005.03.016.
|
| 822 |
Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas.J Natl Cancer Inst. 2004 Mar 17;96(6):483-6. doi: 10.1093/jnci/djh064.
|
| 823 |
Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules.J Drug Target. 2019 Jun-Jul;27(5-6):634-645. doi: 10.1080/1061186X.2018.1547733. Epub 2018 Nov 29.
|
| 824 |
Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.Cancer Res. 2001 Mar 15;61(6):2759-65.
|
| 825 |
Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas.J Neurosurg. 2005 Nov;103(5):873-81. doi: 10.3171/jns.2005.103.5.0873.
|
| 826 |
ATDC contributes to sustaining the growth and invasion of glioma cells through regulating Wnt/-catenin signaling.Chem Biol Interact. 2019 May 25;305:148-155. doi: 10.1016/j.cbi.2019.03.033. Epub 2019 Mar 29.
|
| 827 |
Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours.Br J Cancer. 2006 Apr 24;94(8):1186-93. doi: 10.1038/sj.bjc.6603006.
|
| 828 |
Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.Acta Neuropathol. 2006 Jan;111(1):29-38. doi: 10.1007/s00401-005-1085-6. Epub 2005 Nov 30.
|
| 829 |
Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.Int J Cancer. 2006 Aug 15;119(4):792-800. doi: 10.1002/ijc.21901.
|
| 830 |
Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism.J Neurosci. 2006 Feb 8;26(6):1864-71. doi: 10.1523/JNEUROSCI.2643-05.2006.
|
| 831 |
Expression of SoxE and SoxD genes in human gliomas.Neuropathol Appl Neurobiol. 2007 Dec;33(6):621-30. doi: 10.1111/j.1365-2990.2007.00881.x. Epub 2007 Oct 24.
|
| 832 |
Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.Mol Ther. 2006 Sep;14(3):371-81. doi: 10.1016/j.ymthe.2006.05.006. Epub 2006 Jun 23.
|
| 833 |
Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: Evidence for a role of alpha5-laminin(s) and alpha3beta1 integrin.Exp Cell Res. 2007 Nov 1;313(18):3819-31. doi: 10.1016/j.yexcr.2007.07.038. Epub 2007 Aug 16.
|
| 834 |
Expression of PINCH protein in gliomas and its clinicopathological significance.Oncology. 2007;72(5-6):343-6. doi: 10.1159/000113064. Epub 2008 Jan 12.
|
| 835 |
EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling.Cancer Res. 2006 Feb 1;66(3):1583-90. doi: 10.1158/0008-5472.CAN-05-2424.
|
| 836 |
S100A13, a new marker of angiogenesis in human astrocytic gliomas.J Neurooncol. 2006 Dec;80(3):251-9. doi: 10.1007/s11060-006-9189-y. Epub 2006 Jun 14.
|
| 837 |
EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.Cancer Res. 2007 Jul 1;67(13):6121-9. doi: 10.1158/0008-5472.CAN-07-0141.
|
| 838 |
STI1 promotes glioma proliferation through MAPK and PI3K pathways.Glia. 2007 Dec;55(16):1690-8. doi: 10.1002/glia.20579.
|
| 839 |
The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.Cancer Res. 2015 Jan 1;75(1):16-21. doi: 10.1158/0008-5472.CAN-14-1891. Epub 2014 Nov 7.
|
| 840 |
GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.Cell Rep. 2017 Nov 21;21(8):2183-2197. doi: 10.1016/j.celrep.2017.10.083.
|
| 841 |
AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival.Int J Oncol. 2018 Jan;52(1):47-54. doi: 10.3892/ijo.2017.4184. Epub 2017 Nov 1.
|
| 842 |
Knockdown of Angiopoietin-Like Protein 2 Inhibits Proliferation and Invasion in Glioma Cells via Suppressing the ERK/MAPK Signaling Pathway.Oncol Res. 2017 Sep 21;25(8):1349-1355. doi: 10.3727/096504017X14874337324615. Epub 2017 Feb 28.
|
| 843 |
PKC- promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.Biochim Biophys Acta. 2011 Jun;1813(6):1190-7. doi: 10.1016/j.bbamcr.2011.03.007. Epub 2011 Mar 17.
|
| 844 |
Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.J Neurol Sci. 2016 Apr 15;363:80-3. doi: 10.1016/j.jns.2016.02.032. Epub 2016 Feb 16.
|
| 845 |
Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.J Mol Neurosci. 2019 Dec;69(4):527-537. doi: 10.1007/s12031-019-01355-3. Epub 2019 Aug 3.
|
| 846 |
MicroRNA-6807-3p promotes the tumorigenesis of glioma by targeting downstream DACH1.Brain Res. 2019 Apr 1;1708:47-57. doi: 10.1016/j.brainres.2018.12.008. Epub 2018 Dec 5.
|
| 847 |
Doublecortin induces mitotic microtubule catastrophe and inhibits glioma cell invasion.J Neurochem. 2009 Jan;108(1):231-45. doi: 10.1111/j.1471-4159.2008.05758.x.
|
| 848 |
ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1.Neuro Oncol. 2019 Mar 18;21(4):462-473. doi: 10.1093/neuonc/noy207.
|
| 849 |
T11TS Treatment Augments Apoptosis of Glioma Associated Brain Endothelial Cells, Hint Toward Anti-Angiogenic Action in Glioma.J Cell Physiol. 2017 Mar;232(3):526-539. doi: 10.1002/jcp.25447. Epub 2016 Jun 21.
|
| 850 |
Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma.Toxicol Appl Pharmacol. 2013 May 1;268(3):318-30. doi: 10.1016/j.taap.2013.02.001. Epub 2013 Feb 9.
|
| 851 |
MicroRNA-302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma.Oncol Rep. 2017 Feb;37(2):1159-1167. doi: 10.3892/or.2016.5320. Epub 2016 Dec 15.
|
| 852 |
Crotoxin from Crotalus durissus terrificus venom: In vitro cytotoxic activity of a heterodimeric phospholipase A(2) on human cancer-derived cell lines.Toxicon. 2018 Dec 15;156:13-22. doi: 10.1016/j.toxicon.2018.10.306. Epub 2018 Nov 2.
|
| 853 |
Tetraspanin 8-rictor-integrin 3 complex is required for glioma cell migration.Int J Mol Sci. 2015 Mar 9;16(3):5363-74. doi: 10.3390/ijms16035363.
|
| 854 |
The molecular and cell biology of pediatric low-grade gliomas.Oncogene. 2014 Apr 17;33(16):2019-26. doi: 10.1038/onc.2013.148. Epub 2013 Apr 29.
|
| 855 |
Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines.Nucl Med Biol. 2000 Apr;27(3):299-307. doi: 10.1016/s0969-8051(00)00085-8.
|
| 856 |
Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling.Biochem Cell Biol. 2019 Aug;97(4):488-496. doi: 10.1139/bcb-2018-0114. Epub 2018 Dec 11.
|
| 857 |
PBX3/MEK/ERK1/2/LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion.J Exp Clin Cancer Res. 2018 Jul 17;37(1):158. doi: 10.1186/s13046-018-0841-0.
|
| 858 |
iASPP, a microRNA?24 target, is aberrantly expressed in astrocytoma and regulatesmalignantgliomacellmigration and viability.Mol Med Rep. 2018 Jan;17(1):1970-1978. doi: 10.3892/mmr.2017.8097. Epub 2017 Nov 15.
|
| 859 |
Baicalein Induces Autophagy and Apoptosis through AMPK Pathway in Human Glioma Cells.Am J Chin Med. 2019;47(6):1405-1418. doi: 10.1142/S0192415X19500721. Epub 2019 Sep 5.
|
| 860 |
PRRT2 inhibits the proliferation of glioma cells by modulating unfolded protein response pathway.Biochem Biophys Res Commun. 2017 Apr 1;485(2):454-460. doi: 10.1016/j.bbrc.2017.02.052. Epub 2017 Feb 10.
|
| 861 |
Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma.Aging (Albany NY). 2019 Aug 4;11(15):5463-5482. doi: 10.18632/aging.102131. Epub 2019 Aug 4.
|
| 862 |
RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs.Brain Pathol. 2009 Apr;19(2):279-92. doi: 10.1111/j.1750-3639.2008.00185.x. Epub 2008 Jun 25.
|
| 863 |
Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner.Oncotarget. 2017 Jan 10;8(2):3380-3395. doi: 10.18632/oncotarget.13769.
|
| 864 |
Glioma and Neurokinin-1 Receptor Antagonists: A New Therapeutic Approach.Anticancer Agents Med Chem. 2019;19(1):92-100. doi: 10.2174/1871520618666180420165401.
|
| 865 |
Human three prime exonuclease TREX1 is induced by genotoxic stress and involved in protection of glioma and melanoma cells to anticancer drugs. Biochim Biophys Acta. 2013 Aug;1833(8):1832-43. doi: 10.1016/j.bbamcr.2013.03.029. Epub 2013 Apr 8.
|
| 866 |
Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.J Exp Clin Cancer Res. 2019 Jun 11;38(1):248. doi: 10.1186/s13046-019-1200-5.
|
| 867 |
Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K/Akt/NF-B signaling pathway.Biosci Rep. 2018 Dec 11;38(6):BSR20181711. doi: 10.1042/BSR20181711. Print 2018 Dec 21.
|
| 868 |
Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.Oncol Lett. 2017 May;13(5):3080-3086. doi: 10.3892/ol.2017.5799. Epub 2017 Mar 3.
|
| 869 |
ACSL4 suppresses glioma cells proliferation via activating ferroptosis.Oncol Rep. 2020 Jan;43(1):147-158. doi: 10.3892/or.2019.7419. Epub 2019 Nov 27.
|
| 870 |
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.Oncogene. 2009 Jan 8;28(1):9-19. doi: 10.1038/onc.2008.355. Epub 2008 Sep 22.
|
| 871 |
ACTC1 as an invasion and prognosis marker in glioma.J Neurosurg. 2017 Feb;126(2):467-475. doi: 10.3171/2016.1.JNS152075. Epub 2016 Apr 15.
|
| 872 |
Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.Cell Death Dis. 2018 May 1;9(5):517. doi: 10.1038/s41419-018-0548-3.
|
| 873 |
The effects of gene polymorphisms on glioma prognosis.J Gene Med. 2017 Nov;19(11):345-352. doi: 10.1002/jgm.2989. Epub 2017 Nov 8.
|
| 874 |
Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma.Onco Targets Ther. 2017 May 24;10:2721-2728. doi: 10.2147/OTT.S138912. eCollection 2017.
|
| 875 |
Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.Acta Neuropathol. 2017 Dec;134(6):905-922. doi: 10.1007/s00401-017-1774-y. Epub 2017 Oct 13.
|
| 876 |
Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.Oncol Rep. 2015 Jun;33(6):2845-52. doi: 10.3892/or.2015.3907. Epub 2015 Apr 8.
|
| 877 |
ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2(Q607R).Cancer Cell Int. 2018 Dec 3;18:196. doi: 10.1186/s12935-018-0695-8. eCollection 2018.
|
| 878 |
Androglobin knockdown inhibits growth of glioma cell lines.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2179-84. eCollection 2014.
|
| 879 |
Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.PLoS One. 2013 Apr 26;8(4):e62765. doi: 10.1371/journal.pone.0062765. Print 2013.
|
| 880 |
ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK/STAT3/HIF-1 signaling axis.Sci Rep. 2019 Sep 25;9(1):13904. doi: 10.1038/s41598-019-50375-x.
|
| 881 |
AdipoR1-mediated miR-3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway.Oncol Rep. 2017 Jun;37(6):3387-3396. doi: 10.3892/or.2017.5589. Epub 2017 Apr 20.
|
| 882 |
AEBP1 down regulation induced cell death pathway depends on PTEN status of glioma cells.Sci Rep. 2019 Oct 10;9(1):14577. doi: 10.1038/s41598-019-51068-1.
|
| 883 |
Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2.Aging (Albany NY). 2019 Aug 5;11(15):5300-5318. doi: 10.18632/aging.102092. Epub 2019 Aug 5.
|
| 884 |
The Effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 Axis Regulating Glioblastoma Angiogenesis.Front Mol Neurosci. 2018 Jan 9;10:437. doi: 10.3389/fnmol.2017.00437. eCollection 2017.
|
| 885 |
Tudor-staphylococcal nuclease regulates the expression and biological function of alkylglycerone phosphate synthase via nuclear factor-B and microRNA-127 in human glioma U87MG cells.Oncol Lett. 2018 Jun;15(6):9553-9558. doi: 10.3892/ol.2018.8484. Epub 2018 Apr 13.
|
| 886 |
AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma.J Cancer. 2017 Aug 25;8(15):2924-2932. doi: 10.7150/jca.20277. eCollection 2017.
|
| 887 |
Deoxypodophyllotoxin triggers parthanatos in glioma cells via induction of excessive ROS.Cancer Lett. 2016 Feb 28;371(2):194-204. doi: 10.1016/j.canlet.2015.11.044. Epub 2015 Dec 9.
|
| 888 |
Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma.Sci Rep. 2019 Jun 11;9(1):8480. doi: 10.1038/s41598-019-44854-4.
|
| 889 |
Endothelial Monocyte-Activating Polypeptide-II Induces BNIP3-Mediated Mitophagy to Enhance Temozolomide Cytotoxicity of Glioma Stem Cells via Down-Regulating MiR-24-3p.Front Mol Neurosci. 2018 Mar 26;11:92. doi: 10.3389/fnmol.2018.00092. eCollection 2018.
|
| 890 |
siRNA-mediated knockdown of JUB expression suppresses the proliferation of glioblastoma cells.Cancer Biomark. 2015;15(4):477-84. doi: 10.3233/CBM-150491.
|
| 891 |
Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.J Neuropathol Exp Neurol. 2013 Oct;72(10):933-41. doi: 10.1097/NEN.0b013e3182a59a88.
|
| 892 |
Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis.BMC Neurol. 2019 Nov 23;19(1):296. doi: 10.1186/s12883-019-1504-2.
|
| 893 |
High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.Cell Biol Int. 2020 Feb;44(2):569-582. doi: 10.1002/cbin.11257. Epub 2019 Nov 7.
|
| 894 |
Whole-Genome mRNA Gene Expression Differs Between Patients With and Without Delirium.J Geriatr Psychiatry Neurol. 2018 Jul;31(4):203-210. doi: 10.1177/0891988718785774. Epub 2018 Jul 10.
|
| 895 |
Up-regulation of ANKDR49, a poor prognostic factor, regulates cell proliferation of gliomas.Biosci Rep. 2017 Aug 4;37(4):BSR20170800. doi: 10.1042/BSR20170800. Print 2017 Aug 31.
|
| 896 |
ANO6 promotes cell proliferation and invasion in glioma through regulating the ERK signaling pathway.Onco Targets Ther. 2019 Aug 20;12:6721-6731. doi: 10.2147/OTT.S211725. eCollection 2019.
|
| 897 |
PHAP1 promotes glioma cell proliferation by regulating the Akt/p27/stathmin pathway.J Cell Mol Med. 2018 Jul;22(7):3595-3604. doi: 10.1111/jcmm.13639. Epub 2018 Apr 18.
|
| 898 |
Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7.Sci Rep. 2015 Jun 11;5:11066. doi: 10.1038/srep11066.
|
| 899 |
Anti-miRNA-23a oligonucleotide suppresses glioma cells growth by targeting apoptotic protease activating factor-1.Curr Pharm Des. 2013;19(35):6382-9. doi: 10.2174/13816128113199990509.
|
| 900 |
Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973-2014.Cancer Med. 2018 Oct;7(10):5281-5290. doi: 10.1002/cam4.1757. Epub 2018 Sep 2.
|
| 901 |
Expression of amyloid precursor-like protein 2 (APLP2) in glioblastoma is associated with patient prognosis.Folia Neuropathol. 2018;56(1):30-38. doi: 10.5114/fn.2018.74657.
|
| 902 |
APOBEC3B is expressed in human glioma, and influences cell proliferation and temozolomide resistance.Oncol Rep. 2018 Nov;40(5):2742-2749. doi: 10.3892/or.2018.6698. Epub 2018 Sep 10.
|
| 903 |
Multifunctional protein APPL2 contributes to survival of human glioma cells.Mol Oncol. 2013 Feb;7(1):67-84. doi: 10.1016/j.molonc.2012.08.003. Epub 2012 Sep 5.
|
| 904 |
Knockdown of apoptosis repressor with caspase recruitment domain (ARC) increases the sensitivity of human glioma cell line U251MG to VM-26.Int J Clin Exp Pathol. 2012;5(6):555-61. Epub 2012 Jul 29.
|
| 905 |
Fine mapping of a region of chromosome 11q23.3 reveals independent locus associated with risk of glioma.PLoS One. 2012;7(12):e52864. doi: 10.1371/journal.pone.0052864. Epub 2012 Dec 31.
|
| 906 |
ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway.Cancer Res. 2009 Feb 1;69(3):794-801. doi: 10.1158/0008-5472.CAN-08-2110. Epub 2009 Jan 20.
|
| 907 |
Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.Cell Death Dis. 2018 Jun 4;9(6):673. doi: 10.1038/s41419-018-0707-6.
|
| 908 |
Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population.Med Oncol. 2011 Dec;28 Suppl 1:S445-52. doi: 10.1007/s12032-010-9671-4. Epub 2010 Sep 16.
|
| 909 |
Expression of CXC-motif-chemokine 12 and the receptor C-X-C receptor 4 in glioma and theeffect on peritumoral brain edema.Oncol Lett. 2018 Feb;15(2):2501-2507. doi: 10.3892/ol.2017.7547. Epub 2017 Dec 8.
|
| 910 |
Interplay between PCBP2 and miRNA modulates ARHGDIA expression and function in glioma migration and invasion.Oncotarget. 2016 Apr 12;7(15):19483-98. doi: 10.18632/oncotarget.6869.
|
| 911 |
PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival.Neoplasia. 2018 Oct;20(10):1045-1058. doi: 10.1016/j.neo.2018.08.008. Epub 2018 Sep 13.
|
| 912 |
SGEF Is Regulated via TWEAK/Fn14/NF-B Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.Mol Cancer Res. 2016 Mar;14(3):302-12. doi: 10.1158/1541-7786.MCR-15-0183. Epub 2016 Jan 13.
|
| 913 |
Absence of host NF-B p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.Cancer Immunol Immunother. 2018 Oct;67(10):1491-1503. doi: 10.1007/s00262-018-2184-2. Epub 2018 Jul 21.
|
| 914 |
ARL3 is downregulated and acts as a prognostic biomarker in glioma.J Transl Med. 2019 Jun 24;17(1):210. doi: 10.1186/s12967-019-1914-3.
|
| 915 |
System analysis identifies distinct and common functional networks governed by transcription factor ASCL1, in glioma and small cell lung cancer.Mol Biosyst. 2017 Jul 25;13(8):1481-1494. doi: 10.1039/c6mb00851h.
|
| 916 |
KLF7 promotes polyamine biosynthesis and glioma development through transcriptionally activating ASL.Biochem Biophys Res Commun. 2019 Jun 18;514(1):51-57. doi: 10.1016/j.bbrc.2019.04.120. Epub 2019 Apr 21.
|
| 917 |
Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma.Anticancer Res. 2018 May;38(5):2627-2634. doi: 10.21873/anticanres.12504.
|
| 918 |
MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells.J Neurooncol. 2015 Jan;121(1):63-72. doi: 10.1007/s11060-014-1607-y. Epub 2014 Sep 26.
|
| 919 |
miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma.Biochem Biophys Res Commun. 2017 Sep 2;490(4):1260-1267. doi: 10.1016/j.bbrc.2017.05.179. Epub 2017 Jun 7.
|
| 920 |
Xanthatin induces glioma cell apoptosis and inhibits tumor growth via activating endoplasmic reticulum stress-dependent CHOP pathway.Acta Pharmacol Sin. 2020 Mar;41(3):404-414. doi: 10.1038/s41401-019-0318-5. Epub 2019 Nov 7.
|
| 921 |
Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.J Exp Clin Cancer Res. 2019 Jul 10;38(1):298. doi: 10.1186/s13046-019-1287-8.
|
| 922 |
Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma.Biochem Biophys Res Commun. 2017 Oct 21;492(3):480-486. doi: 10.1016/j.bbrc.2017.08.070. Epub 2017 Aug 20.
|
| 923 |
Radiosensitization of orthotopic GIC-driven glioblastoma by doxycycline causes skin damage.Radiat Oncol. 2019 Apr 8;14(1):58. doi: 10.1186/s13014-019-1266-4.
|
| 924 |
Glioma-amplified sequence KUB3 influences double-strand break repair after ionizing radiation.Int J Oncol. 2013 Jul;43(1):50-6. doi: 10.3892/ijo.2013.1937. Epub 2013 May 13.
|
| 925 |
(Pro)renin receptor is crucial for glioma development via the Wnt/-catenin signaling pathway.J Neurosurg. 2017 Oct;127(4):819-828. doi: 10.3171/2016.9.JNS16431. Epub 2017 Jan 6.
|
| 926 |
Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration.Clin Cancer Res. 2006 Nov 1;12(21):6331-6. doi: 10.1158/1078-0432.CCR-06-1296.
|
| 927 |
Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition.Cancer Res. 2020 Feb 1;80(3):510-523. doi: 10.1158/0008-5472.CAN-18-3374. Epub 2019 Sep 24.
|
| 928 |
Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.AJNR Am J Neuroradiol. 2018 Oct;39(10):1814-1820. doi: 10.3174/ajnr.A5794. Epub 2018 Sep 6.
|
| 929 |
1,4-Galactosyltransferase V activates Notch1 signaling in glioma stem-like cells and promotes their transdifferentiation into endothelial cells.J Biol Chem. 2018 Feb 9;293(6):2219-2230. doi: 10.1074/jbc.RA117.000682. Epub 2017 Dec 21.
|
| 930 |
Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE.J Exp Clin Cancer Res. 2016 Oct 12;35(1):162. doi: 10.1186/s13046-016-0431-y.
|
| 931 |
BAMBI promotes macrophage proliferation and differentiation in gliomas.Mol Med Rep. 2018 Mar;17(3):3960-3966. doi: 10.3892/mmr.2017.8320. Epub 2017 Dec 20.
|
| 932 |
Upregulation of circular RNA circ_0034642 indicates unfavorable prognosis in glioma and facilitates cell proliferation and invasion via the miR-1205/BATF3 axis.J Cell Biochem. 2019 Aug;120(8):13737-13744. doi: 10.1002/jcb.28646. Epub 2019 Apr 2.
|
| 933 |
Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells.Mol Cell Biol. 2011 Mar;31(6):1174-85. doi: 10.1128/MCB.00903-10. Epub 2011 Jan 18.
|
| 934 |
ZNF436 promotes tumor cell proliferation through transcriptional activation of BCL10 in glioma.Biochem Biophys Res Commun. 2019 Aug 6;515(4):572-578. doi: 10.1016/j.bbrc.2019.06.004. Epub 2019 Jun 6.
|
| 935 |
Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.Mol Neurobiol. 2016 Aug;53(6):3528-3539. doi: 10.1007/s12035-015-9231-1. Epub 2015 Jun 23.
|
| 936 |
Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.Int J Oncol. 2015 Mar;46(3):1304-16. doi: 10.3892/ijo.2015.2838. Epub 2015 Jan 13.
|
| 937 |
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas.Sci Transl Med. 2018 Jul 4;10(448):eaar2238. doi: 10.1126/scitranslmed.aar2238.
|
| 938 |
CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.Brain Pathol. 2018 Sep;28(5):710-720. doi: 10.1111/bpa.12585. Epub 2017 Dec 28.
|
| 939 |
Hypoxia-inducible factor-2 (HIF-2), but not HIF-1, is essential for hypoxic induction of class III -tubulin expression in human glioblastoma cells.FEBS J. 2014 Dec;281(23):5220-36. doi: 10.1111/febs.13062. Epub 2014 Oct 13.
|
| 940 |
FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG.J Exp Clin Cancer Res. 2019 Jan 28;38(1):37. doi: 10.1186/s13046-018-0991-0.
|
| 941 |
BHLHE41 promotes U87 and U251 cell proliferation via ERK/cyclinD1 signaling pathway.Cancer Manag Res. 2019 Aug 14;11:7657-7672. doi: 10.2147/CMAR.S214697. eCollection 2019.
|
| 942 |
Bromodomain PHDfinger transcription factor promotes glioma progression and indicates poor prognosis.Oncol Rep. 2019 Jan;41(1):246-256. doi: 10.3892/or.2018.6832. Epub 2018 Oct 30.
|
| 943 |
BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-/PI3K/AKT/mTOR signalling pathway.Cell Oncol (Dordr). 2020 Apr;43(2):223-235. doi: 10.1007/s13402-019-00482-8. Epub 2019 Nov 27.
|
| 944 |
Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.Oncotarget. 2014 Nov 15;5(21):10901-15. doi: 10.18632/oncotarget.2543.
|
| 945 |
BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells.PLoS One. 2014 May 30;9(5):e98544. doi: 10.1371/journal.pone.0098544. eCollection 2014.
|
| 946 |
Decreased BRMS1L expression is correlated with glioma grade and predicts poor survival in glioblastoma via an invasive phenotype.Cancer Biomark. 2018;22(2):311-316. doi: 10.3233/CBM-171019.
|
| 947 |
Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.Gene. 2004 Sep 29;340(1):61-9. doi: 10.1016/j.gene.2004.05.028.
|
| 948 |
-transducin repeat-containing E3 ubiquitin protein ligase inhibits migration, invasion and proliferation of glioma cells.Oncol Lett. 2017 Sep;14(3):3131-3135. doi: 10.3892/ol.2017.6533. Epub 2017 Jul 7.
|
| 949 |
An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome.Cancer Causes Control. 2012 Sep;23(9):1443-9. doi: 10.1007/s10552-012-0018-7. Epub 2012 Jun 28.
|
| 950 |
Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.Eur J Pharm Biopharm. 2018 Nov;132:168-179. doi: 10.1016/j.ejpb.2018.09.012. Epub 2018 Sep 20.
|
| 951 |
CA10 and CA11 negatively regulate neuronal activity-dependent growth of gliomas.Mol Oncol. 2019 May;13(5):1018-1032. doi: 10.1002/1878-0261.12445. Epub 2019 Mar 20.
|
| 952 |
MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1/VEGF Signaling Pathway by Targeting CAB39.Hum Gene Ther Clin Dev. 2018 Sep;29(3):156-166. doi: 10.1089/humc.2018.133.
|
| 953 |
CacyBP/SIP inhibits the migration and invasion behaviors of glioblastoma cells through activating Siah1 mediated ubiquitination and degradation of cytoplasmic p27.Cell Biol Int. 2018 Feb;42(2):216-226. doi: 10.1002/cbin.10889. Epub 2017 Nov 15.
|
| 954 |
LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.Int J Clin Exp Pathol. 2014 May 15;7(6):3065-72. eCollection 2014.
|
| 955 |
CADM2 inhibits human glioma proliferation, migration and invasion.Oncol Rep. 2019 Apr;41(4):2273-2280. doi: 10.3892/or.2019.7010. Epub 2019 Feb 13.
|
| 956 |
Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.Glia. 2009 Jul;57(9):989-99. doi: 10.1002/glia.20823.
|
| 957 |
Low-molecular weight caldesmon as a potential serum marker for glioma.Clin Cancer Res. 2005 Jun 15;11(12):4388-92. doi: 10.1158/1078-0432.CCR-04-2512.
|
| 958 |
Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma.Drug Deliv. 2018 Nov;25(1):1718-1727. doi: 10.1080/10717544.2018.1494225.
|
| 959 |
Analysis of clinical characteristics of macrophage capping protein (CAPG) gene expressed in glioma based on TCGA data and clinical experiments.Oncol Lett. 2019 Aug;18(2):1344-1350. doi: 10.3892/ol.2019.10396. Epub 2019 May 23.
|
| 960 |
Increased expression of Capn4 is associated with the malignancy of human glioma.CNS Neurosci Ther. 2014 Jun;20(6):521-7. doi: 10.1111/cns.12248. Epub 2014 Mar 15.
|
| 961 |
CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line.Tumour Biol. 2014 Jan;35(1):149-54. doi: 10.1007/s13277-013-1018-2. Epub 2013 Jul 27.
|
| 962 |
Long Non-Coding RNA LINC01260 Inhibits the Proliferation, Migration and Invasion of Spinal Cord Glioma Cells by Targeting CARD11 Via the NF-B Signaling Pathway.Cell Physiol Biochem. 2018;48(4):1563-1578. doi: 10.1159/000492279. Epub 2018 Aug 2.
|
| 963 |
SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.J Neurooncol. 2019 May;142(3):423-434. doi: 10.1007/s11060-019-03126-x. Epub 2019 Mar 5.
|
| 964 |
Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.CNS Neurosci Ther. 2019 Mar;25(3):343-354. doi: 10.1111/cns.13072. Epub 2018 Oct 11.
|
| 965 |
Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma.Onco Targets Ther. 2018 Oct 17;11:7133-7142. doi: 10.2147/OTT.S176410. eCollection 2018.
|
| 966 |
Circ-EZH2 knockdown reverses DDAH1 and CBX3-mediated cell growth and invasion in glioma through miR-1265 sponge activity.Gene. 2020 Feb 5;726:144196. doi: 10.1016/j.gene.2019.144196. Epub 2019 Oct 26.
|
| 967 |
Chemokine (C-C motif) ligand 18 is highly expressed in glioma tissues and promotes invasion of glioblastoma cells.J Cancer Res Ther. 2019;15(2):358-364. doi: 10.4103/jcrt.JCRT_360_17.
|
| 968 |
CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling.Lab Invest. 2020 Apr;100(4):619-629. doi: 10.1038/s41374-019-0345-3. Epub 2019 Nov 20.
|
| 969 |
Revealing the potential pathogenesis of glioma by utilizing a glioma associated protein-protein interaction network.Pathol Oncol Res. 2015 Apr;21(2):455-62. doi: 10.1007/s12253-014-9848-9. Epub 2014 Nov 20.
|
| 970 |
Three meta-analyses define a set of commonly overexpressed genes from microarray datasets on astrocytomas.Mol Neurobiol. 2013 Feb;47(1):325-36. doi: 10.1007/s12035-012-8367-5. Epub 2012 Nov 8.
|
| 971 |
Cyclin F-Dependent Degradation of RBPJ Inhibits IDH1(R132H)-Mediated Tumorigenesis.Cancer Res. 2018 Nov 15;78(22):6386-6398. doi: 10.1158/0008-5472.CAN-18-1772. Epub 2018 Sep 25.
|
| 972 |
Cyclin G2 Inhibits the Warburg Effect and Tumour Progression by Suppressing LDHA Phosphorylation in Glioma.Int J Biol Sci. 2019 Jan 1;15(3):544-555. doi: 10.7150/ijbs.30297. eCollection 2019.
|
| 973 |
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults.Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1655-61. doi: 10.1158/1055-9965.EPI-07-0314.
|
| 974 |
(18)F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy.J Neurooncol. 2018 Sep;139(3):721-730. doi: 10.1007/s11060-018-2919-0. Epub 2018 Jun 8.
|
| 975 |
Upregulation of chemokine receptor CCR10 is essential for glioma proliferation, invasion and patient survival.Oncotarget. 2014 Aug 30;5(16):6576-83. doi: 10.18632/oncotarget.2134.
|
| 976 |
Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.Artif Cells Nanomed Biotechnol. 2018;46(sup2):704-719. doi: 10.1080/21691401.2018.1468768. Epub 2018 May 10.
|
| 977 |
Overexpression of CCT8 and its significance for tumor cell proliferation, migration and invasion in glioma.Pathol Res Pract. 2015 Oct;211(10):717-25. doi: 10.1016/j.prp.2015.04.012. Epub 2015 May 19.
|
| 978 |
Revealing the glioma cancer stem cell interactome, one niche at a time.J Pathol. 2018 Mar;244(3):260-264. doi: 10.1002/path.5024. Epub 2018 Feb 2.
|
| 979 |
CD164 regulates proliferation, progression, and invasion of human glioblastoma cells.Oncotarget. 2019 Mar 12;10(21):2041-2054. doi: 10.18632/oncotarget.26724. eCollection 2019 Mar 12.
|
| 980 |
Epigenetic biomarkers of T-cells in human glioma.Epigenetics. 2012 Dec 1;7(12):1391-402. doi: 10.4161/epi.22675. Epub 2012 Oct 29.
|
| 981 |
CD48 is a key molecule of immunomodulation affecting prognosis in glioma.Onco Targets Ther. 2019 May 28;12:4181-4193. doi: 10.2147/OTT.S198762. eCollection 2019.
|
| 982 |
Characteristics of the expression of KAI1/CD82 and PDGFR and their impact on glioma progression.Folia Neuropathol. 2016;54(3):241-248. doi: 10.5114/fn.2016.62554.
|
| 983 |
Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.Cancer Res. 2015 Nov 1;75(21):4504-16. doi: 10.1158/0008-5472.CAN-14-3636. Epub 2015 Sep 11.
|
| 984 |
CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and Invasion.Int J Mol Sci. 2019 Mar 6;20(5):1137. doi: 10.3390/ijms20051137.
|
| 985 |
Elevated IQGAP1 and CDC42 levels correlate with tumor malignancy of human glioma.Oncol Rep. 2017 Feb;37(2):768-776. doi: 10.3892/or.2016.5341. Epub 2016 Dec 29.
|
| 986 |
Overexpression of circular RNA circ-CDC45 facilitates glioma cell progression by sponging miR-516b and miR-527 and predicts an adverse prognosis.J Cell Biochem. 2020 Jan;121(1):690-697. doi: 10.1002/jcb.29315. Epub 2019 Aug 12.
|
| 987 |
Cell division cycle associated 7 like predicts unfavorable prognosis and promotes invasion in glioma.Pathol Res Pract. 2019 Jan;215(1):50-56. doi: 10.1016/j.prp.2018.10.023. Epub 2018 Oct 24.
|
| 988 |
Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.J Neurosurg. 2013 Nov;119(5):1331-9. doi: 10.3171/2013.7.JNS122340. Epub 2013 Sep 6.
|
| 989 |
A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients.Cell Physiol Biochem. 2018;48(4):1755-1770. doi: 10.1159/000492317. Epub 2018 Aug 3.
|
| 990 |
Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.Oncogene. 2018 Feb 1;37(5):651-662. doi: 10.1038/onc.2017.372. Epub 2017 Oct 9.
|
| 991 |
Cdh4 Down-Regulation Impairs in Vivo Infiltration and Malignancy in Patients Derived Glioblastoma Cells.Int J Mol Sci. 2019 Aug 18;20(16):4028. doi: 10.3390/ijms20164028.
|
| 992 |
Cyclindependent kinase 10 prevents glioma metastasis via modulation of Snail expression.Mol Med Rep. 2018 Jul;18(1):1165-1170. doi: 10.3892/mmr.2018.9059. Epub 2018 May 23.
|
| 993 |
Knockdown of CDK2AP1 by RNA interference inhibits cell growth and tumorigenesis of human glioma.Neurol Res. 2014 Jul;36(7):659-65. doi: 10.1179/1743132813Y.0000000298. Epub 2013 Dec 19.
|
| 994 |
Anti-proliferative effect of Zea mays L. cob extract on rat C6 glioma cells through regulation of glycolysis, mitochondrial ROS, and apoptosis.Biomed Pharmacother. 2018 Feb;98:726-732. doi: 10.1016/j.biopha.2017.12.115. Epub 2018 Jan 4.
|
| 995 |
3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas.AJNR Am J Neuroradiol. 2017 Oct;38(10):1876-1883. doi: 10.3174/ajnr.A5299. Epub 2017 Jul 20.
|
| 996 |
CELF1 is Up-Regulated in Glioma and Promotes Glioma Cell Proliferation by Suppression of CDKN1B.Int J Biol Sci. 2015 Sep 22;11(11):1314-24. doi: 10.7150/ijbs.11344. eCollection 2015.
|
| 997 |
Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.Int J Oncol. 2015 Sep;47(3):1025-33. doi: 10.3892/ijo.2015.3080. Epub 2015 Jul 10.
|
| 998 |
Knockdown of circular RNA CEP128 suppresses proliferation and improves cytotoxic efficacy of temozolomide in glioma cells by regulating miR-145-5p.Neuroreport. 2019 Dec 18;30(18):1231-1238. doi: 10.1097/WNR.0000000000001326.
|
| 999 |
CEP55 promoted the migration, invasion and neuroshpere formation of the glioma cell line U251.Neurosci Lett. 2019 Jul 13;705:80-86. doi: 10.1016/j.neulet.2019.04.038. Epub 2019 Apr 18.
|
| 1000 |
Overexpression of ceramide synthase 1 increases C18-ceramide and leads to lethal autophagy in human glioma.Oncotarget. 2017 Oct 23;8(61):104022-104036. doi: 10.18632/oncotarget.21955. eCollection 2017 Nov 28.
|
| 1001 |
The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity.Neuropharmacology. 2017 Apr;116:300-314. doi: 10.1016/j.neuropharm.2016.12.011. Epub 2016 Dec 13.
|
| 1002 |
MATN1-AS1 promotes glioma progression by functioning as ceRNA of miR-200b/c/429 to regulate CHD1 expression.Cell Prolif. 2020 Jan;53(1):e12700. doi: 10.1111/cpr.12700. Epub 2019 Oct 30.
|
| 1003 |
EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients.J Mol Cell Biol. 2017 Dec 1;9(6):477-488. doi: 10.1093/jmcb/mjx056.
|
| 1004 |
Role of CHD5 in human cancers: 10 years later.Cancer Res. 2014 Feb 1;74(3):652-8. doi: 10.1158/0008-5472.CAN-13-3056. Epub 2014 Jan 13.
|
| 1005 |
CHL1 Is Expressed and Functions as a Malignancy Promoter in Glioma Cells.Front Mol Neurosci. 2017 Oct 17;10:324. doi: 10.3389/fnmol.2017.00324. eCollection 2017.
|
| 1006 |
CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas.Ann Neurol. 2015 Sep;78(3):355-74. doi: 10.1002/ana.24443. Epub 2015 Jul 27.
|
| 1007 |
CISD2 promotes the proliferation of glioma cells via suppressing beclin?mediated autophagy and is targeted by microRNA?49a.Mol Med Rep. 2017 Dec;16(6):7939-7948. doi: 10.3892/mmr.2017.7642. Epub 2017 Sep 27.
|
| 1008 |
CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in highgradeglioma.Oncol Rep. 2018 Oct;40(4):2036-2046. doi: 10.3892/or.2018.6611. Epub 2018 Aug 1.
|
| 1009 |
GLI2 promotes cell proliferation and migration through transcriptional activation of ARHGEF16 in human glioma cells.J Exp Clin Cancer Res. 2018 Oct 11;37(1):247. doi: 10.1186/s13046-018-0917-x.
|
| 1010 |
Role of Cl(-) channels in primary brain tumour.Cell Calcium. 2019 Jul;81:1-11. doi: 10.1016/j.ceca.2019.05.004. Epub 2019 May 14.
|
| 1011 |
Clozapine induces chloride channel-4 expression through PKA activation and modulates CDK5 expression in SH-SY5Y and U87 cells.Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:168-73. doi: 10.1016/j.pnpbp.2014.09.002. Epub 2014 Sep 20.
|
| 1012 |
CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma.Cancer Gene Ther. 2020 Sep;27(9):669-679. doi: 10.1038/s41417-019-0140-8. Epub 2019 Oct 8.
|
| 1013 |
Inhibition of CLIC4 enhances autophagy and triggers mitochondrial and ER stress-induced apoptosis in human glioma U251 cells under starvation.PLoS One. 2012;7(6):e39378. doi: 10.1371/journal.pone.0039378. Epub 2012 Jun 25.
|
| 1014 |
Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population.Int J Cancer. 2012 Oct 1;131(7):1569-76. doi: 10.1002/ijc.27417. Epub 2012 Mar 2.
|
| 1015 |
CMIP Promotes Proliferation and Metastasis in Human Glioma.Biomed Res Int. 2017;2017:5340160. doi: 10.1155/2017/5340160. Epub 2017 Jul 4.
|
| 1016 |
CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas.EBioMedicine. 2018 Sep;35:233-243. doi: 10.1016/j.ebiom.2018.08.012. Epub 2018 Aug 18.
|
| 1017 |
Knockdown of collagen -1(III) inhibits glioma cell proliferation and migration and is regulated by miR128-3p.Oncol Lett. 2018 Aug;16(2):1917-1923. doi: 10.3892/ol.2018.8830. Epub 2018 May 30.
|
| 1018 |
Tumstatin transfected into human glioma cell line U251 represses tumor growth by inhibiting angiogenesis.Chin Med J (Engl). 2013;126(9):1720-5.
|
| 1019 |
The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.Mol Neurobiol. 2017 Sep;54(7):5008-5016. doi: 10.1007/s12035-016-0033-x. Epub 2016 Aug 17.
|
| 1020 |
Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas.J Geriatr Oncol. 2014 Oct 1;5(4):389-99. doi: 10.1016/j.jgo.2014.08.003. Epub 2014 Sep 11.
|
| 1021 |
miR-26b Mimic Inhibits Glioma Proliferation In Vitro and In Vivo Suppressing COX-2 Expression. Oncol Res. 2019 Feb 5;27(2):147-155.
|
| 1022 |
Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit.Oncotarget. 2017 Jun 6;8(23):37568-37583. doi: 10.18632/oncotarget.17247.
|
| 1023 |
Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.Br J Pharmacol. 2019 Jun;176(11):1680-1699. doi: 10.1111/bph.14622. Epub 2019 Apr 29.
|
| 1024 |
Identification of COX5B as a novel biomarker in high-grade glioma patients.Onco Targets Ther. 2017 Nov 15;10:5463-5470. doi: 10.2147/OTT.S139243. eCollection 2017.
|
| 1025 |
Overexpression of COX7A2 is associated with a good prognosis in patients with glioma.J Neurooncol. 2018 Jan;136(1):41-50. doi: 10.1007/s11060-017-2637-z. Epub 2017 Oct 27.
|
| 1026 |
Long non-coding RNA HCG11 modulates glioma progression through cooperating with miR-496/CPEB3 axis.Cell Prolif. 2019 Sep;52(5):e12615. doi: 10.1111/cpr.12615. Epub 2019 Jul 16.
|
| 1027 |
CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.Clin Neurol Neurosurg. 2018 Jun;169:92-97. doi: 10.1016/j.clineuro.2018.04.008. Epub 2018 Apr 3.
|
| 1028 |
Differential Effects of Doxazosin on Renin-Angiotensin-System- Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells.CNS Neurol Disord Drug Targets. 2019;18(1):29-36. doi: 10.2174/1871527317666181029111739.
|
| 1029 |
CREB3L1 and PTN expressions correlate with prognosis of brain glioma patients.Biosci Rep. 2018 May 22;38(3):BSR20170100. doi: 10.1042/BSR20170100. Print 2018 May 29.
|
| 1030 |
Overexpression of thrombospondin-1 reduces growth and vascular index but not perfusion in glioblastoma.Cancer Res. 2002 Feb 15;62(4):1191-5.
|
| 1031 |
Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas.Lab Invest. 2008 Sep;88(9):910-25. doi: 10.1038/labinvest.2008.66. Epub 2008 Jul 7.
|
| 1032 |
C-Terminal Binding Protein is Involved in Promoting to the Carcinogenesis of Human Glioma.Mol Neurobiol. 2017 Oct;54(8):6121-6132. doi: 10.1007/s12035-016-0159-x. Epub 2016 Oct 3.
|
| 1033 |
MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma.Cancer Biomark. 2017 Sep 7;20(3):289-297. doi: 10.3233/CBM-170128.
|
| 1034 |
miR-603 promotes glioma cell growth via Wnt/-catenin pathway by inhibiting WIF1 and CTNNBIP1.Cancer Lett. 2015 Apr 28;360(1):76-86. doi: 10.1016/j.canlet.2015.02.003. Epub 2015 Feb 10.
|
| 1035 |
-Catenin Promotes Bevacizumab-Induced Glioma Invasion.Mol Cancer Ther. 2019 Apr;18(4):812-822. doi: 10.1158/1535-7163.MCT-18-0138. Epub 2019 Mar 14.
|
| 1036 |
CUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-B signaling pathway.Int J Oncol. 2017 Jul;51(1):115-127. doi: 10.3892/ijo.2017.4009. Epub 2017 May 17.
|
| 1037 |
Cullin1 regulates proliferation, migration and invasion of glioma cells.Med Oncol. 2014 Oct;31(10):227. doi: 10.1007/s12032-014-0227-x. Epub 2014 Sep 9.
|
| 1038 |
Long non-coding RNA UCA1/miR-182/PFKFB2 axis modulates glioblastoma-associated stromal cells-mediated glycolysis and invasion of glioma cells.Biochem Biophys Res Commun. 2018 Jun 7;500(3):569-576. doi: 10.1016/j.bbrc.2018.04.091. Epub 2018 Apr 25.
|
| 1039 |
CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma.Front Immunol. 2018 Nov 27;9:2750. doi: 10.3389/fimmu.2018.02750. eCollection 2018.
|
| 1040 |
Selection of suitable reference genes for expression analysis in human glioma using RT-qPCR.J Neurooncol. 2015 May;123(1):35-42. doi: 10.1007/s11060-015-1772-7. Epub 2015 Apr 11.
|
| 1041 |
CYP4X1 Inhibition by Flavonoid CH625 Normalizes Glioma Vasculature through Reprogramming TAMs via CB2 and EGFR-STAT3 Axis.J Pharmacol Exp Ther. 2018 Apr;365(1):72-83. doi: 10.1124/jpet.117.247130. Epub 2018 Feb 1.
|
| 1042 |
Upregulation of DACT2 suppresses proliferation and enhances apoptosis of glioma cell via inactivation of YAP signaling pathway.Cell Death Dis. 2017 Aug 10;8(8):e2981. doi: 10.1038/cddis.2017.385.
|
| 1043 |
Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas.Mod Pathol. 2015 Aug;28(8):1064-73. doi: 10.1038/modpathol.2015.67. Epub 2015 May 29.
|
| 1044 |
The role of drebrin in glioma migration and invasion.Exp Cell Res. 2013 Feb 15;319(4):517-28. doi: 10.1016/j.yexcr.2012.11.008. Epub 2012 Nov 29.
|
| 1045 |
Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma.J Clin Neurosci. 2012 Jul;19(7):1016-21. doi: 10.1016/j.jocn.2011.10.008. Epub 2012 Apr 23.
|
| 1046 |
Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma.Oncogene. 2019 Dec;38(50):7473-7490. doi: 10.1038/s41388-019-0956-6. Epub 2019 Aug 23.
|
| 1047 |
TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway.J Neurooncol. 2019 Nov;145(2):211-222. doi: 10.1007/s11060-019-03301-0. Epub 2019 Oct 11.
|
| 1048 |
DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis.Brain. 2015 Sep;138(Pt 9):2553-70. doi: 10.1093/brain/awv167. Epub 2015 Jun 29.
|
| 1049 |
MicroRNA-628-5p inhibits cell proliferation in glioma by targeting DDX59.J Cell Biochem. 2019 Oct;120(10):17293-17302. doi: 10.1002/jcb.28991. Epub 2019 May 20.
|
| 1050 |
Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility.Sci Rep. 2015 Nov 27;5:17367. doi: 10.1038/srep17367.
|
| 1051 |
TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1/Derlin-1 pathway.J Hematol Oncol. 2017 Feb 20;10(1):52. doi: 10.1186/s13045-017-0422-2.
|
| 1052 |
RNA helicase DHX15 acts as a tumour suppressor in glioma.Br J Cancer. 2017 Oct 24;117(9):1349-1359. doi: 10.1038/bjc.2017.273. Epub 2017 Aug 22.
|
| 1053 |
Knockdown of Diaph1 expression inhibits migration and decreases the expression of MMP2 and MMP9 in human glioma cells.Biomed Pharmacother. 2017 Dec;96:596-602. doi: 10.1016/j.biopha.2017.10.031. Epub 2017 Oct 13.
|
| 1054 |
Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma.BMC Cancer. 2019 May 14;19(1):441. doi: 10.1186/s12885-019-5643-z.
|
| 1055 |
Knockdown of DIXDC1 Inhibits the Proliferation and Migration of Human Glioma Cells.Cell Mol Neurobiol. 2017 Aug;37(6):1009-1019. doi: 10.1007/s10571-016-0433-5. Epub 2016 Nov 5.
|
| 1056 |
Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasion.Invest New Drugs. 2019 Dec;37(6):1177-1186. doi: 10.1007/s10637-019-00748-w. Epub 2019 Mar 7.
|
| 1057 |
DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.Cancer Res. 2002 Mar 15;62(6):1790-6.
|
| 1058 |
Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma.J Neurooncol. 2017 Jan;131(2):255-265. doi: 10.1007/s11060-016-2308-5. Epub 2016 Nov 11.
|
| 1059 |
The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma.Neuro Oncol. 2018 Jun 18;20(7):930-941. doi: 10.1093/neuonc/noy007.
|
| 1060 |
In Vivo Molecular Profiling of Human Glioma : Cross-Sectional Observational Study Using Dynamic Susceptibility Contrast Magnetic Resonance Perfusion Imaging.Clin Neuroradiol. 2019 Sep;29(3):479-491. doi: 10.1007/s00062-018-0676-2. Epub 2018 Feb 21.
|
| 1061 |
Knockdown of DSPP inhibits the migration and invasion of glioma cells.Pathol Res Pract. 2018 Dec;214(12):2025-2030. doi: 10.1016/j.prp.2018.09.024. Epub 2018 Sep 29.
|
| 1062 |
DTX3L is upregulated in glioma and is associated with glioma progression.Int J Mol Med. 2017 Aug;40(2):491-498. doi: 10.3892/ijmm.2017.3023. Epub 2017 Jun 13.
|
| 1063 |
GFAP alternative splicing regulates glioma cell-ECM interaction in a DUSP4-dependent manner.FASEB J. 2019 Nov;33(11):12941-12959. doi: 10.1096/fj.201900916R. Epub 2019 Aug 31.
|
| 1064 |
Lectin from Dioclea violacea induces autophagy in U87 glioma cells.Int J Biol Macromol. 2019 Aug 1;134:660-672. doi: 10.1016/j.ijbiomac.2019.04.203. Epub 2019 May 1.
|
| 1065 |
DLC2 inhibits development of glioma through regulating the expression ratio of TAp73/TAp73.Am J Cancer Res. 2018 Jul 1;8(7):1200-1213. eCollection 2018.
|
| 1066 |
Elevated E2F7 expression predicts poor prognosis in human patients with gliomas.J Clin Neurosci. 2016 Nov;33:187-193. doi: 10.1016/j.jocn.2016.04.019. Epub 2016 Jul 22.
|
| 1067 |
Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion.J Exp Clin Cancer Res. 2010 Jul 4;29(1):89. doi: 10.1186/1756-9966-29-89.
|
| 1068 |
Alterations in Eukaryotic Elongation Factor complex proteins (EEF1s) in cancer and their implications in epigenetic regulation.Life Sci. 2019 Dec 1;238:116977. doi: 10.1016/j.lfs.2019.116977. Epub 2019 Oct 19.
|
| 1069 |
Impact of interaction between the G870A and EFEMP1 gene polymorphism on glioma risk in Chinese Han population.Oncotarget. 2017 Jun 6;8(23):37561-37567. doi: 10.18632/oncotarget.16581.
|
| 1070 |
EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.Cancer Cell. 2009 Jul 7;16(1):9-20. doi: 10.1016/j.ccr.2009.04.009.
|
| 1071 |
The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion.Int J Cancer. 2010 Mar 1;126(5):1155-65. doi: 10.1002/ijc.24849.
|
| 1072 |
Ehd3, a regulator of vesicular trafficking, is silenced in gliomas and functions as a tumor suppressor by controlling cell cycle arrest and apoptosis.Carcinogenesis. 2014 Apr;35(4):877-85. doi: 10.1093/carcin/bgt399. Epub 2013 Dec 4.
|
| 1073 |
Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma.Cancer Cell Int. 2019 Jun 4;19:155. doi: 10.1186/s12935-019-0867-1. eCollection 2019.
|
| 1074 |
Eukaryotic initiation factor 3C silencing inhibits cell proliferation and promotes apoptosis in human glioma.Oncol Rep. 2015 Jun;33(6):2954-62. doi: 10.3892/or.2015.3881. Epub 2015 Mar 30.
|
| 1075 |
RNAi-Mediated Silencing of EIF3D Alleviates Proliferation and Migration of Glioma U251 and U87MG Cells.Chem Biol Drug Des. 2015 Oct;86(4):715-22. doi: 10.1111/cbdd.12542. Epub 2015 Jul 28.
|
| 1076 |
MEF promotes stemness in the pathogenesis of gliomas.Cell Stem Cell. 2012 Dec 7;11(6):836-44. doi: 10.1016/j.stem.2012.09.012.
|
| 1077 |
PSMB8-AS1 activated by ELK1 promotes cell proliferation in glioma via regulating miR-574-5p/RAB10.Biomed Pharmacother. 2020 Feb;122:109658. doi: 10.1016/j.biopha.2019.109658. Epub 2019 Dec 4.
|
| 1078 |
Upregulation of long noncoding RNA MRCCAT1 predicts poor prognosis and functions as an oncogene in glioma.Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8406-8414. doi: 10.26355/eurrev_201812_16539.
|
| 1079 |
Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-B-Snail signaling in glioma.Cancer Biol Ther. 2015;16(6):898-911. doi: 10.1080/15384047.2015.1028702. Epub 2015 Apr 14.
|
| 1080 |
Epigenetic Control of Fatty-Acid Metabolism Sustains Glioma Stem Cells.Cancer Discov. 2019 Sep;9(9):1161-1163. doi: 10.1158/2159-8290.CD-19-0733.
|
| 1081 |
hHSS1: a novel secreted factor and suppressor of glioma growth located at chromosome 19q13.33.J Neurooncol. 2011 Apr;102(2):197-211. doi: 10.1007/s11060-010-0314-6. Epub 2010 Jul 31.
|
| 1082 |
EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44.J Cell Biochem. 2019 Oct;120(10):17142-17150. doi: 10.1002/jcb.28974. Epub 2019 May 20.
|
| 1083 |
miR-133b acts as a tumor suppressor and negatively regulates EMP2 in glioma.Neoplasma. 2018;65(4):494-504. doi: 10.4149/neo_2018_170510N337.
|
| 1084 |
Redistribution of EZH2 promotes malignant phenotypes by rewiring developmental programmes.EMBO Rep. 2019 Oct 4;20(10):e48155. doi: 10.15252/embr.201948155. Epub 2019 Aug 29.
|
| 1085 |
Hsa-miR-27b is up-regulated in cytomegalovirus-infected human glioma cells, targets engrailed-2 and inhibits its expression.Exp Biol Med (Maywood). 2017 Jun;242(12):1227-1233. doi: 10.1177/1535370217699535. Epub 2017 Mar 26.
|
| 1086 |
Enolase-phosphatase 1 as a novel potential malignant glioma indicator promotes cell proliferation and migration.Oncol Rep. 2018 Oct;40(4):2233-2241. doi: 10.3892/or.2018.6592. Epub 2018 Jul 24.
|
| 1087 |
Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System() (RTS()) gene switch as gene therapy for the treatment of glioma.Cancer Gene Ther. 2018 Jun;25(5-6):106-116. doi: 10.1038/s41417-018-0019-0. Epub 2018 May 14.
|
| 1088 |
Overexpression of Epsin3 enhances migration and invasion of glioma cells by inducing epithelialmesenchymal transition.Oncol Rep. 2018 Nov;40(5):3049-3059. doi: 10.3892/or.2018.6691. Epub 2018 Sep 10.
|
| 1089 |
Eps8 promotes cellular growth of human malignant gliomas.Oncol Rep. 2013 Feb;29(2):697-703. doi: 10.3892/or.2012.2160. Epub 2012 Nov 29.
|
| 1090 |
Screening and functional analysis ofgliomarelated genes induced by candoxin.Mol Med Rep. 2014 Aug;10(2):767-72. doi: 10.3892/mmr.2014.2311. Epub 2014 Jun 10.
|
| 1091 |
A Comprehensive Meta-analysis of Genetic Associations Between Key Polymorphic Loci in DNA Repair Genes and Glioma Risk.Mol Neurobiol. 2017 Mar;54(2):1314-1325. doi: 10.1007/s12035-016-9725-5. Epub 2016 Feb 3.
|
| 1092 |
HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas.Oncotarget. 2016 Mar 22;7(12):14429-40. doi: 10.18632/oncotarget.7418.
|
| 1093 |
Additional evidence supports association of common genetic variants in VTI1A and ETFA with increased risk of glioma susceptibility.J Neurol Sci. 2017 Apr 15;375:282-288. doi: 10.1016/j.jns.2017.02.013. Epub 2017 Feb 8.
|
| 1094 |
Functional interaction of E1AF and Sp1 in glioma invasion.Mol Cell Biol. 2007 Dec;27(24):8770-82. doi: 10.1128/MCB.02302-06. Epub 2007 Oct 15.
|
| 1095 |
Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.Int J Mol Sci. 2017 Nov 1;18(11):2301. doi: 10.3390/ijms18112301.
|
| 1096 |
EYA4 Promotes Cell Proliferation Through Downregulation of p27Kip1 in Glioma.Cell Physiol Biochem. 2018;49(5):1856-1869. doi: 10.1159/000493631. Epub 2018 Sep 19.
|
| 1097 |
Methylation-mediated miR-155-FAM133A axis contributes to the attenuated invasion and migration of IDH mutant gliomas.Cancer Lett. 2018 Sep 28;432:93-102. doi: 10.1016/j.canlet.2018.06.007. Epub 2018 Jun 6.
|
| 1098 |
Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5.Exp Mol Med. 2011 Jan 31;43(1):24-34. doi: 10.3858/emm.2011.43.1.003.
|
| 1099 |
MiR-650 inhibits the progression of glioma by targeting FAM83F.Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8391-8398. doi: 10.26355/eurrev_201812_16537.
|
| 1100 |
FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents.Oncotarget. 2014 Aug 15;5(15):6414-24. doi: 10.18632/oncotarget.2225.
|
| 1101 |
Migfilin promotes migration and invasion in glioma by driving EGFR and MMP-2 signalings: A positive feedback loop regulation.J Genet Genomics. 2017 Dec 20;44(12):557-565. doi: 10.1016/j.jgg.2017.09.008. Epub 2017 Oct 16.
|
| 1102 |
Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.Mol Carcinog. 2015 May;54(5):405-15. doi: 10.1002/mc.22114. Epub 2013 Dec 17.
|
| 1103 |
Inhibition of JMJD6 expression reduces the proliferation, migration and invasion of neuroglioma stem cells.Neoplasma. 2017;64(5):700-708. doi: 10.4149/neo_2017_507.
|
| 1104 |
The F-box protein FBXL18 promotes glioma progression by promoting K63-linked ubiquitination of Akt.FEBS Lett. 2017 Jan;591(1):145-154. doi: 10.1002/1873-3468.12521. Epub 2016 Dec 20.
|
| 1105 |
Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma.J Neurooncol. 2013 Jun;113(2):229-38. doi: 10.1007/s11060-013-1122-6. Epub 2013 Mar 25.
|
| 1106 |
The Association of Flap Endonuclease 1 Genotypes with the Risk of Childhood Leukemia.Cancer Genomics Proteomics. 2016 Jan-Feb;13(1):69-74.
|
| 1107 |
Prognostic value of Kindlin-2 expression in patients with solid tumors: a meta-analysis.Cancer Cell Int. 2018 Oct 22;18:166. doi: 10.1186/s12935-018-0651-7. eCollection 2018.
|
| 1108 |
FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling.Neurosci Lett. 2017 Sep 14;657:77-83. doi: 10.1016/j.neulet.2017.07.057. Epub 2017 Aug 1.
|
| 1109 |
Over-Expressed FEZF1 Predicts a Poor Prognosis in Glioma and Promotes Glioma Cell Malignant Biological Properties by Regulating Akt-ERK Pathway.J Mol Neurosci. 2018 Aug;65(4):411-419. doi: 10.1007/s12031-018-1108-0. Epub 2018 Jul 20.
|
| 1110 |
FHL2 interacts with EGFR to promote glioblastoma growth.Oncogene. 2018 Mar;37(10):1386-1398. doi: 10.1038/s41388-017-0068-0. Epub 2018 Jan 11.
|
| 1111 |
Mechanical confinement triggers glioma linear migration dependent on formin FHOD3.Mol Biol Cell. 2016 Apr 15;27(8):1246-61. doi: 10.1091/mbc.E15-08-0565. Epub 2016 Feb 24.
|
| 1112 |
Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction.Biomed Pharmacother. 2018 Nov;107:1230-1236. doi: 10.1016/j.biopha.2018.08.113. Epub 2018 Aug 29.
|
| 1113 |
Epidemiology of human atopic dermatitis--seven areas of notable progress and seven areas of notable ignorance.Vet Dermatol. 2013 Feb;24(1):3-9.e1-2. doi: 10.1111/j.1365-3164.2012.01079.x.
|
| 1114 |
Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas.BMC Cancer. 2014 Jun 18;14:452. doi: 10.1186/1471-2407-14-452.
|
| 1115 |
Flot2 targeted by miR-449 acts as a prognostic biomarker in glioma.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):250-255. doi: 10.1080/21691401.2018.1549062.
|
| 1116 |
Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration.Oncogene. 2017 Jan 5;36(1):71-83. doi: 10.1038/onc.2016.176. Epub 2016 May 23.
|
| 1117 |
RETRACTED: NY-SAR-35 is involved in apoptosis, cell migration, invasion and epithelial to mesenchymal transition in glioma.Biomed Pharmacother. 2018 Jan;97:1632-1638. doi: 10.1016/j.biopha.2017.11.076. Epub 2017 Dec 6.
|
| 1118 |
Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.Biomed Res Int. 2019 Mar 4;2019:5437531. doi: 10.1155/2019/5437531. eCollection 2019.
|
| 1119 |
KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.Brain. 2012 Apr;135(Pt 4):1027-41. doi: 10.1093/brain/aws045. Epub 2012 Mar 16.
|
| 1120 |
Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA.Biochem Biophys Res Commun. 2019 May 7;512(3):558-563. doi: 10.1016/j.bbrc.2019.03.124. Epub 2019 Mar 23.
|
| 1121 |
Forkhead Box A2 (FOXA2) Inhibits Invasion and Tumorigenesis in Glioma Cells.Oncol Res. 2017 May 24;25(5):701-708. doi: 10.3727/096504016X14772378087005. Epub 2016 Oct 27.
|
| 1122 |
FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide resistance in a O(6)-methylguanine-DNA methyltransferase-dependent manner.Korean J Physiol Pharmacol. 2019 Nov;23(6):475-482. doi: 10.4196/kjpp.2019.23.6.475. Epub 2019 Oct 24.
|
| 1123 |
FOXG1 Expression Is Elevated in Glioma and Inhibits Glioma Cell Apoptosis.J Cancer. 2018 Feb 11;9(5):778-783. doi: 10.7150/jca.22282. eCollection 2018.
|
| 1124 |
ZRANB2/SNHG20/FOXK1 Axis regulates Vasculogenic mimicry formation in glioma.J Exp Clin Cancer Res. 2019 Feb 11;38(1):68. doi: 10.1186/s13046-019-1073-7.
|
| 1125 |
Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis.Onco Targets Ther. 2018 Feb 27;11:1067-1075. doi: 10.2147/OTT.S157126. eCollection 2018.
|
| 1126 |
FOXL1 overexpression is associated with poor outcome in patients with glioma.Oncol Lett. 2019 Jul;18(1):751-757. doi: 10.3892/ol.2019.10351. Epub 2019 May 13.
|
| 1127 |
FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of -catenin nuclear accumulation.Oncol Rep. 2017 Apr;37(4):2391-2397. doi: 10.3892/or.2017.5459. Epub 2017 Feb 16.
|
| 1128 |
Overexpression of FRAT1 is associated with malignant phenotype and poor prognosis in human gliomas.Dis Markers. 2015;2015:289750. doi: 10.1155/2015/289750. Epub 2015 Apr 2.
|
| 1129 |
Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway.Cell Physiol Biochem. 2017;44(4):1616-1628. doi: 10.1159/000485759. Epub 2017 Dec 6.
|
| 1130 |
Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity.Neuropathol Appl Neurobiol. 2014 Feb;40(2):205-16. doi: 10.1111/nan.12088.
|
| 1131 |
Expression profile and clinical significance of Wnt signaling in human gliomas.Oncol Lett. 2018 Jan;15(1):610-617. doi: 10.3892/ol.2017.7315. Epub 2017 Nov 1.
|
| 1132 |
MicroRNA-29a-3p Downregulation Causes Gab1 Upregulation to Promote Glioma Cell Proliferation.Cell Physiol Biochem. 2018;48(2):450-460. doi: 10.1159/000491776. Epub 2018 Jul 17.
|
| 1133 |
Gab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation.PLoS One. 2017 Mar 14;12(3):e0173473. doi: 10.1371/journal.pone.0173473. eCollection 2017.
|
| 1134 |
MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.Oncotarget. 2017 Apr 11;8(15):25345-25361. doi: 10.18632/oncotarget.15867.
|
| 1135 |
Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.Clin Sci (Lond). 2019 May 21;133(10):1167-1184. doi: 10.1042/CS20190145. Print 2019 May 31.
|
| 1136 |
High expression of GALNT7 promotes invasion and proliferation of glioma cells.Oncol Lett. 2018 Nov;16(5):6307-6314. doi: 10.3892/ol.2018.9498. Epub 2018 Sep 25.
|
| 1137 |
Neural stem cells producing an inducible and soluble form of Gas1 target and inhibit intracranial glioma growth.Cytotherapy. 2014 Jul;16(7):1011-23. doi: 10.1016/j.jcyt.2013.12.004. Epub 2014 Feb 12.
|
| 1138 |
GATAD1 gene amplification promotes glioma malignancy by directly regulating CCND1 transcription.Cancer Med. 2019 Sep;8(11):5242-5253. doi: 10.1002/cam4.2405. Epub 2019 Jul 8.
|
| 1139 |
Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.Cancer Biomark. 2019;25(3):275-290. doi: 10.3233/CBM-171177.
|
| 1140 |
GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis.Biochem Biophys Res Commun. 2018 Jan 1;495(1):446-453. doi: 10.1016/j.bbrc.2017.11.050. Epub 2017 Nov 8.
|
| 1141 |
MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.Neuropathol Appl Neurobiol. 2019 Aug;45(5):441-458. doi: 10.1111/nan.12532. Epub 2019 Feb 19.
|
| 1142 |
GGNBP2 Suppresses the Proliferation, Invasion, and Migration of Human Glioma Cells.Oncol Res. 2017 May 24;25(5):831-842. doi: 10.3727/096504016X14816726393937. Epub 2016 Dec 15.
|
| 1143 |
Loss of GINS2 inhibits cell proliferation and tumorigenesis in human gliomas.CNS Neurosci Ther. 2019 Feb;25(2):273-287. doi: 10.1111/cns.13064. Epub 2018 Oct 18.
|
| 1144 |
Neuropilin-1 (NRP-1)/GIPC1 pathway mediates glioma progression.Tumour Biol. 2016 Oct;37(10):13777-13788. doi: 10.1007/s13277-016-5138-3. Epub 2016 Aug 1.
|
| 1145 |
GLIPR-2 overexpression in HK-2 cells promotes cell EMT and migration through ERK1/2 activation.PLoS One. 2013;8(3):e58574. doi: 10.1371/journal.pone.0058574. Epub 2013 Mar 13.
|
| 1146 |
Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.Neuro Oncol. 2019 Feb 19;21(3):337-347. doi: 10.1093/neuonc/noy185.
|
| 1147 |
Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma.Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14217-22. doi: 10.1073/pnas.1409653111. Epub 2014 Sep 15.
|
| 1148 |
Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1(R132H)-Induced Metabolic Liabilities.Cancer Res. 2018 Jan 1;78(1):36-50. doi: 10.1158/0008-5472.CAN-17-1352. Epub 2017 Nov 2.
|
| 1149 |
Genome-wide association study identifies multiple susceptibility loci for glioma.Nat Commun. 2015 Oct 1;6:8559. doi: 10.1038/ncomms9559.
|
| 1150 |
GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis.Mol Ther Nucleic Acids. 2019 Dec 6;18:56-65. doi: 10.1016/j.omtn.2019.08.006. Epub 2019 Aug 14.
|
| 1151 |
PDGFA/PDGFR-regulated GOLM1 promotes human glioma progression through activation of AKT.J Exp Clin Cancer Res. 2017 Dec 28;36(1):193. doi: 10.1186/s13046-017-0665-3.
|
| 1152 |
Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma.J Mol Med (Berl). 2019 Nov;97(11):1575-1588. doi: 10.1007/s00109-019-01843-4. Epub 2019 Nov 14.
|
| 1153 |
GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.J Neuropathol Exp Neurol. 2019 Dec 1;78(12):1089-1099. doi: 10.1093/jnen/nlz093.
|
| 1154 |
MicroRNA-301b promotes the proliferation and invasion of glioma cells through enhancing activation of Wnt/-catenin signaling via targeting Glypican-5.Eur J Pharmacol. 2019 Jul 5;854:39-47. doi: 10.1016/j.ejphar.2019.03.057. Epub 2019 Apr 3.
|
| 1155 |
GPIHBP1 expression in gliomas promotes utilization of lipoprotein-derived nutrients.Elife. 2019 Jun 6;8:e47178. doi: 10.7554/eLife.47178.
|
| 1156 |
Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades.Oncogene. 2018 Aug;37(31):4313-4333. doi: 10.1038/s41388-018-0277-1. Epub 2018 May 3.
|
| 1157 |
Genetic ablation of Gpr37l1 delays tumor occurrence in Ptch1(+/-) mouse models of medulloblastoma.Exp Neurol. 2019 Feb;312:33-42. doi: 10.1016/j.expneurol.2018.11.004. Epub 2018 Nov 16.
|
| 1158 |
Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.Clin Neurol Neurosurg. 2018 Jan;164:132-137. doi: 10.1016/j.clineuro.2017.11.017. Epub 2017 Nov 29.
|
| 1159 |
Gpx 4 is involved in the proliferation, migration and apoptosis of glioma cells.Pathol Res Pract. 2017 Jun;213(6):626-633. doi: 10.1016/j.prp.2017.04.025. Epub 2017 May 4.
|
| 1160 |
G protein-coupled receptor kinase 6 is overexpressed in glioma and promotes glioma cell proliferation.Oncotarget. 2017 Apr 18;8(33):54227-54235. doi: 10.18632/oncotarget.17203. eCollection 2017 Aug 15.
|
| 1161 |
Bioactive 3,8-Epoxy Iridoids from Valeriana jatamansi.Chem Biodivers. 2019 May;16(5):e1800474. doi: 10.1002/cbdv.201800474. Epub 2019 Apr 8.
|
| 1162 |
Possible association between genetic variants in the H2AFX promoter region and risk of adult glioma in a Chinese Han population.J Neurooncol. 2011 Nov;105(2):211-8. doi: 10.1007/s11060-011-0586-5. Epub 2011 Apr 22.
|
| 1163 |
WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial.Neuro Oncol. 2020 Jan 11;22(1):116-127. doi: 10.1093/neuonc/noz142.
|
| 1164 |
Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.Brain Pathol. 2016 Sep;26(5):569-80. doi: 10.1111/bpa.12336. Epub 2015 Dec 14.
|
| 1165 |
Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16.Life Sci. 2019 May 15;225:55-63. doi: 10.1016/j.lfs.2019.03.079. Epub 2019 Apr 1.
|
| 1166 |
Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas.BMC Cancer. 2018 Jun 18;18(1):664. doi: 10.1186/s12885-018-4569-1.
|
| 1167 |
Tim-3 expression in glioma cells is associated with drug resistance.J Cancer Res Ther. 2019;15(4):882-888. doi: 10.4103/jcrt.JCRT_630_18.
|
| 1168 |
miR-155 contributes to the progression of glioma by enhancing Wnt/-catenin pathway.Tumour Biol. 2015 Jul;36(7):5323-31. doi: 10.1007/s13277-015-3193-9. Epub 2015 Feb 12.
|
| 1169 |
Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.J Immunol Res. 2014;2014:131494. doi: 10.1155/2014/131494. Epub 2014 Jul 9.
|
| 1170 |
Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma.Oncotarget. 2017 Mar 7;8(10):16650-16668. doi: 10.18632/oncotarget.14287.
|
| 1171 |
MiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma.PLoS One. 2017 Apr 21;12(4):e0174839. doi: 10.1371/journal.pone.0174839. eCollection 2017.
|
| 1172 |
HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation.Oncogene. 2012 Mar 8;31(10):1299-310. doi: 10.1038/onc.2011.316. Epub 2011 Jul 25.
|
| 1173 |
HFE polymorphisms affect survival of brain tumor patients.J Neurooncol. 2015 Mar;122(1):97-104. doi: 10.1007/s11060-014-1681-1. Epub 2014 Dec 10.
|
| 1174 |
Epigenetic regulation of human hedgehog interacting protein in glioma cell lines and primary tumor samples.Tumour Biol. 2015 Apr;36(4):2383-91. doi: 10.1007/s13277-014-2846-4. Epub 2014 Nov 22.
|
| 1175 |
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma.Oncol Rep. 2019 Dec;42(6):2309-2322. doi: 10.3892/or.2019.7343. Epub 2019 Oct 1.
|
| 1176 |
P53 induction accompanying G2/M arrest upon knockdown of tumor suppressor HIC1 in U87MG glioma cells.Mol Cell Biochem. 2014 Oct;395(1-2):281-90. doi: 10.1007/s11010-014-2137-9. Epub 2014 Jul 4.
|
| 1177 |
Circular RNA HIPK3 promotes glioma progression by binding to miR-124-3p.Gene. 2019 Mar 30;690:81-89. doi: 10.1016/j.gene.2018.11.073. Epub 2018 Dec 18.
|
| 1178 |
Identification and characterization of human MIBP1 gene in glioma cell differentiation.J Mol Neurosci. 2014 Feb;52(2):294-301. doi: 10.1007/s12031-013-0144-z. Epub 2013 Oct 26.
|
| 1179 |
MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/-catenin signaling pathway.Oncogene. 2020 Jan;39(5):1098-1111. doi: 10.1038/s41388-019-1045-6. Epub 2019 Oct 7.
|
| 1180 |
Proteomic comparison of 3D and 2D glioma models reveals increased HLA-E expression in 3D models is associated with resistance to NK cell-mediated cytotoxicity.J Proteome Res. 2014 May 2;13(5):2272-81. doi: 10.1021/pr500064m. Epub 2014 Apr 17.
|
| 1181 |
Correlation of alteration of HLA-F expression and clinical characterization in 593 brain glioma samples.J Neuroinflammation. 2019 Feb 12;16(1):33. doi: 10.1186/s12974-019-1418-3.
|
| 1182 |
Homeoboxcontaining protein 1 loss is associated with clinicopathological performance in glioma.Mol Med Rep. 2017 Oct;16(4):4101-4106. doi: 10.3892/mmr.2017.7050. Epub 2017 Jul 21.
|
| 1183 |
MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-Mobility Group Nucleosome-Binding Domain 5.Oncol Res. 2017 Aug 7;25(7):1097-1107. doi: 10.3727/096504017X14836170586829. Epub 2017 Jan 20.
|
| 1184 |
Glioma infiltration and extracellular matrix: key players and modulators.Glia. 2018 Aug;66(8):1542-1565. doi: 10.1002/glia.23309. Epub 2018 Feb 21.
|
| 1185 |
Proteomic screening and identification of microRNA-128 targets in glioma cells.Proteomics. 2015 Aug;15(15):2602-17. doi: 10.1002/pmic.201400128. Epub 2015 May 15.
|
| 1186 |
RTVP-1 regulates glioma cell migration and invasion via interaction with N-WASP and hnRNPK.Oncotarget. 2015 Aug 14;6(23):19826-40. doi: 10.18632/oncotarget.4471.
|
| 1187 |
HOXA10AS: A novel oncogenic long noncoding RNA in glioma.Oncol Rep. 2018 Nov;40(5):2573-2583. doi: 10.3892/or.2018.6662. Epub 2018 Aug 21.
|
| 1188 |
Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome.J Cancer Res Clin Oncol. 2012 Jan;138(1):35-47. doi: 10.1007/s00432-011-1070-5. Epub 2011 Sep 27.
|
| 1189 |
MiR-638 serves as a tumor suppressor by targeting HOXA9 in glioma.Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7798-7806. doi: 10.26355/eurrev_201811_16404.
|
| 1190 |
HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.PLoS One. 2015 Nov 13;10(11):e0142387. doi: 10.1371/journal.pone.0142387. eCollection 2015.
|
| 1191 |
MicroRNA-10b-5p downregulation inhibits the invasion of glioma cells via modulating homeobox B3 expression.Exp Ther Med. 2019 Jun;17(6):4577-4585. doi: 10.3892/etm.2019.7506. Epub 2019 Apr 19.
|
| 1192 |
HOXB7 promotes proliferation and metastasis of glioma by regulating the Wnt/-catenin pathway.Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2476-2485. doi: 10.26355/eurrev_201903_17395.
|
| 1193 |
Overexpressed homeobox B9 regulates oncogenic activities by transforming growth factor-1 in gliomas.Biochem Biophys Res Commun. 2014 Mar 28;446(1):272-9. doi: 10.1016/j.bbrc.2014.02.095. Epub 2014 Feb 28.
|
| 1194 |
HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.FEBS J. 2018 Jun;285(12):2278-2291. doi: 10.1111/febs.14476. Epub 2018 May 25.
|
| 1195 |
Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.Pathol Res Pract. 2018 Nov;214(11):1818-1824. doi: 10.1016/j.prp.2018.09.001. Epub 2018 Sep 12.
|
| 1196 |
Effect of rs11614913 Polymorphism on Mature miR196a2 Expression and its Target Gene HOXC8 Expression in Human Glioma.J Mol Neurosci. 2017 Feb;61(2):144-151. doi: 10.1007/s12031-016-0855-z. Epub 2016 Oct 28.
|
| 1197 |
MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.Brain Res. 2011 May 10;1389:9-18. doi: 10.1016/j.brainres.2011.03.013. Epub 2011 Mar 16.
|
| 1198 |
Clinicopathological analysis of HOXD4 expression in diffuse gliomas and its correlation with IDH mutations and 1p/19q co-deletion.Oncotarget. 2017 Dec 18;8(70):115657-115666. doi: 10.18632/oncotarget.23371. eCollection 2017 Dec 29.
|
| 1199 |
11 Long noncoding RNA UCA1 functions as miR-135a sponge to promote the epithelial to mesenchymal transition in glioma.J Cell Biochem. 2020 Mar;121(3):2447-2457. doi: 10.1002/jcb.29467. Epub 2019 Nov 3.
|
| 1200 |
Mechanism of 4-HPR-induced apoptosis in glioma cells: evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress. Carcinogenesis. 2006 Oct;27(10):2047-58. doi: 10.1093/carcin/bgl051. Epub 2006 May 4.
|
| 1201 |
Leukocyte Differentiation by Histidine-Rich Glycoprotein/Stanniocalcin-2 Complex Regulates Murine Glioma Growth through Modulation of Antitumor Immunity.Mol Cancer Ther. 2018 Sep;17(9):1961-1972. doi: 10.1158/1535-7163.MCT-18-0097. Epub 2018 Jun 26.
|
| 1202 |
Overexpression of immediate early gene X-1 (IEX-1) enhances gamma-radiation-induced apoptosis of human glioma cell line, U87-MG.Neuropathology. 2009 Feb;29(1):20-4. doi: 10.1111/j.1440-1789.2008.00932.x. Epub 2008 Jun 17.
|
| 1203 |
Lentivirus mediated -interferon-inducible lysosomal thiol reductase (GILT) knockdown suppresses human glioma U373MG cell proliferation.Biochem Biophys Res Commun. 2019 Jan 29;509(1):182-187. doi: 10.1016/j.bbrc.2018.12.099. Epub 2018 Dec 23.
|
| 1204 |
IFITM3/STAT3 axis promotes glioma cells invasion and is modulated by TGF-.Mol Biol Rep. 2020 Jan;47(1):433-441. doi: 10.1007/s11033-019-05146-2. Epub 2019 Oct 21.
|
| 1205 |
microRNA-4500 inhibits human glioma cell progression by targeting IGF2BP1.Biochem Biophys Res Commun. 2019 Jun 11;513(4):800-806. doi: 10.1016/j.bbrc.2019.04.058. Epub 2019 Apr 16.
|
| 1206 |
microRNA?88 acts as a tumour suppressor in glioma by directly targeting the IGF2BP2 gene.Mol Med Rep. 2017 Nov;16(5):7124-7130. doi: 10.3892/mmr.2017.7433. Epub 2017 Sep 7.
|
| 1207 |
Seven genes for the prognostic prediction in patients with glioma.Clin Transl Oncol. 2019 Oct;21(10):1327-1335. doi: 10.1007/s12094-019-02057-3. Epub 2019 Feb 14.
|
| 1208 |
Identification of the potential biomarkers in patients with glioma: a weighted gene co-expression network analysis.Carcinogenesis. 2020 Jul 10;41(6):743-750. doi: 10.1093/carcin/bgz194.
|
| 1209 |
Anti-inflammatory Effects of Atorvastatin in Human Glioblastoma Spheroids Cultured in a Three-dimensional Model: Possible Relevance to Glioblastoma Treatment.Mol Neurobiol. 2018 Mar;55(3):2102-2110. doi: 10.1007/s12035-017-0445-2. Epub 2017 Mar 10.
|
| 1210 |
Elevation of circ-PITX1 upregulates interleukin 17 receptor D expression via sponging miR-518a-5p and facilitates cell progression in glioma.J Cell Biochem. 2019 Oct;120(10):16495-16502. doi: 10.1002/jcb.28868. Epub 2019 May 8.
|
| 1211 |
The inflammatory cytokine IL-22 promotes murine gliomas via proliferation.Exp Ther Med. 2017 Mar;13(3):1087-1092. doi: 10.3892/etm.2017.4059. Epub 2017 Jan 18.
|
| 1212 |
ILF2 promotes anchorage independence through direct regulation of PTEN.Oncol Lett. 2019 Aug;18(2):1689-1696. doi: 10.3892/ol.2019.10510. Epub 2019 Jun 21.
|
| 1213 |
Autophagy suppression sensitizes glioma cells to IMP dehydrogenase inhibition-induced apoptotic death.Exp Cell Res. 2017 Jan 1;350(1):32-40. doi: 10.1016/j.yexcr.2016.11.001. Epub 2016 Nov 4.
|
| 1214 |
-Internexin in the diagnosis of oligodendroglial tumors and association with 1p/19q status.J Neuropathol Exp Neurol. 2011 Nov;70(11):970-8. doi: 10.1097/NEN.0b013e3182333ef5.
|
| 1215 |
The inhibitor of growth 1 (ING1) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma cells.Oncol Res. 2009;18(2-3):95-105. doi: 10.3727/096504009789954645.
|
| 1216 |
Synergistic antitumor effect of ING4/PTEN double tumor suppressors mediated by adenovirus modified with arginine-glycine-aspartate on glioma.J Neurosurg Sci. 2020 Apr;64(2):173-180. doi: 10.23736/S0390-5616.17.03978-9. Epub 2017 Apr 12.
|
| 1217 |
The roles of ING5 in gliomas: a good marker for tumorigenesis and a potential target for gene therapy.Oncotarget. 2017 May 11;8(34):56558-56568. doi: 10.18632/oncotarget.17802. eCollection 2017 Aug 22.
|
| 1218 |
IRF7 promotes glioma cell invasion by inhibiting AGO2 expression.Tumour Biol. 2015 Jul;36(7):5561-9. doi: 10.1007/s13277-015-3226-4. Epub 2015 Feb 14.
|
| 1219 |
High expression of immunity-related GTPase family M protein in glioma promotes cell proliferation and autophagy protein expression.Pathol Res Pract. 2019 Jan;215(1):90-96. doi: 10.1016/j.prp.2018.10.004. Epub 2018 Oct 24.
|
| 1220 |
Clinical significance of Iroquois Homeobox Gene - IRX1 in human glioma.Mol Med Rep. 2018 Mar;17(3):4651-4656. doi: 10.3892/mmr.2018.8404. Epub 2018 Jan 9.
|
| 1221 |
ISG20 promotes local tumor immunity and contributes to poor survival in human glioma.Oncoimmunology. 2018 Oct 31;8(2):e1534038. doi: 10.1080/2162402X.2018.1534038. eCollection 2019.
|
| 1222 |
Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma.J Neurooncol. 2018 Jan;136(2):317-326. doi: 10.1007/s11060-017-2655-x. Epub 2017 Nov 15.
|
| 1223 |
Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma.Front Oncol. 2019 Sep 20;9:904. doi: 10.3389/fonc.2019.00904. eCollection 2019.
|
| 1224 |
HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell.Cancers (Basel). 2018 Sep 1;10(9):301. doi: 10.3390/cancers10090301.
|
| 1225 |
Mining the glioma susceptibility genes in children from gene expression profiles and a methylation database.Oncol Lett. 2017 Sep;14(3):3473-3479. doi: 10.3892/ol.2017.6579. Epub 2017 Jul 15.
|
| 1226 |
Molecular mechanism of SSFA2 deletion inhibiting cell proliferation and promoting cell apoptosis in glioma.Pathol Res Pract. 2019 Mar;215(3):600-606. doi: 10.1016/j.prp.2018.12.035. Epub 2018 Dec 31.
|
| 1227 |
Alternative splicing-derived intersectin1-L and intersectin1-S exert opposite function in glioma progression.Cell Death Dis. 2019 Jun 3;10(6):431. doi: 10.1038/s41419-019-1668-0.
|
| 1228 |
PVT1 regulates the malignant behaviors of human glioma cells by targeting miR-190a-5p and miR-488-3p.Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1783-1794. doi: 10.1016/j.bbadis.2018.02.022. Epub 2018 Mar 1.
|
| 1229 |
Reduced Expression of Jumonji AT-Rich Interactive Domain 2 (JARID2) in Glioma Inhibits Tumor Growth In Vitro and In Vivo.Oncol Res. 2017 Mar 13;25(3):365-372. doi: 10.3727/096504016X14738135889976. Epub 2016 Sep 16.
|
| 1230 |
The -catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.Oncotarget. 2017 Apr 18;8(16):27300-27313. doi: 10.18632/oncotarget.15934.
|
| 1231 |
CacyBP/SIP protein is important for the proliferation of human glioma cells.IUBMB Life. 2014 Apr;66(4):286-91. doi: 10.1002/iub.1263. Epub 2014 Apr 17.
|
| 1232 |
GCN5 Potentiates Glioma Proliferation and Invasion via STAT3 and AKT Signaling Pathways.Int J Mol Sci. 2015 Sep 10;16(9):21897-910. doi: 10.3390/ijms160921897.
|
| 1233 |
MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.Cancer Med. 2019 Dec;8(18):7793-7808. doi: 10.1002/cam4.2639. Epub 2019 Nov 5.
|
| 1234 |
Epigenetic silencing of KAZALD1 confers a better prognosis and is associated with malignant transformation/progression in glioma.Oncol Rep. 2013 Nov;30(5):2089-96. doi: 10.3892/or.2013.2706. Epub 2013 Aug 29.
|
| 1235 |
KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.Cell Death Differ. 2017 Apr;24(4):649-659. doi: 10.1038/cdd.2016.151. Epub 2017 Jan 6.
|
| 1236 |
KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth.Onco Targets Ther. 2018 Jan 8;11:201-209. doi: 10.2147/OTT.S149833. eCollection 2018.
|
| 1237 |
KIF1B promotes glioma migration and invasion via cell surface localization of MT1-MMP.Oncol Rep. 2016 Feb;35(2):971-7. doi: 10.3892/or.2015.4426. Epub 2015 Nov 16.
|
| 1238 |
MiR-876-3p targets KIF20A to block JAK2/STAT3 pathway in glioma.Am J Transl Res. 2019 Aug 15;11(8):4957-4966. eCollection 2019.
|
| 1239 |
Role of KIF2A in the progression and metastasis of human glioma.Mol Med Rep. 2016 Feb;13(2):1781-7. doi: 10.3892/mmr.2015.4700. Epub 2015 Dec 22.
|
| 1240 |
Kinesin family member 2C (KIF2C/MCAK) is a novel marker for prognosis in human gliomas.Clin Neurol Neurosurg. 2012 May;114(4):356-60. doi: 10.1016/j.clineuro.2011.11.005. Epub 2011 Nov 29.
|
| 1241 |
Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma.Brain Tumor Pathol. 2019 Jan;36(1):14-19. doi: 10.1007/s10014-018-0330-3. Epub 2018 Oct 22.
|
| 1242 |
Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion.Onco Targets Ther. 2019 Feb 22;12:1509-1520. doi: 10.2147/OTT.S188270. eCollection 2019.
|
| 1243 |
KLF16 suppresses human glioma cell proliferation and tumourigenicity by targeting TFAM.Artif Cells Nanomed Biotechnol. 2018;46(sup1):608-615. doi: 10.1080/21691401.2018.1431654. Epub 2018 Jan 29.
|
| 1244 |
LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21.Biosci Rep. 2018 Sep 7;38(5):BSR20180420. doi: 10.1042/BSR20180420. Print 2018 Oct 31.
|
| 1245 |
MKK7 transcription positively or negatively regulated by SP1 and KLF5 depends on HDAC4 activity in glioma.Int J Cancer. 2019 Nov 1;145(9):2496-2508. doi: 10.1002/ijc.32321. Epub 2019 May 3.
|
| 1246 |
KLF8 Promotes Temozolomide Resistance in Glioma Cells via -Catenin Activation.Cell Physiol Biochem. 2016;38(4):1596-604. doi: 10.1159/000443100. Epub 2016 Apr 18.
|
| 1247 |
MicroRNA?40 promotes cell proliferation and invasion of glioma by directly targeting Kruppellike factor9.Mol Med Rep. 2019 Jan;19(1):734-742. doi: 10.3892/mmr.2018.9630. Epub 2018 Nov 7.
|
| 1248 |
Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.Sci Rep. 2016 Feb 23;6:22066. doi: 10.1038/srep22066.
|
| 1249 |
KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.J Exp Clin Cancer Res. 2018 Aug 16;37(1):194. doi: 10.1186/s13046-018-0861-9.
|
| 1250 |
Overexpression of LACTB, a Mitochondrial Protein That Inhibits Proliferation and Invasion in Glioma Cells.Oncol Res. 2019 Mar 29;27(4):423-429. doi: 10.3727/096504017X15030178624579. Epub 2017 Aug 23.
|
| 1251 |
MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1.Neuro Oncol. 2014 May;16(5):637-51. doi: 10.1093/neuonc/not300. Epub 2014 Feb 3.
|
| 1252 |
High LAMC1 expression in glioma is associated with poor prognosis.Onco Targets Ther. 2019 May 29;12:4253-4260. doi: 10.2147/OTT.S205333. eCollection 2019.
|
| 1253 |
Identification of RNA-Binding Protein LARP4B as a Tumor Suppressor in Glioma.Cancer Res. 2016 Apr 15;76(8):2254-64. doi: 10.1158/0008-5472.CAN-15-2308. Epub 2016 Mar 1.
|
| 1254 |
Methylmercury-l-Cysteine targeting L-type amino acid transporter conjugate cytotoxicity on C6 glioma cells.J Biol Regul Homeost Agents. 2018 Jan-Feb;32(1):147-151.
|
| 1255 |
Molecular and clinical characterization of Galectin-9 in glioma through 1,027 samples.J Cell Physiol. 2020 May;235(5):4326-4334. doi: 10.1002/jcp.29309. Epub 2019 Oct 14.
|
| 1256 |
Down-Regulation of Astrocytic Kir4.1 Channels during the Audiogenic Epileptogenesis in Leucine-Rich Glioma-Inactivated 1 (Lgi1) Mutant Rats.Int J Mol Sci. 2019 Feb 26;20(5):1013. doi: 10.3390/ijms20051013.
|
| 1257 |
Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signals.Oncogene. 2015 Mar 5;34(10):1270-9. doi: 10.1038/onc.2014.70. Epub 2014 Mar 24.
|
| 1258 |
MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells.Biosci Rep. 2019 Mar 1;39(3):BSR20180879. doi: 10.1042/BSR20180879. Print 2019 Mar 29.
|
| 1259 |
Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.Int J Cancer. 2018 Apr 15;142(8):1627-1639. doi: 10.1002/ijc.31179. Epub 2017 Dec 11.
|
| 1260 |
LITAF Enhances Radiosensitivity of Human Glioma Cells via the FoxO1 Pathway.Cell Mol Neurobiol. 2019 Aug;39(6):871-882. doi: 10.1007/s10571-019-00686-4. Epub 2019 May 16.
|
| 1261 |
Hugl-1 inhibits glioma cell growth in intracranial model.J Neurooncol. 2015 Oct;125(1):113-21. doi: 10.1007/s11060-015-1901-3. Epub 2015 Sep 4.
|
| 1262 |
Mutation and copy number analysis of LNX1 and Numbl in nervous system tumors.Cancer Genet Cytogenet. 2008 Oct 15;186(2):103-9. doi: 10.1016/j.cancergencyto.2008.07.003.
|
| 1263 |
LRG1 modulates invasion and migration of glioma cell lines through TGF- signaling pathway.Acta Histochem. 2015 Jul;117(6):551-8. doi: 10.1016/j.acthis.2015.05.001. Epub 2015 Jun 3.
|
| 1264 |
Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF-A pathway.Oncol Lett. 2017 Oct;14(4):4021-4028. doi: 10.3892/ol.2017.6671. Epub 2017 Jul 26.
|
| 1265 |
A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.Acta Oncol. 2010 Aug;49(6):767-75. doi: 10.3109/0284186X.2010.480980.
|
| 1266 |
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.Nat Genet. 2014 Jul;46(7):731-5. doi: 10.1038/ng.3004. Epub 2014 Jun 8.
|
| 1267 |
Function and mechanism of tumor suppressor gene LRRC4/NGL-2.Mol Cancer. 2014 Dec 19;13:266. doi: 10.1186/1476-4598-13-266.
|
| 1268 |
LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway.Hum Cell. 2019 Jan;32(1):41-50. doi: 10.1007/s13577-018-0221-2. Epub 2018 Nov 13.
|
| 1269 |
Oligo-astrocytoma in LZTR1-related Noonan syndrome.Eur J Med Genet. 2020 Jan;63(1):103617. doi: 10.1016/j.ejmg.2019.01.007. Epub 2019 Jan 19.
|
| 1270 |
Silence of MACC1 expression by RNA interference inhibits proliferation, invasion and metastasis, and promotes apoptosis in U251 human malignant glioma cells.Mol Med Rep. 2015 Sep;12(3):3423-3431. doi: 10.3892/mmr.2015.3886. Epub 2015 Jun 3.
|
| 1271 |
MAD2-p31(comet) axis deficiency reduces cell proliferation, migration and sensitivity of microtubule-interfering agents in glioma.Biochem Biophys Res Commun. 2018 Mar 25;498(1):157-163. doi: 10.1016/j.bbrc.2018.02.011. Epub 2018 Feb 3.
|
| 1272 |
Mitotic arrest deficient protein MAD2B is overexpressed in human glioma, with depletion enhancing sensitivity to ionizing radiation.J Clin Neurosci. 2011 Jun;18(6):827-33. doi: 10.1016/j.jocn.2010.11.009. Epub 2011 Apr 21.
|
| 1273 |
Dlxin-1, a member of MAGE family, inhibits cell proliferation, invasion and tumorigenicity of glioma stem cells.Cancer Gene Ther. 2011 Mar;18(3):206-18. doi: 10.1038/cgt.2010.71. Epub 2010 Nov 26.
|
| 1274 |
Prognostic and clinicopathological value of melanoma-associated antigen D4 in patients with glioma.Oncol Lett. 2018 Apr;15(4):4151-4160. doi: 10.3892/ol.2018.7884. Epub 2018 Jan 26.
|
| 1275 |
MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression.Biomed Environ Sci. 2015 Jul;28(7):502-9. doi: 10.3967/bes2015.072.
|
| 1276 |
microRNA-199a-5p suppresses glioma progression by inhibiting MAGT1.J Cell Biochem. 2019 Sep;120(9):15248-15254. doi: 10.1002/jcb.28791. Epub 2019 Apr 30.
|
| 1277 |
Effects of the MAML2 genetic variants in glioma susceptibility and prognosis.Biosci Rep. 2019 Oct 30;39(10):BSR20192091. doi: 10.1042/BSR20192091.
|
| 1278 |
Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.Cell Cycle. 2017 Sep 17;16(18):1705-1718. doi: 10.1080/15384101.2017.1356507. Epub 2017 Aug 2.
|
| 1279 |
Microtubule-associated protein 2 knockdown sensitizes glioma cells to vincristine treatment.Neuroreport. 2020 Feb 5;31(3):197-204. doi: 10.1097/WNR.0000000000001378.
|
| 1280 |
Associations of miR?46aC>G, miR?49C>T, miR?96a2C>T and miR?99A>G polymorphisms with brain tumors.Oncol Rep. 2018 Sep;40(3):1813-1823. doi: 10.3892/or.2018.6557. Epub 2018 Jul 11.
|
| 1281 |
MiR-520b inhibits the development of glioma by directly targeting MBD2.Am J Cancer Res. 2017 Jul 1;7(7):1528-1539. eCollection 2017.
|
| 1282 |
Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression.Oncotarget. 2016 Jul 12;7(28):43654-43668. doi: 10.18632/oncotarget.9661.
|
| 1283 |
Coiled-coil domain containing 109B is a HIF1-regulated gene critical for progression of human gliomas.J Transl Med. 2017 Jul 28;15(1):165. doi: 10.1186/s12967-017-1266-9.
|
| 1284 |
MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma.Biomed Pharmacother. 2016 Jul;81:203-209. doi: 10.1016/j.biopha.2016.03.002. Epub 2016 Apr 18.
|
| 1285 |
Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model.Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:32-38. doi: 10.1016/j.msec.2017.03.292. Epub 2017 Apr 6.
|
| 1286 |
Long noncoding RNA DLEU1 aggravates glioma progression via the miR-421/MEF2D axis.Onco Targets Ther. 2019 Jul 8;12:5405-5414. doi: 10.2147/OTT.S207542. eCollection 2019.
|
| 1287 |
MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status.Dis Markers. 2018 May 20;2018:5975216. doi: 10.1155/2018/5975216. eCollection 2018.
|
| 1288 |
Prognostic significance of MEOX2 in gliomas.Mod Pathol. 2019 Jun;32(6):774-786. doi: 10.1038/s41379-018-0192-6. Epub 2019 Jan 18.
|
| 1289 |
N?Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling.Genes (Basel). 2019 Feb 13;10(2):141. doi: 10.3390/genes10020141.
|
| 1290 |
1,6 GlcNAc branches-modified protein tyrosine phosphatase Mu attenuates its tyrosine phosphatase activity and promotes glioma cell migration through PLC-PKC pathways.Biochem Biophys Res Commun. 2018 Oct 28;505(2):569-577. doi: 10.1016/j.bbrc.2018.09.150. Epub 2018 Sep 29.
|
| 1291 |
Phase II study of protracted daily temozolomide for low-grade gliomas in adults.Clin Cancer Res. 2009 Jan 1;15(1):330-7. doi: 10.1158/1078-0432.CCR-08-0888.
|
| 1292 |
RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.Cancer Res. 2004 Oct 15;64(20):7596-603. doi: 10.1158/0008-5472.CAN-04-1627.
|
| 1293 |
MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.J Pathol. 2017 Jan;241(1):67-79. doi: 10.1002/path.4823. Epub 2016 Nov 24.
|
| 1294 |
Regulation and function of aquaporin-1 in glioma cells.Neoplasia. 2007 Sep;9(9):777-87. doi: 10.1593/neo.07454.
|
| 1295 |
Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene.Genes Chromosomes Cancer. 2015 Nov;54(11):655-67. doi: 10.1002/gcc.22266. Epub 2015 Aug 25.
|
| 1296 |
MLKL contributes to shikonin-induced glioma cell necroptosis via promotion of chromatinolysis.Cancer Lett. 2019 Dec 28;467:58-71. doi: 10.1016/j.canlet.2019.09.007. Epub 2019 Sep 24.
|
| 1297 |
Brain tumor risk according to germ-line variation in the MLLT10 locus.Eur J Hum Genet. 2015 Jan;23(1):132-4. doi: 10.1038/ejhg.2014.70. Epub 2014 Apr 23.
|
| 1298 |
High MMP-26 expression in glioma is correlated with poor clinical outcome of patients.Oncol Lett. 2018 Aug;16(2):2237-2242. doi: 10.3892/ol.2018.8880. Epub 2018 Jun 4.
|
| 1299 |
The function of MMP-28/TGF- induced cell apoptosis in human glioma cells.Exp Ther Med. 2018 Oct;16(4):2867-2874. doi: 10.3892/etm.2018.6566. Epub 2018 Aug 2.
|
| 1300 |
MicroRNA-519d-3p inhibits cell proliferation and cell cycle G1/S transition in glioma by targeting CCND1.Biosci Biotechnol Biochem. 2020 Feb;84(2):297-304. doi: 10.1080/09168451.2019.1682510. Epub 2019 Oct 29.
|
| 1301 |
MOV10 binding circ-DICER1 regulates the angiogenesis of glioma via miR-103a-3p/miR-382-5p mediated ZIC4 expression change.J Exp Clin Cancer Res. 2019 Jan 8;38(1):9. doi: 10.1186/s13046-018-0990-1.
|
| 1302 |
Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.J Neurosurg. 2018 Mar 16;130(1):56-66. doi: 10.3171/2017.9.JNS172036.
|
| 1303 |
N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.Neuro Oncol. 2011 May;13(5):471-86. doi: 10.1093/neuonc/nor011. Epub 2011 Mar 3.
|
| 1304 |
Diagnostic accuracy of MRI texture analysis for grading gliomas.J Neurooncol. 2018 Dec;140(3):583-589. doi: 10.1007/s11060-018-2984-4. Epub 2018 Aug 25.
|
| 1305 |
Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivity. PLoS One. 2014 Oct 14;9(10):e110345.
|
| 1306 |
SMAD3 silencing enhances DNA damage in radiation therapy by interacting with MRE11-RAD50-NBS1 complex in glioma.J Biochem. 2019 Apr 1;165(4):317-322. doi: 10.1093/jb/mvy110.
|
| 1307 |
Knockdown of MRPL42 suppresses glioma cell proliferation by inducing cell cycle arrest and apoptosis.Biosci Rep. 2018 Apr 27;38(2):BSR20171456. doi: 10.1042/BSR20171456. Print 2018 Apr 27.
|
| 1308 |
MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin.Theranostics. 2017 Apr 10;7(6):1663-1673. doi: 10.7150/thno.17886. eCollection 2017.
|
| 1309 |
miR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2.Neuroreport. 2016 Dec 7;27(17):1266-1273. doi: 10.1097/WNR.0000000000000690.
|
| 1310 |
Expression of metastasis-associated protein 3 in human brain glioma related to tumor prognosis.Neurol Sci. 2015 Oct;36(10):1799-804. doi: 10.1007/s10072-015-2252-8. Epub 2015 May 23.
|
| 1311 |
MicroRNA-940 inhibits glioma progression by blocking mitochondrial folate metabolism through targeting of MTHFD2.Am J Cancer Res. 2019 Feb 1;9(2):250-269. eCollection 2019.
|
| 1312 |
MicroRNA 10a induces glioma tumorigenesis by targeting myotubularin-related protein 3 and regulating the Wnt/-catenin signaling pathway.FEBS J. 2019 Jul;286(13):2577-2592. doi: 10.1111/febs.14824. Epub 2019 Apr 11.
|
| 1313 |
Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.Oncotarget. 2013 Nov;4(11):1904-18. doi: 10.18632/oncotarget.1264.
|
| 1314 |
Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.World Neurosurg. 2019 Dec;132:e76-e88. doi: 10.1016/j.wneu.2019.08.253. Epub 2019 Sep 10.
|
| 1315 |
Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.J Exp Clin Cancer Res. 2017 Aug 7;36(1):105. doi: 10.1186/s13046-017-0573-6.
|
| 1316 |
Siglec-h on activated microglia for recognition and engulfment of glioma cells.Glia. 2013 Jul;61(7):1122-33. doi: 10.1002/glia.22501. Epub 2013 Apr 30.
|
| 1317 |
Myosin Heavy Chain 10 (MYH10) Gene Silencing Reduces Cell Migration and Invasion in the Glioma Cell Lines U251, T98G, and SHG44 by Inhibiting the Wnt/-Catenin Pathway.Med Sci Monit. 2018 Dec 15;24:9110-9119. doi: 10.12659/MSM.911523.
|
| 1318 |
Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme.Oncogene. 2013 Feb 14;32(7):872-82. doi: 10.1038/onc.2012.104. Epub 2012 Apr 2.
|
| 1319 |
Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.J Clin Invest. 2019 Feb 1;129(2):676-693. doi: 10.1172/JCI120279. Epub 2019 Jan 14.
|
| 1320 |
From the Cover: Neutralization of terminal differentiation in gliomagenesis.Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14520-7. doi: 10.1073/pnas.1308610110. Epub 2013 Aug 5.
|
| 1321 |
Increased expression of NAF1 contributes to malignant phenotypes of glioma cells through promoting protein synthesis and associates with poor patient survival.Oncogenesis. 2019 Apr 1;8(4):25. doi: 10.1038/s41389-019-0134-2.
|
| 1322 |
Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.Oncotarget. 2016 Nov 15;7(46):74630-74647. doi: 10.18632/oncotarget.11858.
|
| 1323 |
MicroRNA-524 inhibits the progress of glioma via the direct targeting of NCF2.Am J Transl Res. 2019 Mar 15;11(3):1605-1615. eCollection 2019.
|
| 1324 |
B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas.Int Immunopharmacol. 2018 Jun;59:318-327. doi: 10.1016/j.intimp.2018.03.020. Epub 2018 Apr 18.
|
| 1325 |
Astrocyte-specific NDRG2 gene: functions in the brain and neurological diseases.Cell Mol Life Sci. 2020 Jul;77(13):2461-2472. doi: 10.1007/s00018-019-03406-9. Epub 2019 Dec 13.
|
| 1326 |
Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system.Neurogenetics. 2019 Oct;20(4):173-186. doi: 10.1007/s10048-019-00587-0. Epub 2019 Sep 4.
|
| 1327 |
IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells totemozolomideby targeting the NEDD4L-inhibited Wnt/-cateninpathway.PLoS One. 2019 Dec 5;14(12):e0225913. doi: 10.1371/journal.pone.0225913. eCollection 2019.
|
| 1328 |
Down-regulation of neogenin accelerated glioma progression through promoter Methylation and its overexpression in SHG-44 Induced Apoptosis.PLoS One. 2012;7(5):e38074. doi: 10.1371/journal.pone.0038074. Epub 2012 May 29.
|
| 1329 |
Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness.Oncogene. 2019 Jul;38(27):5367-5380. doi: 10.1038/s41388-019-0809-3. Epub 2019 Apr 9.
|
| 1330 |
Transcription Factor NFAT5 Promotes Glioblastoma Cell-driven Angiogenesis via SBF2-AS1/miR-338-3p-Mediated EGFL7 Expression Change.Front Mol Neurosci. 2017 Sep 21;10:301. doi: 10.3389/fnmol.2017.00301. eCollection 2017.
|
| 1331 |
NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells.Sci Rep. 2019 Jun 27;9(1):9361. doi: 10.1038/s41598-019-45731-w.
|
| 1332 |
MicroRNA-346 inhibits the growth of glioma by directly targeting NFIB.Cancer Cell Int. 2019 Nov 14;19:294. doi: 10.1186/s12935-019-1017-5. eCollection 2019.
|
| 1333 |
NFIX Circular RNA Promotes Glioma Progression by Regulating miR-34a-5p via Notch Signaling Pathway.Front Mol Neurosci. 2018 Jul 18;11:225. doi: 10.3389/fnmol.2018.00225. eCollection 2018.
|
| 1334 |
Tunicamycin inhibits progression of glioma cells through downregulation of the MEG-3-regulated wnt/-catenin signaling pathway.Oncol Lett. 2018 Jun;15(6):8470-8476. doi: 10.3892/ol.2018.8416. Epub 2018 Apr 3.
|
| 1335 |
Ninjurin2 overexpression promotes glioma cell growth.Aging (Albany NY). 2019 Dec 2;11(23):11136-11147. doi: 10.18632/aging.102515. Epub 2019 Dec 2.
|
| 1336 |
NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling.J Exp Clin Cancer Res. 2019 Jul 6;38(1):291. doi: 10.1186/s13046-019-1281-1.
|
| 1337 |
Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients.Sci Rep. 2019 May 27;9(1):7895. doi: 10.1038/s41598-019-44261-9.
|
| 1338 |
High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.Oncotarget. 2015 Mar 10;6(7):4901-19. doi: 10.18632/oncotarget.3208.
|
| 1339 |
Phototheranostics: Active Targeting of Orthotopic Glioma Using Biomimetic Proteolipid Nanoparticles.ACS Nano. 2019 Jan 22;13(1):386-398. doi: 10.1021/acsnano.8b06556. Epub 2018 Dec 27.
|
| 1340 |
Specific Preferences in Lineage Choice and Phenotypic Plasticity of Glioma Stem Cells Under BMP4 and Noggin Influence.Brain Pathol. 2016 Jan;26(1):43-61. doi: 10.1111/bpa.12263. Epub 2015 May 19.
|
| 1341 |
Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling.Int J Med Sci. 2019 Apr 25;16(4):614-622. doi: 10.7150/ijms.31579. eCollection 2019.
|
| 1342 |
MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.J Cell Biochem. 2019 Apr;120(4):6188-6197. doi: 10.1002/jcb.27906. Epub 2018 Oct 10.
|
| 1343 |
Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells.Mol Carcinog. 2016 Nov;55(11):1613-1626. doi: 10.1002/mc.22413. Epub 2015 Oct 12.
|
| 1344 |
NR2C2-uORF targeting UCA1-miR-627-5p-NR2C2 feedback loop to regulate the malignant behaviors of glioma cells.Cell Death Dis. 2018 Dec 5;9(12):1165. doi: 10.1038/s41419-018-1149-x.
|
| 1345 |
Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion.J Mol Neurosci. 2019 Jun;68(2):234-242. doi: 10.1007/s12031-019-01281-4. Epub 2019 Mar 30.
|
| 1346 |
FoxQ1 promotes glioma cells proliferation and migration by regulating NRXN3 expression.PLoS One. 2013;8(1):e55693. doi: 10.1371/journal.pone.0055693. Epub 2013 Jan 30.
|
| 1347 |
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program.Acta Neuropathol. 2019 Dec;138(6):1053-1074. doi: 10.1007/s00401-019-02062-4. Epub 2019 Aug 19.
|
| 1348 |
NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.Cancer Lett. 2019 Jul 10;454:98-107. doi: 10.1016/j.canlet.2019.04.003. Epub 2019 Apr 10.
|
| 1349 |
Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.Mol Cancer. 2015 Feb 3;14:21. doi: 10.1186/s12943-015-0290-8.
|
| 1350 |
Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients.CNS Neurosci Ther. 2018 Mar;24(3):178-186. doi: 10.1111/cns.12803. Epub 2018 Jan 15.
|
| 1351 |
OIP5 Expression Sensitize Glioblastoma Cells to Lomustine Treatment.J Mol Neurosci. 2018 Nov;66(3):383-389. doi: 10.1007/s12031-018-1184-1. Epub 2018 Oct 3.
|
| 1352 |
Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.Neuropathol Appl Neurobiol. 2018 Feb;44(2):207-223. doi: 10.1111/nan.12447. Epub 2017 Nov 23.
|
| 1353 |
PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo.J Control Release. 2019 Mar 28;298:194-201. doi: 10.1016/j.jconrel.2019.02.008. Epub 2019 Feb 11.
|
| 1354 |
Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses.Dis Markers. 2019 Oct 20;2019:7049294. doi: 10.1155/2019/7049294. eCollection 2019.
|
| 1355 |
Allergy and glioma risk: test of association by genotype.Int J Cancer. 2011 Apr 1;128(7):1736-40. doi: 10.1002/ijc.25483. Epub 2010 May 25.
|
| 1356 |
P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.Oncol Rep. 2018 Feb;39(2):501-510. doi: 10.3892/or.2017.6134. Epub 2017 Dec 4.
|
| 1357 |
miR?89 promotes apoptosis and inhibits invasiveness of glioma cells by targeting PAK5/RAF1 signaling pathways.Oncol Rep. 2019 Dec;42(6):2390-2401. doi: 10.3892/or.2019.7381. Epub 2019 Oct 22.
|
| 1358 |
MicroRNA-423-3p promotes glioma growth by targeting PANX2.Oncol Lett. 2018 Jul;16(1):179-188. doi: 10.3892/ol.2018.8636. Epub 2018 May 4.
|
| 1359 |
PAQR3 inhibits the proliferation, migration and invasion in human glioma cells.Biomed Pharmacother. 2017 Aug;92:24-32. doi: 10.1016/j.biopha.2017.05.046. Epub 2017 May 18.
|
| 1360 |
PAS Domain Containing Repressor 1 (PASD1) Promotes Glioma Cell Proliferation Through Inhibiting Apoptosis In Vitro.Med Sci Monit. 2019 Sep 16;25:6955-6964. doi: 10.12659/MSM.916308.
|
| 1361 |
PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas.Cancers (Basel). 2019 Oct 11;11(10):1537. doi: 10.3390/cancers11101537.
|
| 1362 |
PAX3 Promotes Proliferation of Human Glioma Cells by WNT/-Catenin Signaling Pathways.J Mol Neurosci. 2019 May;68(1):66-77. doi: 10.1007/s12031-019-01283-2. Epub 2019 Mar 2.
|
| 1363 |
PAXX Participates in Base Excision Repair via Interacting with Pol and Contributes to TMZ Resistance in Glioma Cells.J Mol Neurosci. 2018 Oct;66(2):214-221. doi: 10.1007/s12031-018-1157-4. Epub 2018 Sep 20.
|
| 1364 |
Evaluation of Tumor Regulatory Genes and Apoptotic Pathways in The Cytotoxic Effect of Cytochalasin H on Malignant Human Glioma Cell Line (U87MG).Cell J. 2019 Apr;21(1):62-69. doi: 10.22074/cellj.2019.5948. Epub 2018 Nov 18.
|
| 1365 |
PCDH8 inhibits glioma cell proliferation by negatively regulating the AKT/GSK3/-catenin signaling pathway.Oncol Lett. 2017 Sep;14(3):3357-3362. doi: 10.3892/ol.2017.6629. Epub 2017 Jul 20.
|
| 1366 |
Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.Oncotarget. 2017 Feb 7;8(6):10287-10297. doi: 10.18632/oncotarget.14396.
|
| 1367 |
LncRNA PCED1B-AS1 activates the proliferation and restricts the apoptosis of glioma through cooperating with miR-194-5p/PCED1B axis.J Cell Biochem. 2020 Feb;121(2):1823-1833. doi: 10.1002/jcb.29417. Epub 2019 Nov 3.
|
| 1368 |
NSPc1 polycomb protein complex binds and crosstalks to lncRNAs in glioma H4 cells.Oncol Rep. 2019 Apr;41(4):2575-2584. doi: 10.3892/or.2019.7000. Epub 2019 Feb 5.
|
| 1369 |
PAF promotes stemness and radioresistance of glioma stem cells.Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9086-E9095. doi: 10.1073/pnas.1708122114. Epub 2017 Oct 9.
|
| 1370 |
Increased expression of platelet-derived growth factor associated protein-1 is associated with PDGF-B mediated glioma progression.Int J Biochem Cell Biol. 2016 Sep;78:194-205. doi: 10.1016/j.biocel.2016.07.016. Epub 2016 Jul 19.
|
| 1371 |
CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma.Exp Cell Res. 2016 May 15;344(1):132-142. doi: 10.1016/j.yexcr.2016.03.017. Epub 2016 Mar 18.
|
| 1372 |
Glioma invasion mediated by the p75 neurotrophin receptor (p75(NTR)/CD271) requires regulated interaction with PDLIM1.Oncogene. 2016 Mar 17;35(11):1411-22. doi: 10.1038/onc.2015.199. Epub 2015 Jun 29.
|
| 1373 |
Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression.Front Oncol. 2019 Mar 26;9:187. doi: 10.3389/fonc.2019.00187. eCollection 2019.
|
| 1374 |
Integrin 51 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.Cell Death Differ. 2016 Apr;23(4):640-53. doi: 10.1038/cdd.2015.131. Epub 2015 Oct 16.
|
| 1375 |
Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway.Mol Carcinog. 2019 Jan;58(1):135-143. doi: 10.1002/mc.22915. Epub 2018 Oct 5.
|
| 1376 |
Prediction of relapse and prognosis by expression levels of long noncoding RNA PEG10 in glioma patients.Medicine (Baltimore). 2019 Nov;98(45):e17583. doi: 10.1097/MD.0000000000017583.
|
| 1377 |
The imprinted gene PEG3 inhibits Wnt signaling and regulates glioma growth.J Biol Chem. 2010 Mar 12;285(11):8472-80. doi: 10.1074/jbc.M109.069450. Epub 2010 Jan 11.
|
| 1378 |
PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.Cell Physiol Biochem. 2018;50(6):2108-2123. doi: 10.1159/000495055. Epub 2018 Nov 9.
|
| 1379 |
Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression throughHIF-1 accumulation.Nat Cell Biol. 2014 May;16(5):445-56. doi: 10.1038/ncb2954. Epub 2014 Apr 20.
|
| 1380 |
Cofilin-1 and phosphoglycerate kinase 1 as promising indicators for glioma radiosensibility and prognosis.Oncotarget. 2017 Jul 5;8(33):55073-55083. doi: 10.18632/oncotarget.19025. eCollection 2017 Aug 15.
|
| 1381 |
Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway.Cancer Cell Int. 2019 Nov 27;19:314. doi: 10.1186/s12935-019-1040-6. eCollection 2019.
|
| 1382 |
microRNA-124a suppresses PHF19 over-expression, EZH2 hyper-activation, and aberrant cell proliferation in human glioma.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1610-1617. doi: 10.1016/j.bbrc.2018.07.089. Epub 2018 Aug 18.
|
| 1383 |
PKB-mediated PHF20 phosphorylation on Ser291 is required for p53 function in DNA damage.Cell Signal. 2013 Jan;25(1):74-84. doi: 10.1016/j.cellsig.2012.09.009. Epub 2012 Sep 11.
|
| 1384 |
The Identification of Key Genes and Pathways in Glioma by Bioinformatics Analysis.J Immunol Res. 2017;2017:1278081. doi: 10.1155/2017/1278081. Epub 2017 Dec 6.
|
| 1385 |
The long non-coding RNA SNHG1 promotes glioma progression by competitively binding to miR-194 to regulate PHLDA1 expression.Cell Death Dis. 2019 Jun 12;10(6):463. doi: 10.1038/s41419-019-1698-7.
|
| 1386 |
Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.Mol Biol Rep. 2020 Feb;47(2):877-886. doi: 10.1007/s11033-019-05178-8. Epub 2019 Nov 12.
|
| 1387 |
Role of PHLPP1 in inflammation response: Its loss contributes to gliomas development and progression.Int Immunopharmacol. 2016 May;34:229-234. doi: 10.1016/j.intimp.2016.02.034. Epub 2016 Mar 10.
|
| 1388 |
miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.J Cell Biochem. 2015 Feb;116(2):225-32. doi: 10.1002/jcb.24949.
|
| 1389 |
Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme.Med Sci Monit. 2019 Apr 9;25:2583-2590. doi: 10.12659/MSM.913895.
|
| 1390 |
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas.Clin Cancer Res. 2014 Feb 15;20(4):827-36. doi: 10.1158/1078-0432.CCR-13-2053. Epub 2013 Dec 3.
|
| 1391 |
Unlocking the Dangers of a Stiffening Brain.Neuron. 2018 Nov 21;100(4):763-765. doi: 10.1016/j.neuron.2018.11.011.
|
| 1392 |
Piezo2 protein: A novel regulator of tumor angiogenesis and hyperpermeability.Oncotarget. 2016 Jul 12;7(28):44630-44643. doi: 10.18632/oncotarget.10134.
|
| 1393 |
Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH.J Neurooncol. 2012 Sep;109(2):405-13. doi: 10.1007/s11060-012-0909-1. Epub 2012 Jul 24.
|
| 1394 |
Next-generation whole exome sequencing of glioblastoma with a primitive neuronal component.Brain Tumor Pathol. 2019 Jul;36(3):129-134. doi: 10.1007/s10014-019-00334-1. Epub 2019 Feb 4.
|
| 1395 |
MicroRNA-365 inhibits proliferation, migration and invasion of glioma by targeting PIK3R3.Oncol Rep. 2017 Apr;37(4):2185-2192. doi: 10.3892/or.2017.5458. Epub 2017 Feb 16.
|
| 1396 |
Mechanism of piR-DQ590027/MIR17HG regulating the permeability of glioma conditioned normal BBB.J Exp Clin Cancer Res. 2018 Oct 11;37(1):246. doi: 10.1186/s13046-018-0886-0.
|
| 1397 |
High expression of PIWIL2 promotes tumor cell proliferation, migration and predicts a poor prognosis in glioma.Oncol Rep. 2017 Jul;38(1):183-192. doi: 10.3892/or.2017.5647. Epub 2017 May 17.
|
| 1398 |
Protein kinase D2: a versatile player in cancer biology.Oncogene. 2018 Mar;37(10):1263-1278. doi: 10.1038/s41388-017-0052-8. Epub 2017 Dec 20.
|
| 1399 |
Up-regulation of plakophilin-2 is correlated with the progression of glioma.Neuropathology. 2017 Jun;37(3):207-216. doi: 10.1111/neup.12363. Epub 2017 Jan 26.
|
| 1400 |
Overexpression of the phospholipase A2 group V gene in glioma tumors is associated with poor patient prognosis.Cancer Manag Res. 2019 Apr 11;11:3139-3152. doi: 10.2147/CMAR.S199207. eCollection 2019.
|
| 1401 |
Combination of phospholipase C knockdown with GANT61 sensitizes castrationresistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway.Oncol Rep. 2019 May;41(5):2689-2702. doi: 10.3892/or.2019.7054. Epub 2019 Mar 7.
|
| 1402 |
Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3421-6. doi: 10.1073/pnas.1414573112. Epub 2015 Mar 3.
|
| 1403 |
PLEKHG5 is a novel prognostic biomarker in glioma patients.Int J Clin Oncol. 2019 Nov;24(11):1350-1358. doi: 10.1007/s10147-019-01503-0. Epub 2019 Jul 15.
|
| 1404 |
Casein Kinase 2 Interacting Protein-1 Suppresses Glioma Cell Proliferation via Regulating the AKT/GSK3/-Catenin Pathway.Biomed Res Int. 2019 Jul 2;2019:5653212. doi: 10.1155/2019/5653212. eCollection 2019.
|
| 1405 |
Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas.Oncotarget. 2018 Feb 28;9(21):15705-15720. doi: 10.18632/oncotarget.24594. eCollection 2018 Mar 20.
|
| 1406 |
Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton.Oncogene. 2012 Feb 2;31(5):595-610. doi: 10.1038/onc.2011.256. Epub 2011 Jun 27.
|
| 1407 |
PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1.Oncogene. 2020 Jan;39(5):1125-1139. doi: 10.1038/s41388-019-1050-9. Epub 2019 Oct 11.
|
| 1408 |
Hereditary nonpolyposis colorectal cancer and related conditions.Am J Med Genet A. 2003 Nov 1;122A(4):325-34. doi: 10.1002/ajmg.a.20475.
|
| 1409 |
Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo.BMC Cancer. 2008 Jan 29;8:29. doi: 10.1186/1471-2407-8-29.
|
| 1410 |
TNF receptor-associated factor 6 regulates proliferation, apoptosis, and invasion of glioma cells.Mol Cell Biochem. 2013 May;377(1-2):87-96. doi: 10.1007/s11010-013-1573-2. Epub 2013 Jan 29.
|
| 1411 |
Impact of Gln94Glu mutation on the structure and function of protection of telomere 1, a cause of cutaneous familial melanoma.J Biomol Struct Dyn. 2020 Mar;38(5):1514-1524. doi: 10.1080/07391102.2019.1610500. Epub 2019 May 7.
|
| 1412 |
POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis.Brain Res. 2011 May 19;1391:125-31. doi: 10.1016/j.brainres.2011.03.042. Epub 2011 Mar 22.
|
| 1413 |
Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3.Eur Rev Med Pharmacol Sci. 2017 Mar;21(5):959-972.
|
| 1414 |
MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma.J Exp Clin Cancer Res. 2019 Feb 22;38(1):99. doi: 10.1186/s13046-019-1078-2.
|
| 1415 |
Cyclophilin J is a novel peptidyl-prolyl isomerase and target for repressing the growth of hepatocellular carcinoma.PLoS One. 2015 May 28;10(5):e0127668. doi: 10.1371/journal.pone.0127668. eCollection 2015.
|
| 1416 |
Downregulation of PRDM1 promotes cellular invasion and lung cancer metastasis.Tumour Biol. 2017 Apr;39(4):1010428317695929. doi: 10.1177/1010428317695929.
|
| 1417 |
Overexpression of PRDM13 inhibits glioma cells via Rho and GTP enzyme activation protein.Int J Mol Med. 2018 Aug;42(2):966-974. doi: 10.3892/ijmm.2018.3679. Epub 2018 May 14.
|
| 1418 |
Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.Cell Mol Neurobiol. 2017 Aug;37(6):1021-1027. doi: 10.1007/s10571-016-0435-3. Epub 2016 Oct 18.
|
| 1419 |
A PRDX1-p38 heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomas.Int J Cancer. 2018 Sep 1;143(5):1176-1187. doi: 10.1002/ijc.31404. Epub 2018 Apr 16.
|
| 1420 |
Protein kinase D2 promotes the proliferation of glioma cells by regulating Golgi phosphoprotein 3.Cancer Lett. 2014 Dec 1;355(1):121-9. doi: 10.1016/j.canlet.2014.09.008. Epub 2014 Sep 16.
|
| 1421 |
MicroRNA-374a Governs Aggressive Cell Behaviors of Glioma by Targeting Prokineticin 2.Technol Cancer Res Treat. 2019 Jan 1;18:1533033818821401. doi: 10.1177/1533033818821401.
|
| 1422 |
Suprasellar mass mimicking a hypothalamic glioma in a patient with a complete PROP1 deletion.Eur J Med Genet. 2013 Aug;56(8):445-51. doi: 10.1016/j.ejmg.2013.06.006. Epub 2013 Jul 3.
|
| 1423 |
Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype.Cancer Res. 2018 Oct 15;78(20):5901-5916. doi: 10.1158/0008-5472.CAN-18-0320. Epub 2018 Aug 22.
|
| 1424 |
The binding of lncRNA RP11-732M18.3 with 14-3-3 / accelerates p21 degradation and promotes glioma growth.EBioMedicine. 2019 Jul;45:58-69. doi: 10.1016/j.ebiom.2019.06.002. Epub 2019 Jun 13.
|
| 1425 |
Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/-catenin signaling pathway.Oncotarget. 2016 Sep 27;7(39):63449-63455. doi: 10.18632/oncotarget.11523.
|
| 1426 |
Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-1/Smad signaling pathway.J Pathol. 2019 Sep;249(1):26-38. doi: 10.1002/path.5278. Epub 2019 May 21.
|
| 1427 |
Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.Cell Physiol Biochem. 2018;45(2):819-831. doi: 10.1159/000487174. Epub 2018 Jan 31.
|
| 1428 |
PTPH1 immunohistochemical expression and promoter methylation in breast cancer patients from India: A retrospective study.J Cell Physiol. 2019 Feb;234(2):1071-1079. doi: 10.1002/jcp.27211. Epub 2018 Sep 6.
|
| 1429 |
EGFR blockade prevents glioma escape from BRAFV600E targeted therapy.Oncotarget. 2015 Sep 8;6(26):21993-2005. doi: 10.18632/oncotarget.4014.
|
| 1430 |
Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma.PLoS One. 2018 Oct 4;13(10):e0204865. doi: 10.1371/journal.pone.0204865. eCollection 2018.
|
| 1431 |
MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma.Int J Clin Exp Pathol. 2014 Dec 1;7(12):8573-82. eCollection 2014.
|
| 1432 |
Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo.J Neurooncol. 2016 Sep;129(2):201-9. doi: 10.1007/s11060-016-2168-z. Epub 2016 Jun 9.
|
| 1433 |
Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.CNS Neurosci Ther. 2017 Jan;23(1):69-75. doi: 10.1111/cns.12606. Epub 2016 Sep 17.
|
| 1434 |
miR-200b as a prognostic factor targets multiple members of RAB family in glioma.Med Oncol. 2014 Mar;31(3):859. doi: 10.1007/s12032-014-0859-x. Epub 2014 Jan 30.
|
| 1435 |
LncRNA DANCR functions as a competing endogenous RNA to regulate RAB1A expression by sponging miR-634 in glioma.Biosci Rep. 2018 Feb 2;38(1):BSR20171664. doi: 10.1042/BSR20171664. Print 2018 Feb 28.
|
| 1436 |
Knockdown of Rab21 inhibits proliferation and induces apoptosis in human glioma cells.Cell Mol Biol Lett. 2017 Dec 19;22:30. doi: 10.1186/s11658-017-0062-0. eCollection 2017.
|
| 1437 |
MicroRNA-599 suppresses glioma progression by targeting RAB27B.Oncol Lett. 2018 Jul;16(1):1243-1252. doi: 10.3892/ol.2018.8727. Epub 2018 May 16.
|
| 1438 |
Over-expression of Rap2a inhibits glioma migration and invasion by down-regulating p-AKT.Cell Biol Int. 2014 Mar;38(3):326-34. doi: 10.1002/cbin.10213. Epub 2013 Dec 2.
|
| 1439 |
RAB34 was a progression- and prognosis-associated biomarker in gliomas.Tumour Biol. 2015 Mar;36(3):1573-8. doi: 10.1007/s13277-014-2732-0. Epub 2014 Dec 13.
|
| 1440 |
RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.Oncol Rep. 2013 Nov;30(5):2350-6. doi: 10.3892/or.2013.2730. Epub 2013 Sep 10.
|
| 1441 |
Rab3a promotes brain tumor initiation and progression.Mol Biol Rep. 2014 Sep;41(9):5903-11. doi: 10.1007/s11033-014-3465-2. Epub 2014 Jun 26.
|
| 1442 |
High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.Oncol Rep. 2017 Feb;37(2):903-912. doi: 10.3892/or.2017.5349. Epub 2017 Jan 3.
|
| 1443 |
High expression of RAD18 in glioma induces radiotherapy resistance via down-regulating P53 expression.Biomed Pharmacother. 2019 Apr;112:108555. doi: 10.1016/j.biopha.2019.01.016. Epub 2019 Feb 21.
|
| 1444 |
Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas.Aging (Albany NY). 2019 Sep 18;11(18):7707-7722. doi: 10.18632/aging.102282. Epub 2019 Sep 18.
|
| 1445 |
A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chinese.J Neurooncol. 2014 Oct;120(1):11-7. doi: 10.1007/s11060-014-1527-x. Epub 2014 Jul 11.
|
| 1446 |
Genetic variations in the homologous recombination repair pathway genes modify risk of glioma.J Neurooncol. 2016 Jan;126(1):11-17. doi: 10.1007/s11060-015-1892-0. Epub 2015 Oct 29.
|
| 1447 |
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer.Nat Commun. 2017 Dec 11;8(1):2035. doi: 10.1038/s41467-017-02185-w.
|
| 1448 |
Inhibition of RNA transportation induces glioma cell apoptosis via downregulation of RanGAP1 expression.Chem Biol Interact. 2015 May 5;232:49-57. doi: 10.1016/j.cbi.2015.02.019. Epub 2015 Mar 3.
|
| 1449 |
Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101.J Neurooncol. 2017 Aug;134(1):19-28. doi: 10.1007/s11060-017-2498-5. Epub 2017 May 27.
|
| 1450 |
Rap2B promotes cell adhesion, proliferation, migration and invasion of human glioma.J Neurooncol. 2019 Jun;143(2):221-229. doi: 10.1007/s11060-019-03163-6. Epub 2019 Apr 17.
|
| 1451 |
Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway.Sci Rep. 2017 Jun 9;7(1):3202. doi: 10.1038/s41598-017-03612-0.
|
| 1452 |
RasGRP3 regulates the migration of glioma cells via interaction with Arp3.Oncotarget. 2015 Jan 30;6(3):1850-64. doi: 10.18632/oncotarget.2575.
|
| 1453 |
Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.Oncogene. 2011 Feb 24;30(8):978-89. doi: 10.1038/onc.2010.471. Epub 2010 Oct 18.
|
| 1454 |
Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.Sci Rep. 2018 May 9;8(1):7352. doi: 10.1038/s41598-018-24580-z.
|
| 1455 |
Expression and clinical role of RBQ3 in gliomas.J Neurol Sci. 2015 Dec 15;359(1-2):177-84. doi: 10.1016/j.jns.2015.10.058. Epub 2015 Nov 9.
|
| 1456 |
Association of genetic variants in the retinoblastoma binding protein 6 gene with the risk of glioma: a case-control study in a Chinese Han population.J Neurosurg. 2014 Nov;121(5):1209-18. doi: 10.3171/2014.6.JNS132240. Epub 2014 Aug 15.
|
| 1457 |
RBM17 controls apoptosis and proliferation to promote Glioma progression.Biochem Biophys Res Commun. 2018 Oct 20;505(1):20-28. doi: 10.1016/j.bbrc.2018.09.056. Epub 2018 Sep 15.
|
| 1458 |
Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.J Natl Cancer Inst. 2012 Oct 3;104(19):1458-69. doi: 10.1093/jnci/djs357. Epub 2012 Sep 3.
|
| 1459 |
The regulator of calcineurin 1 (RCAN1) inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth.Oncotarget. 2017 Feb 14;8(7):12003-12012. doi: 10.18632/oncotarget.14479.
|
| 1460 |
Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-/SMAD signaling pathway.Chin Med J (Engl). 2019 Oct 20;132(20):2430-2437. doi: 10.1097/CM9.0000000000000478.
|
| 1461 |
RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis.Oncol Lett. 2018 Apr;15(4):4404-4410. doi: 10.3892/ol.2018.7894. Epub 2018 Jan 29.
|
| 1462 |
Hsa-mir-127 impairs survival of patients with glioma and promotes proliferation, migration and invasion of cancerous cells by modulating replication initiator 1.Neuroreport. 2018 Sep 26;29(14):1166-1173. doi: 10.1097/WNR.0000000000001089.
|
| 1463 |
LincRNA-p21 knockdown enhances radiosensitivity of hypoxic tumor cells by reducing autophagy through HIF-1/Akt/mTOR/P70S6K pathway.Exp Cell Res. 2017 Sep 15;358(2):188-198. doi: 10.1016/j.yexcr.2017.06.016. Epub 2017 Jul 8.
|
| 1464 |
RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation.Cancer Res. 2013 Aug 15;73(16):5140-50. doi: 10.1158/0008-5472.CAN-13-1168-T. Epub 2013 Jun 17.
|
| 1465 |
The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway.Cancer Lett. 2018 Feb 28;415:151-163. doi: 10.1016/j.canlet.2017.12.010. Epub 2017 Dec 9.
|
| 1466 |
The Histone Demethylase NO66 Induces Glioma Cell Proliferation.Anticancer Res. 2019 Nov;39(11):6007-6014. doi: 10.21873/anticanres.13806.
|
| 1467 |
AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields).Cell Death Dis. 2018 Oct 19;9(11):1074. doi: 10.1038/s41419-018-1085-9.
|
| 1468 |
RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis.Oncol Rep. 2016 Jul;36(1):173-80. doi: 10.3892/or.2016.4802. Epub 2016 May 10.
|
| 1469 |
Znf179 induces differentiation and growth arrest of human primary glioblastoma multiforme in a p53-dependent cell cycle pathway.Sci Rep. 2017 Jul 6;7(1):4787. doi: 10.1038/s41598-017-05305-0.
|
| 1470 |
Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway.Oncol Rep. 2018 Dec;40(6):3285-3296. doi: 10.3892/or.2018.6744. Epub 2018 Sep 28.
|
| 1471 |
Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27(Kip1).J Neurooncol. 2015 Sep;124(3):357-64. doi: 10.1007/s11060-015-1851-9. Epub 2015 Jun 19.
|
| 1472 |
Ubiquitin ligase RNF5 serves an important role in the development of human glioma.Oncol Lett. 2019 Nov;18(5):4659-4666. doi: 10.3892/ol.2019.10801. Epub 2019 Sep 4.
|
| 1473 |
TP53 and RPA3 gene variations were associated with risk of glioma in a Chinese Han population.Cancer Biother Radiopharm. 2013 Apr;28(3):248-53. doi: 10.1089/cbr.2012.1291.
|
| 1474 |
Knockdown of RPL34 inhibits the proliferation and migration of glioma cells through the inactivation of JAK/STAT3 signaling pathway.J Cell Biochem. 2019 Mar;120(3):3259-3267. doi: 10.1002/jcb.27592. Epub 2018 Sep 14.
|
| 1475 |
LncRNA PLAC2 down-regulates RPL36 expression and blocks cell cycle progression in glioma through a mechanism involving STAT1.J Cell Mol Med. 2018 Jan;22(1):497-510. doi: 10.1111/jcmm.13338. Epub 2017 Sep 18.
|
| 1476 |
Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose flux.Oncotarget. 2017 Jun 27;8(40):67567-67591. doi: 10.18632/oncotarget.18747. eCollection 2017 Sep 15.
|
| 1477 |
Identification of expression quantitative trait loci of RPTOR for susceptibility to glioma.Tumour Biol. 2016 Feb;37(2):2305-11. doi: 10.1007/s13277-015-3956-3. Epub 2015 Sep 11.
|
| 1478 |
MicroRNA-375 inhibits glioma cell proliferation and migration by downregulating RWDD3 invitro.Oncol Rep. 2018 Apr;39(4):1825-1834. doi: 10.3892/or.2018.6261. Epub 2018 Feb 13.
|
| 1479 |
Ryk is essential for Wnt-5a-dependent invasiveness in human glioma.J Biochem. 2014 Jul;156(1):29-38. doi: 10.1093/jb/mvu015. Epub 2014 Mar 11.
|
| 1480 |
S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-B positive feedback loop.J Cell Mol Med. 2019 Oct;23(10):6907-6918. doi: 10.1111/jcmm.14574. Epub 2019 Aug 20.
|
| 1481 |
SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways.Cell Commun Signal. 2019 Jul 25;17(1):82. doi: 10.1186/s12964-019-0392-9.
|
| 1482 |
Methylation-induced downregulation and tumor-suppressive role of microRNA-98 in glioma through targeting Sal-like protein 4.Int J Mol Med. 2018 May;41(5):2651-2659. doi: 10.3892/ijmm.2018.3464. Epub 2018 Feb 6.
|
| 1483 |
Homeobox B8 Targets Sterile Alpha Motif Domain-Containing Protein 9 and Drives Glioma Progression.Neurosci Bull. 2020 Apr;36(4):359-371. doi: 10.1007/s12264-019-00436-y. Epub 2019 Oct 23.
|
| 1484 |
SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.PLoS One. 2013 Nov 22;8(11):e81905. doi: 10.1371/journal.pone.0081905. eCollection 2013.
|
| 1485 |
Exosomal and extracellular HMGB1 have opposite effects on SASH1 expression in rat astrocytes and glioma C6 cells.Biochem Biophys Res Commun. 2019 Oct 15;518(2):325-330. doi: 10.1016/j.bbrc.2019.08.057. Epub 2019 Aug 14.
|
| 1486 |
Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/-catenin signaling.Biochem Biophys Res Commun. 2014 May 30;448(2):206-11. doi: 10.1016/j.bbrc.2014.04.098. Epub 2014 Apr 29.
|
| 1487 |
Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acid.J Biol Chem. 2014 Jan 31;289(5):2826-38. doi: 10.1074/jbc.M113.527754. Epub 2013 Dec 5.
|
| 1488 |
Mechanism of SEMA3B gene silencing and clinical significance in glioma.Genet Mol Res. 2016 Mar 18;15(1). doi: 10.4238/gmr.15017664.
|
| 1489 |
High level of Sema3C is associated with glioma malignancy.Diagn Pathol. 2015 Jun 2;10:58. doi: 10.1186/s13000-015-0298-9.
|
| 1490 |
Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanism.Sci Rep. 2018 Jan 8;8(1):93. doi: 10.1038/s41598-017-18551-z.
|
| 1491 |
Long noncoding RNA CASC15 is upregulated in glioma and facilitates cell proliferation and metastasis via targeting miR-130b-3p.Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7475-7481. doi: 10.26355/eurrev_201909_18857.
|
| 1492 |
Semaphorin-7A on Exosomes: A Promigratory Signal in the Glioma Microenvironment.Cancers (Basel). 2019 May 30;11(6):758. doi: 10.3390/cancers11060758.
|
| 1493 |
Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.Cell Death Dis. 2018 May 1;9(5):514. doi: 10.1038/s41419-018-0547-4.
|
| 1494 |
SEPT7 overexpression inhibits glioma cell migration by targeting the actin cytoskeleton pathway.Oncol Rep. 2016 Apr;35(4):2003-10. doi: 10.3892/or.2016.4609. Epub 2016 Feb 3.
|
| 1495 |
Serine protease inhibitor (SERPIN) B1 suppresses cell migration and invasion in glioma cells.Brain Res. 2015 Mar 10;1600:59-69. doi: 10.1016/j.brainres.2014.06.017. Epub 2014 Jun 23.
|
| 1496 |
The Opposing Contribution of SMS1 and SMS2 to Glioma Progression and Their Value in the Therapeutic Response to 2OHOA.Cancers (Basel). 2019 Jan 14;11(1):88. doi: 10.3390/cancers11010088.
|
| 1497 |
Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.J Cell Mol Med. 2017 Nov;21(11):2685-2694. doi: 10.1111/jcmm.13184. Epub 2017 May 4.
|
| 1498 |
Prognostic significance of Tks5 expression in gliomas.J Clin Neurosci. 2012 Mar;19(3):436-42. doi: 10.1016/j.jocn.2011.11.013. Epub 2012 Jan 16.
|
| 1499 |
Genome-wide association study identifies five susceptibility loci for glioma.Nat Genet. 2009 Aug;41(8):899-904. doi: 10.1038/ng.407. Epub 2009 Jul 5.
|
| 1500 |
Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.Clin Neurol Neurosurg. 2017 Mar;154:28-33. doi: 10.1016/j.clineuro.2017.01.005. Epub 2017 Jan 16.
|
| 1501 |
SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.EBioMedicine. 2016 Nov;13:80-89. doi: 10.1016/j.ebiom.2016.10.040. Epub 2016 Oct 28.
|
| 1502 |
A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis.Oncogene. 2018 Mar;37(13):1805-1814. doi: 10.1038/s41388-017-0019-9. Epub 2018 Jan 18.
|
| 1503 |
Ubiquitin ligase Siah1 promotes the migration and invasion of human glioma cells by regulating HIF-1 signaling under hypoxia.Oncol Rep. 2015 Mar;33(3):1185-90. doi: 10.3892/or.2014.3695. Epub 2014 Dec 23.
|
| 1504 |
SIL1 functions as an oncogene in glioma by AKT/mTOR signaling pathway.Onco Targets Ther. 2018 Jul 2;11:3775-3783. doi: 10.2147/OTT.S167552. eCollection 2018.
|
| 1505 |
Targeting SIM2-s decreases glioma cell invasion through mesenchymal--epithelial transition.J Cell Biochem. 2014 Nov;115(11):1900-7. doi: 10.1002/jcb.24859.
|
| 1506 |
Sirtuin 7 promotes glioma proliferation and invasion through activation of the ERK/STAT3 signaling pathway.Oncol Lett. 2019 Feb;17(2):1445-1452. doi: 10.3892/ol.2018.9800. Epub 2018 Dec 6.
|
| 1507 |
Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members.J Neurooncol. 2017 Jul;133(3):509-518. doi: 10.1007/s11060-017-2476-y. Epub 2017 Jun 22.
|
| 1508 |
SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways.Cancer Cell Int. 2019 Dec 3;19:324. doi: 10.1186/s12935-019-1047-z. eCollection 2019.
|
| 1509 |
Epigenetic modification of miR-141 regulates SKA2 by an endogenous 'sponge' HOTAIR in glioma.Oncotarget. 2016 May 24;7(21):30610-25. doi: 10.18632/oncotarget.8895.
|
| 1510 |
Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.PLoS One. 2015 Feb 24;10(2):e0118302. doi: 10.1371/journal.pone.0118302. eCollection 2015.
|
| 1511 |
Costimulatory checkpoint SLAMF8 is an independent prognosis factor in glioma.CNS Neurosci Ther. 2019 Mar;25(3):333-342. doi: 10.1111/cns.13041. Epub 2018 Aug 13.
|
| 1512 |
Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.Oncogene. 2017 Oct 26;36(43):6006-6019. doi: 10.1038/onc.2017.205. Epub 2017 Jul 3.
|
| 1513 |
Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers.Br J Cancer. 2004 Dec 13;91(12):2071-8. doi: 10.1038/sj.bjc.6602222.
|
| 1514 |
The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cells.Sci Rep. 2017 Apr 18;7(1):889. doi: 10.1038/s41598-017-00982-3.
|
| 1515 |
SWI/SNF gene variants and glioma risk and outcome.Cancer Epidemiol. 2013 Apr;37(2):162-5. doi: 10.1016/j.canep.2012.12.001. Epub 2012 Dec 29.
|
| 1516 |
Overexpression of hSNF2H in glioma promotes cell proliferation, invasion, and chemoresistance through its interaction with Rsf-1.Tumour Biol. 2016 Jun;37(6):7203-12. doi: 10.1007/s13277-015-4579-4. Epub 2015 Dec 14.
|
| 1517 |
Knocking down SMC1A inhibits growth and leads to G2/M arrest in human glioma cells.Int J Clin Exp Pathol. 2013 Apr 15;6(5):862-9. Print 2013.
|
| 1518 |
Overexpression of SMC4 activates TGF/Smad signaling and promotes aggressive phenotype in glioma cells.Oncogenesis. 2017 Mar 13;6(3):e301. doi: 10.1038/oncsis.2017.8.
|
| 1519 |
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0.Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557. doi: 10.1007/s00259-018-4207-9. Epub 2018 Dec 5.
|
| 1520 |
Suppression of the Smurf1 Expression Inhibits Tumor Progression in Gliomas.Cell Mol Neurobiol. 2018 Mar;38(2):421-430. doi: 10.1007/s10571-017-0485-1. Epub 2017 Mar 20.
|
| 1521 |
Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study.BMC Cancer. 2012 Dec 22;12:617. doi: 10.1186/1471-2407-12-617.
|
| 1522 |
Oncogenic activity of SOX1 in glioblastoma.Sci Rep. 2017 Apr 20;7:46575. doi: 10.1038/srep46575.
|
| 1523 |
FHL3 links cell growth and self-renewal by modulating SOX4 in glioma.Cell Death Differ. 2019 May;26(5):796-811. doi: 10.1038/s41418-018-0152-1. Epub 2018 Jun 28.
|
| 1524 |
Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy.Int J Cancer. 2010 Feb 15;126(4):919-29. doi: 10.1002/ijc.24851.
|
| 1525 |
Long noncoding RNA AB073614 promotes the malignance of glioma by activating Wnt/-catenin signaling through downregulating SOX7.Oncotarget. 2017 Jul 17;8(39):65577-65587. doi: 10.18632/oncotarget.19305. eCollection 2017 Sep 12.
|
| 1526 |
The unique transcriptional activation domain of nuclear factor-I-X3 is critical to specifically induce marker gene expression in astrocytes.J Biol Chem. 2011 Mar 4;286(9):7315-26. doi: 10.1074/jbc.M110.152421. Epub 2010 Dec 28.
|
| 1527 |
The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma.Cancer Cell. 2014 Jan 13;25(1):64-76. doi: 10.1016/j.ccr.2013.12.006.
|
| 1528 |
Transcription factor PU.1 is involved in the progression of glioma.Oncol Lett. 2018 Mar;15(3):3753-3759. doi: 10.3892/ol.2018.7766. Epub 2018 Jan 10.
|
| 1529 |
Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2.Cell Oncol (Dordr). 2020 Feb;43(1):107-121. doi: 10.1007/s13402-019-00475-7. Epub 2019 Nov 7.
|
| 1530 |
SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3.Am J Cancer Res. 2018 Apr 1;8(4):624-635. eCollection 2018.
|
| 1531 |
Decreased expression of the SPOP gene is associated with poor prognosis in glioma.Int J Oncol. 2015 Jan;46(1):333-41. doi: 10.3892/ijo.2014.2729. Epub 2014 Oct 24.
|
| 1532 |
miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis.Oncol Rep. 2017 Nov;38(5):2717-2726. doi: 10.3892/or.2017.6003. Epub 2017 Sep 26.
|
| 1533 |
Subcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissues.J Exp Clin Cancer Res. 2009 Aug 9;28(1):111. doi: 10.1186/1756-9966-28-111.
|
| 1534 |
The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma.Int J Biochem Cell Biol. 2019 Aug;113:75-86. doi: 10.1016/j.biocel.2019.06.003. Epub 2019 Jun 11.
|
| 1535 |
SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.Cancer Res. 2019 Oct 15;79(20):5288-5301. doi: 10.1158/0008-5472.CAN-19-1504. Epub 2019 Aug 28.
|
| 1536 |
The role of DNA methylation in ST6Gal1 expression in gliomas.Glycobiology. 2016 Dec;26(12):1271-1283. doi: 10.1093/glycob/cww058. Epub 2016 Aug 10.
|
| 1537 |
Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.Int J Oncol. 2018 Apr;52(4):1255-1266. doi: 10.3892/ijo.2018.4266. Epub 2018 Feb 7.
|
| 1538 |
Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion.Neoplasia. 2018 Jun;20(6):543-554. doi: 10.1016/j.neo.2018.04.002. Epub 2018 May 3.
|
| 1539 |
Overexpression of SCLIP promotes growth and motility in glioblastoma cells.Cancer Biol Ther. 2015;16(1):97-105. doi: 10.4161/15384047.2014.987037.
|
| 1540 |
Galectin-9: A Predictive Biomarker Negatively Regulating Immune Response in Glioma Patients.World Neurosurg. 2019 Dec;132:e455-e462. doi: 10.1016/j.wneu.2019.08.117. Epub 2019 Aug 27.
|
| 1541 |
Serine/threonine/tyrosine-interacting-like protein 1 (STYXL1), a pseudo phosphatase, promotes oncogenesis in glioma.Biochem Biophys Res Commun. 2019 Jul 12;515(1):241-247. doi: 10.1016/j.bbrc.2019.05.093. Epub 2019 May 27.
|
| 1542 |
Frequent and variable abnormalities in p14 tumor suppressor gene in glioma cell lines.Brain Tumor Pathol. 2008;25(1):9-17. doi: 10.1007/s10014-007-0226-0. Epub 2008 Apr 16.
|
| 1543 |
Histone methyltransferase SUV39H2 regulates cell growth and chemosensitivity in glioma via regulation of hedgehog signaling.Cancer Cell Int. 2019 Oct 16;19:269. doi: 10.1186/s12935-019-0982-z. eCollection 2019.
|
| 1544 |
Regulation of p53wt glioma cell proliferation by androgen receptor-mediated inhibition of small VCP/p97-interacting protein expression.Oncotarget. 2017 Apr 4;8(14):23142-23154. doi: 10.18632/oncotarget.15509.
|
| 1545 |
Knocking down the expression of SYF2 inhibits the proliferation of glioma cells.Med Oncol. 2014 Aug;31(8):101. doi: 10.1007/s12032-014-0101-x. Epub 2014 Jul 2.
|
| 1546 |
Task-evoked reconfiguration of the fronto-parietal network is associated with cognitive performance in brain tumor patients.Brain Imaging Behav. 2020 Dec;14(6):2351-2366. doi: 10.1007/s11682-019-00189-2.
|
| 1547 |
RNAi-mediated SYT14 knockdown inhibits the growth of human glioma cell line U87MG.Brain Res Bull. 2018 Jun;140:60-64. doi: 10.1016/j.brainresbull.2018.04.002. Epub 2018 Apr 7.
|
| 1548 |
Downregulation of SYT7 inhibits glioblastoma growth by promoting cellular apoptosis.Mol Med Rep. 2017 Dec;16(6):9017-9022. doi: 10.3892/mmr.2017.7723. Epub 2017 Oct 4.
|
| 1549 |
TROY interacts with RKIP to promote glioma development.Oncogene. 2019 Feb;38(9):1544-1559. doi: 10.1038/s41388-018-0503-x. Epub 2018 Oct 18.
|
| 1550 |
-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.Biomed Pharmacother. 2017 Jun;90:368-374. doi: 10.1016/j.biopha.2017.03.083. Epub 2017 Apr 2.
|
| 1551 |
circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma.J Exp Clin Cancer Res. 2019 Sep 11;38(1):398. doi: 10.1186/s13046-019-1376-8.
|
| 1552 |
Long non-coding RNA Linc00320 inhibits glioma cell proliferation through restraining Wnt/-catenin signaling.Biochem Biophys Res Commun. 2019 Jan 8;508(2):458-464. doi: 10.1016/j.bbrc.2018.11.101. Epub 2018 Nov 30.
|
| 1553 |
Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype.Sci Rep. 2017 Jan 3;7:39011. doi: 10.1038/srep39011.
|
| 1554 |
Lentivirus-Mediated Knockdown of TCTN1 Inhibits Glioma Cell Proliferation.Appl Biochem Biotechnol. 2015 May;176(1):13-21. doi: 10.1007/s12010-015-1498-1. Epub 2015 Mar 4.
|
| 1555 |
Ten-eleven translocation 1 regulates methylation of autophagy-related genes in human glioma.Neuroreport. 2018 Jun 13;29(9):731-738. doi: 10.1097/WNR.0000000000001024.
|
| 1556 |
Integrin 6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells.Oncogene. 2020 Mar;39(10):2156-2169. doi: 10.1038/s41388-019-1134-6. Epub 2019 Dec 9.
|
| 1557 |
Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells.J Pineal Res. 2019 Apr;66(3):e12556. doi: 10.1111/jpi.12556. Epub 2019 Feb 14.
|
| 1558 |
Trefoil factor 3 contributes to the malignancy of glioma via regulating HIF-1.Oncotarget. 2017 Aug 7;8(44):76770-76782. doi: 10.18632/oncotarget.20010. eCollection 2017 Sep 29.
|
| 1559 |
Knockdown of TFPI-2 promotes migration and invasion of glioma cells.Neurosci Lett. 2011 Jun 15;497(1):49-54. doi: 10.1016/j.neulet.2011.04.027. Epub 2011 Apr 20.
|
| 1560 |
Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells.Cancer Manag Res. 2019 Jul 25;11:6995-7006. doi: 10.2147/CMAR.S208984. eCollection 2019.
|
| 1561 |
MiR-129-5p inhibits glioma cell progression invitro and invivo by targeting TGIF2.J Cell Mol Med. 2018 Apr;22(4):2357-2367. doi: 10.1111/jcmm.13529. Epub 2018 Feb 12.
|
| 1562 |
Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma.Neuropathology. 2000 Sep;20(3):161-9. doi: 10.1046/j.1440-1789.2000.00327.x.
|
| 1563 |
Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.Cell Physiol Biochem. 2018;46(1):279-290. doi: 10.1159/000488429. Epub 2018 Mar 22.
|
| 1564 |
The analysis of deregulated expression of the timeless genes in gliomas.J Cancer Res Ther. 2018 Sep;14(Supplement):S708-S712. doi: 10.4103/0973-1482.187382.
|
| 1565 |
Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence.Biomed Pharmacother. 2019 Oct;118:109369. doi: 10.1016/j.biopha.2019.109369. Epub 2019 Sep 1.
|
| 1566 |
Knockdown of TMEM45A inhibits the proliferation, migration and invasion of glioma cells.Int J Clin Exp Pathol. 2015 Oct 1;8(10):12657-67. eCollection 2015.
|
| 1567 |
Molecular and clinical characterization of TMEM71 expression at the transcriptional level in glioma.CNS Neurosci Ther. 2019 Sep;25(9):965-975. doi: 10.1111/cns.13137. Epub 2019 Jun 10.
|
| 1568 |
Actin-capping protein CapG is associated with prognosis, proliferation and metastasis in human glioma.Oncol Rep. 2018 Mar;39(3):1011-1022. doi: 10.3892/or.2018.6225. Epub 2018 Jan 22.
|
| 1569 |
Knockdown of TMPRSS3 inhibits cell proliferation, migration/invasion and induces apoptosis of glioma cells.J Cell Biochem. 2019 May;120(5):7794-7801. doi: 10.1002/jcb.28054. Epub 2018 Nov 15.
|
| 1570 |
MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.J Exp Clin Cancer Res. 2015 Mar 26;34(1):27. doi: 10.1186/s13046-015-0142-9.
|
| 1571 |
TIPE2 Inhibits Hypoxia-Induced Wnt/-Catenin Pathway Activation and EMT in Glioma Cells.Oncol Res. 2016;24(4):255-61. doi: 10.3727/096504016X14666990347356.
|
| 1572 |
CD30 ligand deficiency accelerates glioma progression by promoting the formation of tumor immune microenvironment.Int Immunopharmacol. 2019 Jun;71:350-360. doi: 10.1016/j.intimp.2019.03.055. Epub 2019 Apr 2.
|
| 1573 |
TNIP1-mediated TNF-/NF-B signalling cascade sustains glioma cell proliferation.J Cell Mol Med. 2020 Jan;24(1):530-538. doi: 10.1111/jcmm.14760. Epub 2019 Nov 5.
|
| 1574 |
Silencing of Mig-7 expression inhibits in-vitro invasiveness and vasculogenic mimicry of human glioma U87 Cells.Neuroreport. 2019 Dec 10;30(17):1135-1142. doi: 10.1097/WNR.0000000000001317.
|
| 1575 |
TP53INP1 3'-UTR functions as a ceRNA in repressing the metastasis of glioma cells by regulating miRNA activity.Biotechnol Lett. 2016 Oct;38(10):1699-707. doi: 10.1007/s10529-016-2159-3. Epub 2016 Jun 24.
|
| 1576 |
Lentivirus-mediated knockdown of tumor protein D52-like 2 inhibits glioma cell proliferation.Cell Mol Biol (Noisy-le-grand). 2014 May 11;60(1):39-44.
|
| 1577 |
Silencing of the TPM1 gene induces radioresistance of glioma U251 cells.Oncol Rep. 2015 Jun;33(6):2807-14. doi: 10.3892/or.2015.3906. Epub 2015 Apr 8.
|
| 1578 |
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.Br J Cancer. 2018 Sep;119(6):693-696. doi: 10.1038/s41416-018-0251-2. Epub 2018 Sep 17.
|
| 1579 |
Role of the microtubule-associated TPPP/p25 in Parkinson's and related diseases and its therapeutic potential.Expert Rev Proteomics. 2017 Apr;14(4):301-309. doi: 10.1080/14789450.2017.1304216. Epub 2017 Mar 15.
|
| 1580 |
TRA2A promotes proliferation, migration, invasion and epithelial mesenchymal transition of glioma cells.Brain Res Bull. 2018 Oct;143:138-144. doi: 10.1016/j.brainresbull.2018.10.006. Epub 2018 Oct 24.
|
| 1581 |
Knocking down the expression of TRA2 inhibits the proliferation and migration of human glioma cells.Pathol Res Pract. 2015 Oct;211(10):731-9. doi: 10.1016/j.prp.2015.04.014. Epub 2015 May 21.
|
| 1582 |
microRNA response elementregulated TIKI2 expression suppresses the tumorigencity of malignant gliomas.Mol Med Rep. 2014 Oct;10(4):2079-86. doi: 10.3892/mmr.2014.2412. Epub 2014 Jul 22.
|
| 1583 |
Cytoplasmic TRADD confers a worse prognosis in glioblastoma.Neoplasia. 2013 Aug;15(8):888-97. doi: 10.1593/neo.13608.
|
| 1584 |
A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma.Glia. 2014 Jun;62(6):971-81. doi: 10.1002/glia.22655. Epub 2014 Mar 2.
|
| 1585 |
TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells.J Exp Clin Cancer Res. 2016 Jun 21;35(1):100. doi: 10.1186/s13046-016-0379-y.
|
| 1586 |
Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma.Cancer Epidemiol. 2012 Jun;36(3):283-7. doi: 10.1016/j.canep.2011.12.011. Epub 2012 Feb 26.
|
| 1587 |
Inhibition of tribbles protein-1 attenuates radioresistance in human glioma cells.Sci Rep. 2015 Nov 2;5:15961. doi: 10.1038/srep15961.
|
| 1588 |
TRIM14 promotes chemoresistance in gliomas by activating Wnt/-catenin signaling via stabilizing Dvl2.Oncogene. 2018 Oct;37(40):5403-5415. doi: 10.1038/s41388-018-0344-7. Epub 2018 Jun 4.
|
| 1589 |
Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma.Cancer Res. 2014 Aug 15;74(16):4536-48. doi: 10.1158/0008-5472.CAN-13-3703. Epub 2014 Jun 19.
|
| 1590 |
TRIM31 promotes glioma proliferation and invasion through activating NF-B pathway.Onco Targets Ther. 2019 Mar 27;12:2289-2297. doi: 10.2147/OTT.S183625. eCollection 2019.
|
| 1591 |
TRIM45 functions as a tumor suppressor in the brain via its E3 ligase activity by stabilizing p53 through K63-linked ubiquitination.Cell Death Dis. 2017 May 25;8(5):e2831. doi: 10.1038/cddis.2017.149.
|
| 1592 |
TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival.BMC Cancer. 2015 Jun 16;15:470. doi: 10.1186/s12885-015-1449-9.
|
| 1593 |
The roles of TRIO and F-actin-binding protein in glioblastoma cells.Mol Med Rep. 2018 Mar;17(3):4540-4546. doi: 10.3892/mmr.2018.8458. Epub 2018 Jan 18.
|
| 1594 |
MiR-338-5p Promotes Glioma Cell Invasion by Regulating TSHZ3 and MMP2.Cell Mol Neurobiol. 2018 Apr;38(3):669-677. doi: 10.1007/s10571-017-0525-x. Epub 2017 Aug 5.
|
| 1595 |
Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers.Lab Invest. 2008 Feb;88(2):153-60. doi: 10.1038/labinvest.3700706. Epub 2007 Dec 3.
|
| 1596 |
Comparative proteomic analysis of cat eye syndrome critical region protein 1- function in tumor-associated macrophages and immune response regulation of glial tumors.Oncotarget. 2018 Sep 11;9(71):33500-33514. doi: 10.18632/oncotarget.26063. eCollection 2018 Sep 11.
|
| 1597 |
The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression.PLoS One. 2011;6(10):e25631. doi: 10.1371/journal.pone.0025631. Epub 2011 Oct 12.
|
| 1598 |
EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.Neuroreport. 2010 Nov 17;21(16):1018-22. doi: 10.1097/WNR.0b013e32833f19f2.
|
| 1599 |
Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival.J Neurooncol. 2010 Mar;97(1):33-40. doi: 10.1007/s11060-009-0004-4. Epub 2009 Aug 25.
|
| 1600 |
MMP-9 silencing regulates hTERT expression via 1 integrin-mediated FAK signaling and induces senescence in glioma xenograft cells.Cell Signal. 2011 Dec;23(12):2065-75. doi: 10.1016/j.cellsig.2011.08.001. Epub 2011 Aug 9.
|
| 1601 |
Construction of a ganciclovir-sensitive lentiviral vector to assess the influence of angiopoietin-3 and soluble Tie2 on glioma growth.J Neurooncol. 2010 Aug;99(1):1-11. doi: 10.1007/s11060-009-0095-y. Epub 2009 Dec 18.
|
| 1602 |
Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN. Laboratory investigation.J Neurosurg. 2008 Feb;108(2):299-303. doi: 10.3171/JNS/2008/108/2/0299.
|
| 1603 |
Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.Oncol Rep. 2008 Aug;20(2):301-8.
|
| 1604 |
MicroRNA-105 targets SOX9 and inhibits human glioma cell progression.FEBS Lett. 2016 Dec;590(23):4329-4342. doi: 10.1002/1873-3468.12458. Epub 2016 Nov 23.
|
| 1605 |
Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy.BMC Cancer. 2011 Jul 26;11:315. doi: 10.1186/1471-2407-11-315.
|
| 1606 |
The BH3 only Bcl-2 family member BNIP3 regulates cellular proliferation.PLoS One. 2018 Oct 11;13(10):e0204792. doi: 10.1371/journal.pone.0204792. eCollection 2018.
|
| 1607 |
Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation.Oncol Res. 2010;18(8):359-64. doi: 10.3727/096504010x12644422320582.
|
| 1608 |
Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.Neoplasia. 2016 Mar;18(3):185-98. doi: 10.1016/j.neo.2016.02.003.
|
| 1609 |
MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14.Biomed Pharmacother. 2018 Feb;98:636-642. doi: 10.1016/j.biopha.2017.12.044. Epub 2017 Dec 29.
|
| 1610 |
Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation.Exp Cell Res. 2008 Dec 10;314(20):3701-11. doi: 10.1016/j.yexcr.2008.09.022. Epub 2008 Oct 7.
|
| 1611 |
Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma.Hum Mol Genet. 2008 Mar 15;17(6):800-5. doi: 10.1093/hmg/ddm351. Epub 2007 Nov 29.
|
| 1612 |
Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q.Oncogene. 2007 Jul 26;26(34):5010-6. doi: 10.1038/sj.onc.1210297. Epub 2007 Feb 19.
|
| 1613 |
The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma.Oncogene. 2010 Nov 18;29(46):6138-48. doi: 10.1038/onc.2010.342. Epub 2010 Aug 16.
|
| 1614 |
Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.Cancer Res. 2010 Dec 1;70(23):9730-41. doi: 10.1158/0008-5472.CAN-10-1882. Epub 2010 Nov 23.
|
| 1615 |
MiR-448 downregulates CTTN to inhibit cell proliferation and promote apoptosis in glioma.Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3847-3854. doi: 10.26355/eurrev_201806_15269.
|
| 1616 |
Knockdown of cytoglobin expression sensitizes human glioma cells to radiation and oxidative stress.Radiat Res. 2011 Aug;176(2):198-207. doi: 10.1667/rr2517.1. Epub 2011 Jun 1.
|
| 1617 |
SCCRO promotes glioma formation and malignant progression in mice.Neoplasia. 2010 Jun;12(6):476-84. doi: 10.1593/neo.10202.
|
| 1618 |
Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31.Neuropathol Appl Neurobiol. 2017 Aug;43(5):419-432. doi: 10.1111/nan.12321. Epub 2016 Apr 28.
|
| 1619 |
Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion.Oncogene. 2009 Feb 5;28(5):752-61. doi: 10.1038/onc.2008.431. Epub 2008 Dec 1.
|
| 1620 |
Clinico-pathological significance of RCAS1 expression in gliomas: a potential mechanism of tumor immune escape.Cancer Lett. 2007 Feb 8;246(1-2):182-9. doi: 10.1016/j.canlet.2006.02.021. Epub 2006 Apr 3.
|
| 1621 |
ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1.Neuro Oncol. 2011 Nov;13(11):1202-12. doi: 10.1093/neuonc/nor119. Epub 2011 Aug 16.
|
| 1622 |
Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.Am J Epidemiol. 2011 Sep 1;174(5):574-81. doi: 10.1093/aje/kwr124. Epub 2011 Jul 8.
|
| 1623 |
Reduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomas.J Biol Chem. 2009 Sep 25;284(39):26547-56. doi: 10.1074/jbc.M109.013185. Epub 2009 Jul 24.
|
| 1624 |
The effect of quercetin and imperatorin on programmed cell death induction in T98G cells in vitro.Pharmacol Rep. 2014 Apr;66(2):292-300. doi: 10.1016/j.pharep.2013.10.003. Epub 2014 Mar 4.
|
| 1625 |
IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway.Oncotarget. 2017 Jul 25;8(30):49502-49514. doi: 10.18632/oncotarget.17738.
|
| 1626 |
IQGAP1siRNA inhibits proliferation and metastasis of U251 and U373 glioma cell lines.Mol Med Rep. 2017 Apr;15(4):2074-2082. doi: 10.3892/mmr.2017.6257. Epub 2017 Feb 28.
|
| 1627 |
Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma.Glia. 2010 Apr;58(5):524-37. doi: 10.1002/glia.20941.
|
| 1628 |
p73 poses a barrier to malignant transformation by limiting anchorage-independent growth.EMBO J. 2008 Mar 5;27(5):792-803. doi: 10.1038/emboj.2008.13. Epub 2008 Jan 31.
|
| 1629 |
MicroRNA-424 inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting KIF23 and functions as a novel prognostic predictor.Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6369-6378. doi: 10.26355/eurrev_201810_16049.
|
| 1630 |
Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood.Neoplasia. 2009 Jul;11(7):700-11. doi: 10.1593/neo.09406.
|
| 1631 |
Association and interactions between DNA repair gene polymorphisms and adult glioma.Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):204-14. doi: 10.1158/1055-9965.EPI-08-0632.
|
| 1632 |
Association of LIG4 and XRCC4 gene polymorphisms with the risk of human glioma in a Chinese population.Int J Clin Exp Pathol. 2015 Feb 1;8(2):2057-62. eCollection 2015.
|
| 1633 |
MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival.Mol Cancer Ther. 2007 Apr;6(4):1212-22. doi: 10.1158/1535-7163.MCT-06-0711. Epub 2007 Apr 3.
|
| 1634 |
Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.Cancer Lett. 2015 Apr 1;359(1):87-96. doi: 10.1016/j.canlet.2014.12.049. Epub 2015 Jan 8.
|
| 1635 |
Expression of 58-kD Microspherule Protein (MSP58) is Highly Correlated with PET Imaging of Tumor Malignancy and Cell Proliferation in Glioma Patients.Cell Physiol Biochem. 2016;38(2):635-45. doi: 10.1159/000438656. Epub 2016 Feb 8.
|
| 1636 |
Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels.Cell Tissue Res. 2013 Nov;354(2):409-30. doi: 10.1007/s00441-013-1704-9. Epub 2013 Aug 21.
|
| 1637 |
Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.Cell Mol Neurobiol. 2016 Nov;36(8):1303-1310. doi: 10.1007/s10571-016-0328-5. Epub 2016 Feb 15.
|
| 1638 |
Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.Cell Mol Life Sci. 2009 Dec;66(24):3967-78. doi: 10.1007/s00018-009-0157-5. Epub 2009 Sep 27.
|
| 1639 |
Neuroglobin promotes the proliferation and suppresses the apoptosis of glioma cells by activating the PI3K/AKT pathway.Mol Med Rep. 2018 Feb;17(2):2757-2763. doi: 10.3892/mmr.2017.8132. Epub 2017 Nov 22.
|
| 1640 |
Role of GLTSCR2 in the regulation of telomerase activity and chromosome stability.Mol Med Rep. 2016 Aug;14(2):1697-703. doi: 10.3892/mmr.2016.5427. Epub 2016 Jun 23.
|
| 1641 |
Knockdown of long non-coding RNA XIST increases blood-tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137.Oncogenesis. 2017 Mar 13;6(3):e303. doi: 10.1038/oncsis.2017.7.
|
| 1642 |
Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.Neuropathol Appl Neurobiol. 2007 Feb;33(1):77-85. doi: 10.1111/j.1365-2990.2006.00786.x.
|
| 1643 |
The importance of expressing PDCD4 and PDCD5 anti-oncogenes in glioma.J Biol Regul Homeost Agents. 2018 May-Jun;32(3):731-736.
|
| 1644 |
Sumoylation of vimentin354 is associated with PIAS3 inhibition of glioma cell migration.Oncotarget. 2010 Nov;1(7):620-627. doi: 10.18632/oncotarget.196.
|
| 1645 |
Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance.Neuro Oncol. 2010 Jul;12(7):679-86. doi: 10.1093/neuonc/nop074. Epub 2010 Feb 17.
|
| 1646 |
Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene.Mol Ther. 2007 Jul;15(7):1373-81. doi: 10.1038/sj.mt.6300155. Epub 2007 Apr 24.
|
| 1647 |
Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines.Brain. 2009 Aug;132(Pt 8):2277-88. doi: 10.1093/brain/awp153. Epub 2009 Jun 8.
|
| 1648 |
Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.Carcinogenesis. 2014 Aug;35(8):1901-10. doi: 10.1093/carcin/bgu123. Epub 2014 May 29.
|
| 1649 |
Mutational analysis of Rac2 in gliomas.J Neurooncol. 2008 May;87(3):365-6. doi: 10.1007/s11060-008-9521-9. Epub 2008 Jan 24.
|
| 1650 |
Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk.Carcinogenesis. 2010 Oct;31(10):1762-9. doi: 10.1093/carcin/bgq141. Epub 2010 Jul 7.
|
| 1651 |
MiRNA-93 functions as an oncogene in glioma by directly targeting RBL2.Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2343-2350. doi: 10.26355/eurrev_201804_14825.
|
| 1652 |
REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.Neuro Oncol. 2009 Dec;11(6):790-802. doi: 10.1215/15228517-2009-015.
|
| 1653 |
Knockdown of the potential cancer stem-like cell marker Rex-1 improves chemotherapeutic effects in gliomas.Hum Gene Ther. 2011 Dec;22(12):1551-62. doi: 10.1089/hum.2011.096. Epub 2011 Sep 29.
|
| 1654 |
Identification of an epigenetically silenced gene, RFX1, in human glioma cells using restriction landmark genomic scanning.Oncogene. 2004 Oct 14;23(47):7772-9. doi: 10.1038/sj.onc.1208058.
|
| 1655 |
Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome.Int J Cancer. 2009 Dec 1;125(11):2624-30. doi: 10.1002/ijc.24639.
|
| 1656 |
Transfection with liver-type glutaminase cDNA alters gene expression and reduces survival, migration and proliferation of T98G glioma cells.Glia. 2009 Jul;57(9):1014-23. doi: 10.1002/glia.20825.
|
| 1657 |
Targeting human glioma cells using HSV-1 amplicon peptide display vector.Gene Ther. 2010 Feb;17(2):250-60. doi: 10.1038/gt.2009.128. Epub 2009 Oct 8.
|
| 1658 |
Effects of syndecan-1 on the expression of syntenin and the migration of U251 glioma cells.Oncol Lett. 2017 Dec;14(6):7217-7224. doi: 10.3892/ol.2017.7170. Epub 2017 Oct 11.
|
| 1659 |
SERPINA3 induced by astroglia/microglia co-culture facilitates glioblastoma stem-like cell invasion.Oncol Lett. 2018 Jan;15(1):285-291. doi: 10.3892/ol.2017.7275. Epub 2017 Oct 26.
|
| 1660 |
Hydrogen Peroxide-Induced Secreted Frizzled-Related Protein 1 Gene Demethylation Contributes to Hydrogen Peroxide-Induced Apoptosis in Human U251 Glioma Cells.DNA Cell Biol. 2017 May;36(5):347-353. doi: 10.1089/dna.2016.3594. Epub 2017 Feb 28.
|
| 1661 |
Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma.Carcinogenesis. 2007 Sep;28(9):1906-13. doi: 10.1093/carcin/bgm073. Epub 2007 Mar 26.
|
| 1662 |
Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells.Int J Cancer. 2011 Jul 1;129(1):45-60. doi: 10.1002/ijc.25647. Epub 2010 Nov 9.
|
| 1663 |
Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2.J Biol Chem. 2008 Feb 8;283(6):3365-3375. doi: 10.1074/jbc.M708241200. Epub 2007 Nov 30.
|
| 1664 |
MiR-21 enhanced glioma cells resistance to carmustine via decreasing Spry2 expression.Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5065-5071. doi: 10.26355/eurrev_201711_13819.
|
| 1665 |
Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo.Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12646-51. doi: 10.1073/pnas.0909862107. Epub 2010 Jun 28.
|
| 1666 |
EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.Mol Cancer Res. 2018 Jul;16(7):1185-1195. doi: 10.1158/1541-7786.MCR-18-0125. Epub 2018 May 3.
|
| 1667 |
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature. 2014 Oct 9;514(7521):247-51.
|
| 1668 |
Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells.Cancer Res. 2008 Jun 15;68(12):4614-22. doi: 10.1158/0008-5472.CAN-07-5291.
|
| 1669 |
si-TP73-AS1 suppressed proliferation and increased the chemotherapeutic response of GC cells to cisplatin.Oncol Lett. 2018 Sep;16(3):3706-3714. doi: 10.3892/ol.2018.9107. Epub 2018 Jul 10.
|
| 1670 |
Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model.J Neurooncol. 2013 Aug;114(1):33-42. doi: 10.1007/s11060-013-1158-7. Epub 2013 May 22.
|
|
|
|
|
|
|
